"_id","cohorts.0.id","cohorts.0.label","dataUseConditions.id","dataUseConditions.label","description","externalReferences.0.id","externalReferences.0.label","followupState.id","followupState.label","histologicalDiagnosis.id","histologicalDiagnosis.label","icdoMorphology.id","icdoMorphology.label","icdoTopography.id","icdoTopography.label","id","individualId","info.callsetIds.0","info.cnvstatistics.cnvcoverage","info.cnvstatistics.cnvfraction","info.cnvstatistics.delcoverage","info.cnvstatistics.delfraction","info.cnvstatistics.dupcoverage","info.cnvstatistics.dupfraction","info.legacyId.0","pathologicalStage","provenance.geoLocation.geometry.coordinates.0","provenance.geoLocation.geometry.coordinates.1","provenance.geoLocation.geometry.type","provenance.geoLocation.properties.ISO3166alpha3","provenance.geoLocation.properties.city","provenance.geoLocation.properties.country","provenance.geoLocation.properties.label","provenance.geoLocation.properties.latitude","provenance.geoLocation.properties.longitude","provenance.geoLocation.properties.precision","provenance.geoLocation.type","provenance.material.id","provenance.material.label","sampledTissue.id","sampledTissue.label","tumorGrade","updated","info.tnm","pathologicalStage.id","pathologicalStage.label","pathologicalTnmFindings.0.id","pathologicalTnmFindings.0.label","individualAgeAtCollection","externalReferences.1.id","externalReferences.1.label","info.death","info.followupMonths","tumorGrade.id","tumorGrade.label","cohorts.1.id","cohorts.1.label","cohorts.2.id","cohorts.2.label","externalReferences.0.description","externalReferences.1.description","externalReferences.2.description","externalReferences.2.id","externalReferences.2.label","info.tumorStage","cohorts.3.id","cohorts.3.label","externalReferences.3.description","externalReferences.3.id","externalReferences.3.label","info.provenance","provenance.populations.0.confidence","provenance.populations.0.description","provenance.populations.0.type.id","provenance.populations.0.type.label","provenance.populations.1.confidence","provenance.populations.1.description","provenance.populations.1.type.id","provenance.populations.1.type.label","externalReferences.4.description","externalReferences.4.id","externalReferences.4.label","cohorts.4.id","cohorts.4.label","info.cellLine","info.samplesource","info.seer"
"5bab56c0727983b2e00aaa1b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial sarcoma [poorly differentiated]","PMID:9790501","Szymanska J, Serra M et al. (1998): Genetic imbalances in 67 synovial sarcomas...","pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovial sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva5ye","pgxind-kftx264u","pgxcs-kftvli3x",116974859,0.041,0,0,116974859,0.041,"PGX_AM_BS_SynSarc-36","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.716000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaab7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Small tumor, less than 5 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65i","pgxind-kftx26dd","pgxcs-kftvlkaz",361397723,0.126,236354617,0.082,125043106,0.043,"PGX_AM_BS_STLMS-04","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.935000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaabc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65q","pgxind-kftx26dn","pgxcs-kftvlkdg",577678438,0.201,354453752,0.123,223224686,0.078,"PGX_AM_BS_STLMS-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.942000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva65y","pgxind-kftx26dx","pgxcs-kftvlkfw",585845331,0.204,256645000,0.089,329200331,0.115,"PGX_AM_BS_STLMS-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.949000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva663","pgxind-kftx26e3","pgxcs-kftvlkhi",1709417508,0.595,628026650,0.218,1081390858,0.376,"PGX_AM_BS_STLMS-17","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.953000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva667","pgxind-kftx26e7","pgxcs-kftvlkii",1444245444,0.502,297997091,0.104,1146248353,0.399,"PGX_AM_BS_STLMS-19","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.956000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaac7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Large tumor, between 5 and 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva669","pgxind-kftx26e9","pgxcs-kftvlkj0",1595707744,0.555,19100019,0.007,1576607725,0.548,"PGX_AM_BS_STLMS-20","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.958000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaacb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Very large tumor, more than 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva66f","pgxind-kftx26eg","pgxcs-kftvlkl2",960384723,0.334,278043257,0.097,682341466,0.237,"PGX_AM_BS_STLMS-24","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.964000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaacc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Very large tumor, more than 20 cm]","PMID:9736047","El-Rifai W, Sarlomo-Rikala M et al. (1998): DNA copy number changes in development...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftva66h","pgxind-kftx26ei","pgxcs-kftvlklk",1300615395,0.452,214931123,0.075,1085684272,0.378,"PGX_AM_BS_STLMS-25","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:05.965000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad1f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage III]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghiw","pgxind-kftx27be","pgxcs-kftvlssx",243174985,0.085,48000048,0.017,195174937,0.068,"PGX_AM_BS_AEB-9327749-13",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.799000","T3","NCITstage-C27970","Stage III","TNM-C48728","T3 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad21","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage III]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghiz","pgxind-kftx27bi","pgxcs-kftvlstu",860444649,0.299,48514605,0.017,811930044,0.282,"PGX_AM_BS_AEB-9327749-15",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.802000","T3","NCITstage-C27970","Stage III","TNM-C48728","T3 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad44","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage III]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghkk","pgxind-kftx27dg","pgxcs-kftvltaa",97200097,0.034,0,0,97200097,0.034,"PGX_AM_BS_AEB-9327749-47",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.851000","T3","NCITstage-C27970","Stage III","TNM-C48728","T3 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad46","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage III]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghkn","pgxind-kftx27dk","pgxcs-kftvltb9",241714798,0.084,205314762,0.071,36400036,0.013,"PGX_AM_BS_AEB-9327749-49",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.854000","T3","NCITstage-C27970","Stage III","TNM-C48728","T3 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad4c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage IV]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghkx","pgxind-kftx27dw","pgxcs-kftvlte4",517151595,0.18,0,0,517151595,0.18,"PGX_AM_BS_AEB-9327749-54",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.862000","T4","NCITstage-C27971","Stage IV","TNM-C48732","T4 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad4d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [stage IV]","PMID:9327749","Larramendy ML, Tarkkanen M et al. (1997): Comparative genomic hybridization of malignant fibrous...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvghkz","pgxind-kftx27dy","pgxcs-kftvltel",1198239973,0.417,125600124,0.044,1072639849,0.373,"PGX_AM_BS_AEB-9327749-55",,24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:06.863000","T4","NCITstage-C27971","Stage IV","TNM-C48732","T4 Stage Finding",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aad87","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:9290705","Packenham JP et al. (1997): Analysis of genetic alterations in uterine...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvghnm","pgxind-kftx27h5","pgxcs-kftvlu7p",179710885,0.063,122674864,0.043,57036021,0.02,"PGX_AM_BS_UtLeio-8","{}",-78.9,35.99,"Point","USA","Durham","United States of America","Durham, United States",35.99,-78.9,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:06.945000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaea7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi0s","pgxind-kftx27x2","pgxcs-kftvly3p",507482721,0.177,51800051,0.018,455682670,0.158,"PGX_AM_BS_ChonSar-lar-08c","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.348000",,,,,,"P64Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi0z","pgxind-kftx27xb","pgxcs-kftvly5k",160820851,0.056,0,0,160820851,0.056,"PGX_AM_BS_ChonSar-lar-12a","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.354000",,,,,,"P37Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaead","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi12","pgxind-kftx27xf","pgxcs-kftvly6h",1176759512,0.409,0,0,1176759512,0.409,"PGX_AM_BS_ChonSar-lar-13","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.356000",,,,,,"P78Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi14","pgxind-kftx27xh","pgxcs-kftvly6y",1176032468,0.409,51800051,0.018,1124232417,0.391,"PGX_AM_BS_ChonSar-lar-14a","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.358000",,,,,,"P34Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi17","pgxind-kftx27xl","pgxcs-kftvly7w",923042480,0.321,0,0,923042480,0.321,"PGX_AM_BS_ChonSar-lar-15","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.361000",,,,,,"P72Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1a","pgxind-kftx27xp","pgxcs-kftvly8u",1358149599,0.472,0,0,1358149599,0.472,"PGX_AM_BS_ChonSar-lar-17a","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.364000",,,,,,"P52Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1i","pgxind-kftx27xy","pgxcs-kftvlyb7",1786212027,0.621,373352757,0.13,1412859270,0.491,"PGX_AM_BS_ChonSar-lar-21","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.371000",,,,,,"P27Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1k","pgxind-kftx27y0","pgxcs-kftvlybo",610853469,0.212,110306090,0.038,500547379,0.174,"PGX_AM_BS_ChonSar-lar-22","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.372000",,,,,,"P43Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaeb9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma, NOS","PMID:9033281","Larramendy ML, Tarkkanen M et al. (1997): Gains, losses, and amplifications of DNA...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi1m","pgxind-kftx27y2","pgxcs-kftvlyc4",1144199139,0.398,0,0,1144199139,0.398,"PGX_AM_BS_ChonSar-lar-23","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.374000",,,,,,"P53Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaf0f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","liposarcoma [well differentiated]","PMID:8834171","Szymanska J, Tarkkanen M et al. (1996): Gains and losses of DNA sequences...","pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi5i","pgxind-kftx282v","pgxcs-kftvlzia",409071604,0.142,252157789,0.088,156913815,0.055,"PGX_AM_BS_8834171-szy-04","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.496000",,,,,,"P47Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaf13","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","liposarcoma","PMID:8834171","Szymanska J, Tarkkanen M et al. (1996): Gains and losses of DNA sequences...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi5o","pgxind-kftx2832","pgxcs-kftvlzk5",510080262,0.177,144524607,0.05,365555655,0.127,"PGX_AM_BS_8834171-szy-07b","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.501000",,,,,,"P31Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaf17","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","liposarcoma [dedifferentiated]","PMID:8834171","Szymanska J, Tarkkanen M et al. (1996): Gains and losses of DNA sequences...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi5v","pgxind-kftx283b","pgxcs-kftvlzm0",1200755658,0.418,604911059,0.21,595844599,0.207,"PGX_AM_BS_8834171-szy-11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.507000",,,,,,"P71Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c0727983b2e00aaf1a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","liposarcoma [pleomorphic]","PMID:8834171","Szymanska J, Tarkkanen M et al. (1996): Gains and losses of DNA sequences...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgi60","pgxind-kftx283h","pgxcs-kftvlzp6",944804039,0.329,191414748,0.067,753389291,0.262,"PGX_AM_BS_8834171-szy-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:07.511000",,,,,,"P63Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c1727983b2e00ab69d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","well-differentiated and dedifferentiated liposarcoma","PMID:22678079","Pedeutour F, Maire G et al. (2012): A newly characterized human well-differentiated liposarcoma...","pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgklh","pgxind-kftx2b21","pgxcs-kftvmq1w",396418119,0.138,0,0,396418119,0.138,"PGX_AM_BS_22678079_WDLPS-ped-01","{}",7.27,43.7,"Point","FRA","Nice","France","Nice, France",43.7,7.27,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:10.244000",,,,,,"P43Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c2727983b2e00ac044","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial sarcoma [cell line Fuji]","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...","pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovial sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgnpv","pgxind-kftx2ev1","pgxcs-kftvnnkh",365637647,0.127,109042790,0.038,256594857,0.089,"PGX_AM_BS_20164920_Fuji","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:13.758000",,,,,,,"geo:GSE19399",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac0c5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Liposarcoma NOS [cell line LiSa-2]","geo:GSE19399",,"pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgnvo","pgxind-kftx2f2b","pgxcs-kftvnpan",562749248,0.196,246180581,0.086,316568667,0.11,"PGX_AM_BS_20164920_LiSa-2","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:13.940000",,,,,,,"PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac21a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial sarcoma [cell line SYO-1]","geo:GSE19399",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovial sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgoba","pgxind-kftx2flm","pgxcs-kftvnty7",471430364,0.164,140350029,0.049,331080335,0.115,"PGX_AM_BS_20164920_SYO-1","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:14.407000",,,,,,,"PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac250","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Upper trunk]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgodq","pgxind-kftx2foo","pgxcs-kftvnupl",1329127181,0.462,307514884,0.107,1021612297,0.355,"PGX_AM_BS_20159821_MPNST-bre-013","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.481000",,,,,,"P26Y",,,"1",79,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac252","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Retroperitoneum]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgodu","pgxind-kftx2fos","pgxcs-kftvnuqj",1636953920,0.569,725961202,0.253,910992718,0.317,"PGX_AM_BS_20159821_MPNST-bre-021","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.484000",,,,,,"P18Y",,,"1",15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac254","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgodx","pgxind-kftx2fow","pgxcs-kftvnuri",1937835042,0.674,951076918,0.331,986758124,0.343,"PGX_AM_BS_20159821_MPNST-bre-024","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.487000",,,,,,"P41Y",,,"0",122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac255","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgodz","pgxind-kftx2foy","pgxcs-kftvnus0",1165492623,0.405,135327390,0.047,1030165233,0.358,"PGX_AM_BS_20159821_MPNST-bre-026","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.489000",,,,,,"P22Y",,,"1",20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac256","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lower trunk]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoe0","pgxind-kftx2fp0","pgxcs-kftvnusg",2763479032,0.961,1140622209,0.397,1622856823,0.564,"PGX_AM_BS_20159821_MPNST-bre-029","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.490000",,,,,,"P33Y",,,"1",15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac257","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Buttock]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoe2","pgxind-kftx2fp2","pgxcs-kftvnusy",1104109901,0.384,446385191,0.155,657724710,0.229,"PGX_AM_BS_20159821_MPNST-bre-032","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.492000",,,,,,"P77Y",,,"1",12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac259","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Pelvis]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoe5","pgxind-kftx2fp5","pgxcs-kftvnutw",1851316984,0.644,604400129,0.21,1246916855,0.434,"PGX_AM_BS_20159821_MPNST-bre-035","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.494000",,,,,,"P42Y",,,"1",12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac25d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lower trunk]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoec","pgxind-kftx2fpe","pgxcs-kftvnuvs",1163881456,0.405,586567547,0.204,577313909,0.201,"PGX_AM_BS_20159821_MPNST-bre-043","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.500000",,,,,,"P14Y",,,"0",105,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac25e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoee","pgxind-kftx2fpg","pgxcs-kftvnuwa",2617449835,0.91,989113185,0.344,1628336650,0.566,"PGX_AM_BS_20159821_MPNST-bre-044","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.501000",,,,,,"P17Y",,,"1",5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac260","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoeh","pgxind-kftx2fpk","pgxcs-kftvnux8",1486291449,0.517,644670186,0.224,841621263,0.293,"PGX_AM_BS_20159821_MPNST-bre-048","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.504000",,,,,,"P35Y",,,"1",12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac262","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Leg]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoek","pgxind-kftx2fpo","pgxcs-kftvnuy6",1254288828,0.436,423375067,0.147,830913761,0.289,"PGX_AM_BS_20159821_MPNST-bre-050","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.507000",,,,,,"P30Y",,,"0",133,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac263","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Buttock]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoem","pgxind-kftx2fpq","pgxcs-kftvnuyn",1984268799,0.69,489597598,0.17,1494671201,0.52,"PGX_AM_BS_20159821_MPNST-bre-051","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.508000",,,,,,"P73Y",,,"1",8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac264","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Proximal arm]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoeo","pgxind-kftx2fps","pgxcs-kftvnuz4",863649586,0.3,659825104,0.23,203824482,0.071,"PGX_AM_BS_20159821_MPNST-bre-052","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.510000",,,,,,"P37Y",,,"1",81,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac265","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Pelvis]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoep","pgxind-kftx2fpu","pgxcs-kftvnuzl",811243086,0.282,494740890,0.172,316502196,0.11,"PGX_AM_BS_20159821_MPNST-bre-053","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.511000",,,,,,"P15Y",,,"1",19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac267","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Intrathoracic]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoet","pgxind-kftx2fpy","pgxcs-kftvnv0j",1489346799,0.518,494635615,0.172,994711184,0.346,"PGX_AM_BS_20159821_MPNST-bre-057","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.514000",,,,,,"P24Y",,,"1",32,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac268","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Pelvis]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoeu","pgxind-kftx2fq0","pgxcs-kftvnv10",2120591325,0.738,1024960418,0.357,1095630907,0.381,"PGX_AM_BS_20159821_MPNST-bre-058","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.516000",,,,,,"P26Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Under arm]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoex","pgxind-kftx2fq4","pgxcs-kftvnv1y",1099256834,0.382,876843898,0.305,222412936,0.077,"PGX_AM_BS_20159821_MPNST-bre-061","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.519000",,,,,,"P59Y",,,"0",142,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoez","pgxind-kftx2fq6","pgxcs-kftvnv2f",1323499107,0.46,471638913,0.164,851860194,0.296,"PGX_AM_BS_20159821_MPNST-bre-063","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.520000",,,,,,"P62Y",,,"1",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thoracic wall]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof1","pgxind-kftx2fq8","pgxcs-kftvnv2w",1437003163,0.5,557693347,0.194,879309816,0.306,"PGX_AM_BS_20159821_MPNST-bre-064","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.522000",,,,,,"P26Y",,,"1",29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Right shoulder]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof2","pgxind-kftx2fqa","pgxcs-kftvnv3e",1350313022,0.47,810871505,0.282,539441517,0.188,"PGX_AM_BS_20159821_MPNST-bre-065","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.523000",,,,,,"P53Y",,,"1",14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac26e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lung]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof4","pgxind-kftx2fqc","pgxcs-kftvnv3v",1540858905,0.536,635641927,0.221,905216978,0.315,"PGX_AM_BS_20159821_MPNST-bre-067","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.525000",,,,,,"P28Y",,,"1",118,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac270","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Mediastinum]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgof7","pgxind-kftx2fqg","pgxcs-kftvnv4s",2510212230,0.873,1444256608,0.502,1065955622,0.371,"PGX_AM_BS_20159821_MPNST-bre-070","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.528000",,,,,,"P73Y",,,"1",14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac272","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Lung]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofb","pgxind-kftx2fqk","pgxcs-kftvnv5r",248896417,0.087,90521516,0.031,158374901,0.055,"PGX_AM_BS_20159821_MPNST-bre-077","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.531000",,,,,,"P26Y",,,"1",20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac275","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Mediastinum]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgoff","pgxind-kftx2fqq","pgxcs-kftvnv76",1958473088,0.681,680007220,0.237,1278465868,0.445,"PGX_AM_BS_20159821_MPNST-bre-083","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.535000",,,,,,"P52Y",,,"1",1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac276","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Neck]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofh","pgxind-kftx2fqs","pgxcs-kftvnv7n",2496649693,0.868,1151180206,0.4,1345469487,0.468,"PGX_AM_BS_20159821_MPNST-bre-086","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.536000",,,,,,"P42Y",,,"1",7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac277","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Axilla]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0004","alive","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofi","pgxind-kftx2fqu","pgxcs-kftvnv84",1267780766,0.441,194785694,0.068,1072995072,0.373,"PGX_AM_BS_20159821_MPNST-bre-087","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.538000",,,,,,"P40Y",,,"0",168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac27a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofn","pgxind-kftx2fr0","pgxcs-kftvnv9k",142617759,0.05,44717661,0.016,97900098,0.034,"PGX_AM_BS_20159821_MPNST-bre-096","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.542000",,,,,,"P15Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac27d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [Thigh]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgofs","pgxind-kftx2fr6","pgxcs-kftvnvay",1099762116,0.383,128240240,0.045,971521876,0.338,"PGX_AM_BS_20159821_MPNST-bre-117","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.547000",,,,,,"P79Y",,,"1",6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c3727983b2e00ac28b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [neurofibromatosis type 1,Neck]","PMID:20159821","Brekke HR, Ribeiro FR et al. (2010): Genomic changes in chromosomes 10, 16,...","pgxfus-0010","dead","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvgogf","pgxind-kftx2fry","pgxcs-kftvnvhj",1830651586,0.637,654808603,0.228,1175842983,0.409,"PGX_AM_BS_20159821_MPNST-bre-080","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:14.566000",,,,,,"P25Y",,,"1",10,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad77a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [cell line HOS]","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvgv66","pgxind-kftx2o64","pgxcs-kftvpy4s",808665157,0.281,183954817,0.064,624710340,0.217,"PGX_AM_BS_OSCl-sel-HOS","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:21.961000",,,,,,,"geo:GSE7077",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad77b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [cell line MG-63]","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvgv68","pgxind-kftx2o66","pgxcs-kftvpy59",1766719390,0.615,1131100928,0.393,635618462,0.221,"PGX_AM_BS_OSCl-sel-MG-63","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:21.962000",,,,,,,"geo:GSE7077",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c6727983b2e00ad794","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [cell line U-2OS]","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvgv7c","pgxind-kftx2o7k","pgxcs-kftvpyhb",1667341894,0.58,1031230263,0.359,636111631,0.221,"PGX_AM_BS_OSCl-sel-U-2OS","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:21.998000",,,,,,,"geo:GSE7077",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae21f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Head and neck, cutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgywr","pgxind-kftx2sfj","pgxcs-kftvr0bm",322306301,0.112,116600117,0.041,205706184,0.072,"PGX_AM_BS_16938566_LMS-lar-02","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.740000",,,,,,"P36Y",,,"0",182.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae221","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Upper trunk, cutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgywu","pgxind-kftx2sfn","pgxcs-kftvr0ck",519905917,0.181,472205870,0.164,47700047,0.017,"PGX_AM_BS_16938566_LMS-lar-04","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.743000",,,,,,"P57Y",,,"0",97.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae226","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Thigh, deep]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgyx2","pgxind-kftx2sfx","pgxcs-kftvr0ey",1035413741,0.36,362307646,0.126,673106095,0.234,"PGX_AM_BS_16938566_LMS-lar-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.750000",,,,,,"P61Y",,,"0",211.87,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae227","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Thigh, cutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgyx4","pgxind-kftx2sfz","pgxcs-kftvr0ff",911611248,0.317,619503455,0.215,292107793,0.102,"PGX_AM_BS_16938566_LMS-lar-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.752000",,,,,,"P46Y",,,"0",49.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae228","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Thigh, subcutaneous]","PMID:16938566","Larramendy ML, Kaur S et al. (2006): Gene copy number profiling of soft-tissue...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgyx6","pgxind-kftx2sg1","pgxcs-kftvr0fx",1343523094,0.467,1089373700,0.379,254149394,0.088,"PGX_AM_BS_16938566_LMS-lar-11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:25.753000",,,,,,"P91Y",,,"1",8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae455","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzm9","pgxind-kftx2tav","pgxcs-kftvr868",519905917,0.181,472205870,0.164,47700047,0.017,"PGX_AM_BS_LMS-sva-02","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.908000",,,,,,"P57Y",,,"0",97.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae456","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmb","pgxind-kftx2tax","pgxcs-kftvr86p",322306301,0.112,116600117,0.041,205706184,0.072,"PGX_AM_BS_LMS-sva-03","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.909000",,,,,,"P36Y",,,"0",182.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae45d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmm","pgxind-kftx2tbb","pgxcs-kftvr8c1",820074047,0.285,412414969,0.143,407659078,0.142,"PGX_AM_BS_LMS-sva-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.919000",,,,,,"P55Y",,,"0",137.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae45f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmq","pgxind-kftx2tbf","pgxcs-kftvr8cz",911611248,0.317,619503455,0.215,292107793,0.102,"PGX_AM_BS_LMS-sva-12","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.922000",,,,,,"P46Y",,,"0",49.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae461","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmt","pgxind-kftx2tbj","pgxcs-kftvr8dy",859969166,0.299,472768129,0.164,387201037,0.135,"PGX_AM_BS_LMS-sva-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.925000",,,,,,"P59Y",,,"0",193.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae462","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmv","pgxind-kftx2tbl","pgxcs-kftvr8eg",491264897,0.171,298869988,0.104,192394909,0.067,"PGX_AM_BS_LMS-sva-15","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.926000",,,,,,"P49Y",,,"0",68.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae463","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmw","pgxind-kftx2tbn","pgxcs-kftvr8ex",1211003198,0.421,582834380,0.203,628168818,0.218,"PGX_AM_BS_LMS-sva-16","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.928000",,,,,,"P62Y",,,"0",159.5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae465","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzmz","pgxind-kftx2tbr","pgxcs-kftvr8fx",1035413741,0.36,362307646,0.126,673106095,0.234,"PGX_AM_BS_LMS-sva-18","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.930000",,,,,,"P61Y",,,"0",211.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae467","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgzn3","pgxind-kftx2tbv","pgxcs-kftvr8gw",1354823105,0.471,1089373700,0.379,265449405,0.092,"PGX_AM_BS_LMS-sva-20","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.933000",,,,,,"P91Y",,,"1",8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae46d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgznc","pgxind-kftx2tc7","pgxcs-kftvr8jt",1040532638,0.362,551134841,0.192,489397797,0.17,"PGX_AM_BS_LMS-sva-26","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.941000",,,,,,"P70Y",,,"0",55.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae472","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgznk","pgxind-kftx2tci","pgxcs-kftvr8m7",841827226,0.293,54300054,0.019,787527172,0.274,"PGX_AM_BS_LMS-sva-31","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.948000",,,,,,"P55Y",,,"0",174.8,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae473","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvgznm","pgxind-kftx2tck","pgxcs-kftvr8mp",526615032,0.183,149943131,0.052,376671901,0.131,"PGX_AM_BS_LMS-sva-32","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:26.950000",,,,,,"P84Y",,,"1",10.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae475","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgznp","pgxind-kftx2tco","pgxcs-kftvr8nn",1620667386,0.564,773129923,0.269,847537463,0.295,"PGX_AM_BS_LMS-sva-34","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.953000",,,,,,"P75Y",,,"0",12.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae47b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgznz","pgxind-kftx2td0","pgxcs-kftvr8qj",941220220,0.327,566020781,0.197,375199439,0.131,"PGX_AM_BS_LMS-sva-40","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.961000",,,,,,"P69Y",,,"1",25.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae47d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzo2","pgxind-kftx2td4","pgxcs-kftvr8ri",908783586,0.316,565920144,0.197,342863442,0.119,"PGX_AM_BS_LMS-sva-42","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.964000",,,,,,"P58Y",,,"0",26.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae481","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0004","alive","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzo9","pgxind-kftx2tdc","pgxcs-kftvr8tf",607720436,0.211,335018058,0.117,272702378,0.095,"PGX_AM_BS_LMS-sva-46","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.969000",,,,,,"P38Y",,,"0",41.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae483","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzoc","pgxind-kftx2tdg","pgxcs-kftvr8ue",1134287499,0.395,773623435,0.269,360664064,0.125,"PGX_AM_BS_LMS-sva-48","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.972000",,,,,,"P69Y",,,"1",121.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae485","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","PMID:16648866","Svarvar C, Larramendy ML et al. (2006): Do DNA copy number changes differentiate...","pgxfus-0010","dead","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvgzof","pgxind-kftx2tdk","pgxcs-kftvr8vd",2094418516,0.728,1203911998,0.419,890506518,0.31,"PGX_AM_BS_LMS-sva-50","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:26.975000",,,,,,"P53Y",,,"1",21.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae490","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzox","pgxind-kftx2te7","pgxcs-kftvr90o",799182250,0.278,229542721,0.08,569639529,0.198,"PGX_AM_BS_MFHbo-tar-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.991000",,,,,,"P44Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae492","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzp1","pgxind-kftx2teb","pgxcs-kftvr91n",1175372317,0.409,32800032,0.011,1142572285,0.397,"PGX_AM_BS_MFHbo-tar-11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.994000",,,,,,"P75Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae494","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzp4","pgxind-kftx2teg","pgxcs-kftvr92l",1386311669,0.482,322357858,0.112,1063953811,0.37,"PGX_AM_BS_MFHbo-tar-13","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.996000",,,,,,"P47Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c7727983b2e00ae495","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [bone, primary tumor]","PMID:16630715","Tarkkanen M, Larramendy ML et al. (2006): Malignant fibrous histiocytoma of bone: analysis...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C40.0","bones and joints","pgxbs-kftvgzp6","pgxind-kftx2tei","pgxcs-kftvr933",1394441198,0.485,381057937,0.133,1013383261,0.352,"PGX_AM_BS_MFHbo-tar-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:26.998000",,,,,,"P18Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00ae711","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Extraskeletal]","PMID:16170537","Knuuttila A, Jee KJ et al. (2006): Spindle cell tumours of the pleura:...","pgxfus-0010","dead","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C38.4","pleura","pgxbs-kftvh0hx","pgxind-kftx2ueb","pgxcs-kftvri0t",788306557,0.274,0,0,788306557,0.274,"PGX_AM_BS_SpindlePleu-knu-06","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000977","pleura","{}","2020-09-10 17:44:27.880000",,,,,,"P66Y",,,"1",12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00ae7b7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [grade 3]","PMID:16080954","Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh0pg","pgxind-kftx2uno","pgxcs-kftvrkep",514946562,0.179,471771776,0.164,43174786,0.015,"PGX_AM_BS_AEB-16080954-11","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:28.117000",,,,,,"P49Y",,,"1",24,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00ae7bd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [grade 3]","PMID:16080954","Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh0pp","pgxind-kftx2uo0","pgxcs-kftvrkhk",634825580,0.221,408711974,0.142,226113606,0.079,"PGX_AM_BS_AEB-16080954-16","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:28.126000",,,,,,"P50Y",,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00ae7c3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [grade 3]","PMID:16080954","Hu J, Rao UN, Jasani S et al. (2005): Loss of DNA copy number of...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh0pz","pgxind-kftx2uod","pgxcs-kftvrkm1",848536129,0.295,515596882,0.179,332939247,0.116,"PGX_AM_BS_AEB-16080954-6","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:28.135000",,,,,,"P46Y",,,"0",60,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed65","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, femur]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2iw","pgxind-kftx2wxk","pgxcs-kftvs4qk",356705573,0.124,0,0,356705573,0.124,"PGX_AM_BS_15540165_OS-ati-08","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.133000",,,,,,"P16Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed67","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, tibia]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2iz","pgxind-kftx2wxo","pgxcs-kftvs4ri",934472891,0.325,146497569,0.051,787975322,0.274,"PGX_AM_BS_15540165_OS-ati-10","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.136000",,,,,,"P16Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56c8727983b2e00aed73","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","osteosarcoma [primary tumor, femur, small cell]","PMID:15540165","Atiye J, Wolf M et al. (2005): Gene amplifications in osteosarcoma-CGH microarray analysis....","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvh2ji","pgxind-kftx2wyd","pgxcs-kftvs4xg",542080236,0.189,106000105,0.037,436080131,0.152,"PGX_AM_BS_15540165_OS-ati-22","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:44:30.153000",,,,,,"P19Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af6ff","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","PMID:14506695","Squire JA, Pei J et al. (2003): High-resolution mapping of amplifications and deletions...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C71.9","Brain, NOS","pgxbs-kftvh5lp","pgxind-kftx30sa","pgxcs-kftvt31n",1364436825,0.475,1033497856,0.359,330938969,0.115,"PGX_AM_BS_14506695_OS-squ-OSM4","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000955","brain","{}","2020-09-10 17:44:33.542000",,,,,,"P14Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af701","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","PMID:14506695","Squire JA, Pei J et al. (2003): High-resolution mapping of amplifications and deletions...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C71.9","Brain, NOS","pgxbs-kftvh5lt","pgxind-kftx30se","pgxcs-kftvt32m",1442842905,0.502,474103318,0.165,968739587,0.337,"PGX_AM_BS_14506695_OS-squ-OSM6","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000955","brain","{}","2020-09-10 17:44:33.545000",,,,,,"P15Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af786","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Liposarcoma [or MFH]","PMID:12960699","Hostein I, Coindre JM et al. (2003): Comparative genomic hybridization study of paraffin-embedded...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5rr","pgxind-kftx30zl","pgxcs-kftvt4vq",506451711,0.176,309591273,0.108,196860438,0.068,"PGX_AM_BS_LPSMFH-BER10","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:33.726000",,,,,,"P77Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af7fa","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Buttock, grade 2, DOD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5wy","pgxind-kftx3160","pgxcs-kftvt6ji",1198099828,0.417,158160294,0.055,1039939534,0.362,"PGX_AM_BS_LMS-STS388","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.886000",,,,,,"P73Y",,,"1",7.6,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af7fe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Thigh, grade 2, AWD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5x5","pgxind-kftx3168","pgxcs-kftvt6lg",918333384,0.319,16100016,0.006,902233368,0.314,"PGX_AM_BS_LMS-STS438","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.892000",,,,,,"P69Y",,,"0",33.6,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af7ff","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Retro abdo, grade 2, DOD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5x7","pgxind-kftx316a","pgxcs-kftvt6ly",703376047,0.245,412951480,0.144,290424567,0.101,"PGX_AM_BS_LMS-STS441","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.893000",,,,,,"P63Y",,,"1",44.5,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af805","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Groin, grade 3, AWD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0004","alive","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5xg","pgxind-kftx316l","pgxcs-kftvt6ou",1062853376,0.37,664757303,0.231,398096073,0.138,"PGX_AM_BS_LMS-STS576","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.901000",,,,,,"P23Y",,,"0",37.3,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00af807","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [Retro Pelvis, grade 2, DOD]","PMID:12920222","Wang R, Titley JC et al. (2003): Loss of 13q14-q21 and gain of...","pgxfus-0010","dead","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh5xk","pgxind-kftx316p","pgxcs-kftvt6pt",633958516,0.221,190214746,0.066,443743770,0.154,"PGX_AM_BS_LMS-STS587","{}",-0.2,51.35,"Point","GBR","Sutton","United Kingdom","Sutton, United Kingdom",51.35,-0.2,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:33.904000",,,,,,"P67Y",,,"1",2.7,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afb84","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","double-component liposarcoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4253","Mixed Liposarcoma","icdom-88553","Mixed liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh71r","pgxind-kftx32l0","pgxcs-kftvtj85",788281505,0.274,455421112,0.158,332860393,0.116,"PGX_AM_BS_Chib-LPS02","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.136000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afb96","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","double-component liposarcoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4253","Mixed Liposarcoma","icdom-88553","Mixed liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh72k","pgxind-kftx32m1","pgxcs-kftvtjgw",1145324768,0.398,955041510,0.332,190283258,0.066,"PGX_AM_BS_Chib-LPS25","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.160000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afbae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh73m","pgxind-kftx32nd","pgxcs-kftvtjsp",845418804,0.294,741543959,0.258,103874845,0.036,"PGX_AM_BS_Chib-MFH15","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.193000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afbb3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh73u","pgxind-kftx32nn","pgxcs-kftvtjv8",392859066,0.137,240113899,0.084,152745167,0.053,"PGX_AM_BS_Chib-MFH40","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.200000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ca727983b2e00afbbb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:12547153","Chibon F, Mariani O et al. (2002): A subgroup of malignant fibrous histiocytomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh747","pgxind-kftx32o4","pgxcs-kftvtk1b",466157104,0.162,380857020,0.132,85300084,0.03,"PGX_AM_BS_Chib-MFH84","{}",2.35,48.85,"Point","FRA","Paris","France","Paris, France",48.85,2.35,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:35.211000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd2b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0010","dead","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7kv","pgxind-kftx338u","pgxcs-kftvtp6d",1203438907,0.419,584438288,0.203,619000619,0.215,"PGX_AM_BS_OstSarc-oza-01","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.717000",,,,,,"P35Y",,,"1",16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd31","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Femur, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7l4","pgxind-kftx3397","pgxcs-kftvtp9a",2258752815,0.786,688359004,0.239,1570393811,0.546,"PGX_AM_BS_OstSarc-oza-07","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.725000",,,,,,"P19Y",,,"0",35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd33","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Tibia, Primary, Fibroblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7l8","pgxind-kftx339b","pgxcs-kftvtpa9",2082369258,0.724,980903263,0.341,1101465995,0.383,"PGX_AM_BS_OstSarc-oza-09","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.728000",,,,,,"P21Y",,,"0",33,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd34","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7l9","pgxind-kftx339d","pgxcs-kftvtpaq",1666218807,0.58,692786238,0.241,973432569,0.339,"PGX_AM_BS_OstSarc-oza-10","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.729000",,,,,,"P13Y",,,"0",34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd37","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Ilium-Sacrum, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0010","dead","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7le","pgxind-kftx339j","pgxcs-kftvtpc6",1161507906,0.404,518626044,0.18,642881862,0.224,"PGX_AM_BS_OstSarc-oza-13","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.734000",,,,,,"P20Y",,,"1",20,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd3d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary, Fibroblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7lo","pgxind-kftx339v","pgxcs-kftvtpf2",1320240031,0.459,721951079,0.251,598288952,0.208,"PGX_AM_BS_OstSarc-oza-19","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.742000",,,,,,"P16Y",,,"0",27,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd49","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Humerus, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7m7","pgxind-kftx33aj","pgxcs-kftvtpku",1625674673,0.565,863740888,0.3,761933785,0.265,"PGX_AM_BS_OstSarc-oza-31","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.759000",,,,,,"P18Y",,,"0",24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd4c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Primary]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7mc","pgxind-kftx33ap","pgxcs-kftvtpma",1733374586,0.603,825134628,0.287,908239958,0.316,"PGX_AM_BS_OstSarc-oza-34","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.764000",,,,,,"P15Y",,,"0",19,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd4e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Fibula, Primary, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7mf","pgxind-kftx33au","pgxcs-kftvtpn9",2221143758,0.773,929870284,0.323,1291273474,0.449,"PGX_AM_BS_OstSarc-oza-36","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.767000",,,,,,"P14Y",,,"0",36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd51","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Proximal Humerus, Primary, Chondroblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0004","alive","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7ml","pgxind-kftx33b0","pgxcs-kftvtpop",2067060142,0.719,960182460,0.334,1106877682,0.385,"PGX_AM_BS_OstSarc-oza-39","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.771000",,,,,,"P16Y",,,"0",12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00afd59","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [Distal Femur, Recurrence, Osteoblastic]","PMID:12402305","Ozaki T, Schaefer KL et al. (2002): Genetic imbalances revealed by comparative genomic...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvh7my","pgxind-kftx33bg","pgxcs-kftvtpsl",629041888,0.219,269700271,0.094,359341617,0.125,"PGX_AM_BS_OstSarc-oza-47","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:35.782000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0108","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [NF1-associated]","PMID:12081210","Koga T, Iwasaki H et al. (2002): Frequent genomic imbalances in chromosomes 17,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvh8tg","pgxind-kftx34sn","pgxcs-kftvu2z0",2086779039,0.726,40817195,0.014,2045961844,0.712,"PGX_AM_BS_MB-PNST-01","{}",130.42,33.61,"Point","JPN","Fukuoka-shi","Japan","Fukuoka-shi, Japan",33.61,130.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:37.078000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b010a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [NF1-associated]","PMID:12081210","Koga T, Iwasaki H et al. (2002): Frequent genomic imbalances in chromosomes 17,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvh8tj","pgxind-kftx34sr","pgxcs-kftvu2zz",48900048,0.017,0,0,48900048,0.017,"PGX_AM_BS_MB-PNST-03","{}",130.42,33.61,"Point","JPN","Fukuoka-shi","Japan","Fukuoka-shi, Japan",33.61,130.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:37.081000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b010c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [sporadic]","PMID:12081210","Koga T, Iwasaki H et al. (2002): Frequent genomic imbalances in chromosomes 17,...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvh8tn","pgxind-kftx34sv","pgxcs-kftvu30x",612713991,0.213,0,0,612713991,0.213,"PGX_AM_BS_MB-PNST-05","{}",130.42,33.61,"Point","JPN","Fukuoka-shi","Japan","Fukuoka-shi, Japan",33.61,130.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:37.083000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02aa","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9ch","pgxind-kftx35gb","pgxcs-kftvu8vp",949061822,0.33,284188650,0.099,664873172,0.231,"PGX_AM_BS_LipSarc-09","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.661000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02ac","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9ck","pgxind-kftx35gf","pgxcs-kftvu8wo",772092075,0.269,255022096,0.089,517069979,0.18,"PGX_AM_BS_LipSarc-11","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.664000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02ae","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9cn","pgxind-kftx35gj","pgxcs-kftvu8xm",977361769,0.34,135102239,0.047,842259530,0.293,"PGX_AM_BS_LipSarc-13","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.666000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02b5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9cz","pgxind-kftx35gx","pgxcs-kftvu90y",1205786887,0.419,495848253,0.172,709938634,0.247,"PGX_AM_BS_LipSarc-20","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.676000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02b6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9d0","pgxind-kftx35gz","pgxcs-kftvu91f",241913620,0.084,0,0,241913620,0.084,"PGX_AM_BS_LipSarc-21","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.678000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02b7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated liposarcoma","PMID:11948494","Rieker RJ, Joos S et al. (2002): Distinct chromosomal imbalances in pleomorphic and...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9d2","pgxind-kftx35h2","pgxcs-kftvu91x",531280066,0.185,205010457,0.071,326269609,0.113,"PGX_AM_BS_LipSarc-22","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.679000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02f3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 3, bone]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9fs","pgxind-kftx35kg","pgxcs-kftvu9x0",941927495,0.328,78774821,0.027,863152674,0.3,"PGX_AM_BS_FibSarc-01b","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.761000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02f8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 3, lower extremity]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9g0","pgxind-kftx35kr","pgxcs-kftvu9ze",577700576,0.201,0,0,577700576,0.201,"PGX_AM_BS_FibSarc-05a","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.768000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02f9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 3, lower extremity]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9g2","pgxind-kftx35kt","pgxcs-kftvu9zw",1057120267,0.368,71891504,0.025,985228763,0.343,"PGX_AM_BS_FibSarc-05b","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.769000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02fd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 2, head]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9g8","pgxind-kftx35l1","pgxcs-kftvua1t",814838051,0.283,0,0,814838051,0.283,"PGX_AM_BS_FibSarc-09","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.774000",,,,,,,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b02ff","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 3, upper extremity]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9gc","pgxind-kftx35l5","pgxcs-kftvua2t",1420662547,0.494,572747714,0.199,847914833,0.295,"PGX_AM_BS_FibSarc-11a","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.777000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0303","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 3, belly wall]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9gi","pgxind-kftx35ld","pgxcs-kftvua4q",603571371,0.21,50700050,0.018,552871321,0.192,"PGX_AM_BS_FibSarc-14","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.783000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b030f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 2, upper extremity]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9h2","pgxind-kftx35m2","pgxcs-kftvuaak",734750043,0.256,0,0,734750043,0.256,"PGX_AM_BS_FibSarc-24","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.799000",,,,,,,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0312","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","adult fibrosarcoma [grade 2, head]","PMID:11921284","Schmidt H, Taubert H et al. (2002): Gains of 12q are the most...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9h7","pgxind-kftx35m8","pgxcs-kftvuac0",174936139,0.061,0,0,174936139,0.061,"PGX_AM_BS_FibSarc-27","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:37.803000",,,,,,,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b033f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9j9","pgxind-kftx35os","pgxcs-kftvuaxo",666277527,0.232,333381029,0.116,332896498,0.116,"PGX_AM_BS_AdrCortPA-37","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.865000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0340","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9jb","pgxind-kftx35ou","pgxcs-kftvuay5",893942296,0.311,588743112,0.205,305199184,0.106,"PGX_AM_BS_AdrCortPA-38","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.866000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0342","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9je","pgxind-kftx35oy","pgxcs-kftvuaz3",182169643,0.063,81700082,0.028,100469561,0.035,"PGX_AM_BS_AdrCortPA-40","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.869000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cb727983b2e00b0344","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:11921282","Zhao J, Roth J, Bode-Lesniewska B et al. (2002): Combined comparative genomic hybridization and genomic...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvh9jh","pgxind-kftx35p2","pgxcs-kftvub23",472618195,0.164,183543165,0.064,289075030,0.101,"PGX_AM_BS_AdrCortPA-42","{}",8.55,47.37,"Point","CHE","Zurich","Switzerland","Zurich, Switzerland",47.37,8.55,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:37.872000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b05d4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [postirradiation, Fibrosarcoma G3, Neck]","PMID:11745275","Tarkkanen M, Wiklund TA et al. (2001): Comparative genomic hybridization of postirradiation sarcomas....","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhacy","pgxind-kftx36pz","pgxcs-kftvuk77",326071058,0.113,0,0,326071058,0.113,"PGX_AM_BS_RadSarc-20b","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:38.776000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06a4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [G4]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhamc","pgxind-kftx371p","pgxcs-kftvun3b",176949522,0.062,0,0,176949522,0.062,"PGX_AM_BS_sts-20","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.058000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06ab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [G4, local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhamn","pgxind-kftx3723","pgxcs-kftvun6q",964148308,0.335,125600124,0.044,838548184,0.292,"PGX_AM_BS_sts-lr07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.068000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06af","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma G3 [local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhamu","pgxind-kftx372b","pgxcs-kftvun8o",828636191,0.288,306217460,0.107,522418731,0.182,"PGX_AM_BS_sts-lr11","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.073000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06b1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma G3 [local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhamx","pgxind-kftx372f","pgxcs-kftvun9n",958213066,0.333,342829475,0.119,615383591,0.214,"PGX_AM_BS_sts-lr13","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.076000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b06b8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma [G4, local recurrence]","PMID:11598167","Popov P, Virolainen M et al. (2001): Primary soft tissue sarcoma and its...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhan8","pgxind-kftx372t","pgxcs-kftvunew",364538345,0.127,0,0,364538345,0.127,"PGX_AM_BS_sts-lr20","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:39.086000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b0a0c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor","PMID:11454424","Schmidt H, Taubert H et al. (2001): Cytogenetic characterization of six malignant peripheral...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhbpk","pgxind-kftx38f2","pgxcs-kftvuzgp",360335164,0.125,31921457,0.011,328413707,0.114,"PGX_AM_BS_MPNST-b-03","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:40.269000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cc727983b2e00b0a0d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor","PMID:11454424","Schmidt H, Taubert H et al. (2001): Cytogenetic characterization of six malignant peripheral...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhbpm","pgxind-kftx38f4","pgxcs-kftvuzh6",308491645,0.107,21517638,0.007,286974007,0.1,"PGX_AM_BS_MPNST-b-04","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:40.271000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b50","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","embryonal sarcoma [liver, undifferentiated]","PMID:11376805","Sowery RD, Jensen C et al. (2001): Comparative genomic hybridization detects multiple chromosomal...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-89913","Embryonal sarcoma","icdot-C22.0","Liver","pgxbs-kftvhc4b","pgxind-kftx38xa","pgxcs-kftvv40j",1446529630,0.503,975929906,0.339,470599724,0.164,"PGX_AM_BS_EmbSarc3a","{}",-123.12,49.25,"Point","CAN","Vancouver","Canada","Vancouver, Canada",49.25,-123.12,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002107","liver","{}","2020-09-10 17:44:40.712000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b53","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","embryonal sarcoma [liver, undifferentiated]","PMID:11376805","Sowery RD, Jensen C et al. (2001): Comparative genomic hybridization detects multiple chromosomal...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-89913","Embryonal sarcoma","icdot-C22.0","Liver","pgxbs-kftvhc4g","pgxind-kftx38xg","pgxcs-kftvv421",148274890,0.052,91700091,0.032,56574799,0.02,"PGX_AM_BS_EmbSarc5","{}",-123.12,49.25,"Point","CAN","Vancouver","Canada","Vancouver, Canada",49.25,-123.12,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002107","liver","{}","2020-09-10 17:44:40.716000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b54","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","embryonal sarcoma [liver, undifferentiated]","PMID:11376805","Sowery RD, Jensen C et al. (2001): Comparative genomic hybridization detects multiple chromosomal...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-89913","Embryonal sarcoma","icdot-C22.0","Liver","pgxbs-kftvhc4h","pgxind-kftx38xi","pgxcs-kftvv42j",1309977861,0.456,226797648,0.079,1083180213,0.377,"PGX_AM_BS_EmbSarc6","{}",-123.12,49.25,"Point","CAN","Vancouver","Canada","Vancouver, Canada",49.25,-123.12,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002107","liver","{}","2020-09-10 17:44:40.718000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b7e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [metastasis]","PMID:11369052","Forus A, Larramendy ML et al. (2001): Dedifferentiation of a well-differentiated liposarcoma to...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhc6d","pgxind-kftx38zm","pgxcs-kftvv4my",575692949,0.2,227999738,0.079,347693211,0.121,"PGX_AM_BS_11369052_WDLPS-forus-2b","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:40.775000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0b81","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [metastasis]","PMID:11369052","Forus A, Larramendy ML et al. (2001): Dedifferentiation of a well-differentiated liposarcoma to...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhc6h","pgxind-kftx38zs","pgxcs-kftvv4qb",789164493,0.274,385712416,0.134,403452077,0.14,"PGX_AM_BS_11369052_WDLPS-forus-3b","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:40.779000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c22","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcdp","pgxind-kftx398r","pgxcs-kftvv6y7",1826767959,0.635,691006974,0.24,1135760985,0.395,"PGX_AM_BS_LMS-12","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.006000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c28","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcdz","pgxind-kftx3993","pgxcs-kftvv714",1120450618,0.39,365910549,0.127,754540069,0.262,"PGX_AM_BS_LMS-18","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.014000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c32","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine leiomyosarcoma","PMID:11319799","Hu J, Khanna V, Jones M et al. (2001): Genomic alterations in uterine leiomyosarcomas: potential...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhcef","pgxind-kftx399n","pgxcs-kftvv77q",1625466078,0.565,706773689,0.246,918692389,0.32,"PGX_AM_BS_LMS-8","{}",-80,40.44,"Point","USA","Pittsburgh","United States of America","Pittsburgh, United States",40.44,-80,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:41.028000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c81","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [grade high, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhchy","pgxind-kftx39e3","pgxcs-kftvv8a5",1519358322,0.528,703153330,0.245,816204992,0.284,"PGX_AM_BS_sarc04","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:41.139000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c84","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [grade III, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhci3","pgxind-kftx39ea","pgxcs-kftvv8bm",1099594097,0.382,609533366,0.212,490060731,0.17,"PGX_AM_BS_sarc07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.143000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c85","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [grade III, local recurrence]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhci5","pgxind-kftx39ec","pgxcs-kftvv8c4",1237803441,0.431,299212278,0.104,938591163,0.326,"PGX_AM_BS_sarc08","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.145000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c89","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma [grade high, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhcib","pgxind-kftx39ek","pgxcs-kftvv8g1",387733303,0.135,37752423,0.013,349980880,0.122,"PGX_AM_BS_sarc12","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:41.151000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c90","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Epitheliod Leiomyosarcoma [grade III, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C3700","Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhcim","pgxind-kftx39ez","pgxcs-kftvv8jg",805429092,0.28,184943165,0.064,620485927,0.216,"PGX_AM_BS_sarc19","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.160000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b0c93","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Liposarcoma, dedifferentiated [grade III, primary]","PMID:11309816","Menghi-Sartorio S et al. (2001): DNA copy number amplifications in sarcomas...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhcir","pgxind-kftx39f5","pgxcs-kftvv8kx",838662578,0.292,42500043,0.015,796162535,0.277,"PGX_AM_BS_sarc22","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:41.165000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b100a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [retroperitoneum, primary, grade III]","PMID:11060455","Otaño-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.9","retroperitoneum and peritoneum","pgxbs-kftvhdn1","pgxind-kftx3at7","pgxcs-kftvvl2x",529547199,0.184,120700120,0.042,408847079,0.142,"PGX_AM_BS_LeioMy01","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space",,"2020-09-10 17:44:42.388000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b100f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [thoracic wall, primary, grade III]","PMID:11060455","Otaño-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhdn9","pgxind-kftx3ath","pgxcs-kftvvl5b",1117106130,0.389,388293917,0.135,728812213,0.253,"PGX_AM_BS_LeioMy06","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:42.395000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1011","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [retroperitoneum, recurrence, grade III]","PMID:11060455","Otaño-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.9","retroperitoneum and peritoneum","pgxbs-kftvhdnc","pgxind-kftx3atl","pgxcs-kftvvl6c",434893528,0.151,212097635,0.074,222795893,0.077,"PGX_AM_BS_LeioMy08","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space",,"2020-09-10 17:44:42.398000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1014","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [femoral vein, primary, grade III]","PMID:11060455","Otaño-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhdnh","pgxind-kftx3atr","pgxcs-kftvvl7v",569169744,0.198,226634641,0.079,342535103,0.119,"PGX_AM_BS_LeioMy11","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:42.402000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1015","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","leiomyosarcoma [uterus, recurrence, grade III]","PMID:11060455","Otaño-Joos M, Mechtersheimer G et al. (2000): Detection of chromosomal imbalances in leiomyosarcoma...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhdnj","pgxind-kftx3att","pgxcs-kftvvl8d",807596273,0.281,300438731,0.105,507157542,0.176,"PGX_AM_BS_LeioMy12","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus",,"2020-09-10 17:44:42.403000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56cd727983b2e00b1151","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","uterine leiomyosarcoma","PMID:10958933","Levy B, Mukherjee T et al. (2000): Molecular cytogenetic analysis of uterine leiomyoma...","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvhe1w","pgxind-kftx3bbm","pgxcs-kftvvpnu",540032039,0.188,183768769,0.064,356263270,0.124,"PGX_AM_BS_ULMS04","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:42.841000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b12f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:10822134","Schmidt H, Taubert H et al. (2000): Gains in chromosomes 7, 8q, 15q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvheku","pgxind-kftx3bz2","pgxcs-kftvvvig",576618995,0.201,147352531,0.051,429266464,0.149,"PGX_AM_BS_MalBen-PNST-01","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:43.410000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b12f9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:10822134","Schmidt H, Taubert H et al. (2000): Gains in chromosomes 7, 8q, 15q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhel7","pgxind-kftx3bzi","pgxcs-kftvvvma",488979922,0.17,84817238,0.03,404162684,0.141,"PGX_AM_BS_MalBen-PNST-04b2","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:43.421000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1351","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhep7","pgxind-kftx3c4i","pgxcs-kftvvwuz",1067579106,0.371,593236690,0.206,474342416,0.165,"PGX_AM_BS_MFH-MFH45","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.548000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1355","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepe","pgxind-kftx3c4q","pgxcs-kftvvwwy",1727417170,0.601,823113412,0.286,904303758,0.315,"PGX_AM_BS_MFH-MFH49","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.554000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1359","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepl","pgxind-kftx3c4y","pgxcs-kftvvwyw",1904604601,0.662,1019834921,0.355,884769680,0.308,"PGX_AM_BS_MFH-T100","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.560000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b135f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepu","pgxind-kftx3c5a","pgxcs-kftvvx1u",471341508,0.164,334013047,0.116,137328461,0.048,"PGX_AM_BS_MFH-T107","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.569000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1360","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepw","pgxind-kftx3c5c","pgxcs-kftvvx2c",1811581511,0.63,848586826,0.295,962994685,0.335,"PGX_AM_BS_MFH-T108","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.571000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1361","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhepy","pgxind-kftx3c5e","pgxcs-kftvvx2t",1077548243,0.375,563149392,0.196,514398851,0.179,"PGX_AM_BS_MFH-T109","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.572000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1365","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant fibrous histiocytoma","PMID:10748288","Simons A, Schepens M et al. (2000): Frequent loss of 9p21 (p16(INK4A)) and...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvheq4","pgxind-kftx3c5m","pgxcs-kftvvx4r",643372788,0.224,180513934,0.063,462858854,0.161,"PGX_AM_BS_MFH-T129","{}",5.84,51.81,"Point","NLD","Nijmegen","Netherlands","Nijmegen, The Netherlands",51.81,5.84,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:43.578000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b14e6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf7k","pgxind-kftx3cr1","pgxcs-kftvw2jm",77774820,0.027,0,0,77774820,0.027,"PGX_AM_BS_stt-34","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.116000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b150c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid liposarcoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf9b","pgxind-kftx3ct4","pgxcs-kftvw325",878813136,0.306,789913047,0.275,88900089,0.031,"PGX_AM_BS_stt-81","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.168000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b150d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid liposarcoma","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf9d","pgxind-kftx3ct6","pgxcs-kftvw32n",107202104,0.037,107202104,0.037,0,0,"PGX_AM_BS_stt-82","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.169000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1516","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Liposarcoma, well differentiated","PMID:10598139","Parente F, Grosgeorge J et al. (1999): Comparative genomic hybridization reveals novel chromosome...","pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhf9r","pgxind-kftx3ctn","pgxcs-kftvw36z",308662153,0.107,177652038,0.062,131010115,0.046,"PGX_AM_BS_stt-93","{}",-0.58,44.84,"Point","FRA","Bordeaux","France","Bordeaux, France",44.84,-0.58,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.182000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b156c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade I, pelvis]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfdo","pgxind-kftx3cyg","pgxcs-kftvw4ee",871242429,0.303,0,0,871242429,0.303,"PGX_AM_BS_AEB-10534175-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.299000",,,,,,"P72Y",,,"0",40,"NCITgrade-C28077","Grade 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1571","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, tibia]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfdw","pgxind-kftx3cyq","pgxcs-kftvw4gw",160820851,0.056,0,0,160820851,0.056,"PGX_AM_BS_AEB-10534175-14","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.306000",,,,,,"P37Y",,,"0",61,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1572","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, rib VIII]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0010","dead","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfdx","pgxind-kftx3cys","pgxcs-kftvw4hd",1176759512,0.409,0,0,1176759512,0.409,"PGX_AM_BS_AEB-10534175-15","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.307000",,,,,,"P78Y",,,"1",60,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1573","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, femur]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfdz","pgxind-kftx3cyu","pgxcs-kftvw4hv",1176032468,0.409,51800051,0.018,1124232417,0.391,"PGX_AM_BS_AEB-10534175-16","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.309000",,,,,,"P34Y",,,"0",47,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b157c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, soft tissue]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfee","pgxind-kftx3czc","pgxcs-kftvw4o6",622482836,0.217,51800051,0.018,570682785,0.198,"PGX_AM_BS_AEB-10534175-23b","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:44.321000",,,,,,"P64Y",,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1583","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade II, tibia]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0010","dead","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfep","pgxind-kftx3czq","pgxcs-kftvw4rl",610853469,0.212,110306090,0.038,500547379,0.174,"PGX_AM_BS_AEB-10534175-28","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.330000",,,,,,"P43Y",,,"1",8,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1586","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade III, femur]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhfeu","pgxind-kftx3czw","pgxcs-kftvw4t2",1786212027,0.621,373352757,0.13,1412859270,0.491,"PGX_AM_BS_AEB-10534175-31","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.335000",,,,,,"P27Y",,,"0",69,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b158c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade III, pelvis]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0004","alive","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhff4","pgxind-kftx3d08","pgxcs-kftvw4vz",303331437,0.106,0,0,303331437,0.106,"PGX_AM_BS_AEB-10534175-37","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:44.343000",,,,,,"P45Y",,,"0",77,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b158f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma [grade III, soft tissue]","PMID:10534175","Larramendy ML, Mandahl N et al. (1999): Clinical significance of genetic imbalances revealed...","pgxfus-0010","dead","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhff9","pgxind-kftx3d0e","pgxcs-kftvw4xg",1144199139,0.398,0,0,1144199139,0.398,"PGX_AM_BS_AEB-10534175-40","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:44:44.347000",,,,,,"P53Y",,,"1",4,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b15a7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma [Knee region]","PMID:10526533","Tarkkanen M, Kiuru-Kuhlefelt S et al. (1999): Clinical correlations of genetic changes by...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvhfgc","pgxind-kftx3d1r","pgxcs-kftvw597",604502231,0.21,0,0,604502231,0.21,"PGX_AM_BS_EWSRT-18","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:44.380000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b15ab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing sarcoma [Spine]","PMID:10526533","Tarkkanen M, Kiuru-Kuhlefelt S et al. (1999): Clinical correlations of genetic changes by...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvhfgi","pgxind-kftx3d1z","pgxcs-kftvw5b8",340243489,0.118,50627305,0.018,289616184,0.101,"PGX_AM_BS_EWSRT-22","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:44:44.385000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1707","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Abdominal cavity, grade GII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwg","pgxind-kftx3dld","pgxcs-kftvwa9t",2314190997,0.805,746482941,0.26,1567708056,0.545,"PGX_AM_BS_MPNST-04","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.865000",,,,,,,,,,,"NCITgrade-C28078","Grade 2",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1708","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Inguinal region, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwi","pgxind-kftx3dlf","pgxcs-kftvwaaa",744472707,0.259,158710142,0.055,585762565,0.204,"PGX_AM_BS_MPNST-05","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.866000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b170c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [primary tumor, Retroperitoneum, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfwo","pgxind-kftx3dln","pgxcs-kftvwac8",1136117465,0.395,144800143,0.05,991317322,0.345,"PGX_AM_BS_MPNST-09","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.872000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1711","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [neurofibromatosis 1, local recurrence, Thigh, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfww","pgxind-kftx3dlx","pgxcs-kftvwaeo",768783802,0.267,171500172,0.06,597283630,0.208,"PGX_AM_BS_MPNST-14","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.879000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1714","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [neurofibromatosis 1, primary tumor, Upper arm, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfx1","pgxind-kftx3dm3","pgxcs-kftvwag5",592982919,0.206,25600025,0.009,567382894,0.197,"PGX_AM_BS_MPNST-17","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.883000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1715","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [neurofibromatosis 1, primary tumor, Inguinal region, grade GI]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfx3","pgxind-kftx3dm5","pgxcs-kftvwagn",691401245,0.24,417560551,0.145,273840694,0.095,"PGX_AM_BS_MPNST-18","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.884000",,,,,,,,,,,"NCITgrade-C28077","Grade 1",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1716","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant peripheral nerve sheath tumor [neurofibromatosis 1, primary tumor, Thigh, grade GIII]","PMID:10398430","Mechtersheimer G et al. (1999): Analysis of chromosomal imbalances in sporadic...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhfx5","pgxind-kftx3dm7","pgxcs-kftvwah4",217078295,0.076,48300048,0.017,168778247,0.059,"PGX_AM_BS_MPNST-19","{}",8.69,49.41,"Point","DEU","Heidelberg","Germany","Heidelberg, Germany",49.41,8.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve",,"2020-09-10 17:44:44.886000",,,,,,,,,,,"NCITgrade-C28079","Grade 3",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1717","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma [metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfx6","pgxind-kftx3dm9","pgxcs-kftvwahm",649109673,0.226,522395887,0.182,126713786,0.044,"PGX_AM_BS_MetSarc-tar-01","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.887000",,,,,,"P38Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1718","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma [metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfx8","pgxind-kftx3dmb","pgxcs-kftvwai3",649109673,0.226,522395887,0.182,126713786,0.044,"PGX_AM_BS_MetSarc-tar-01M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.888000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1719","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxa","pgxind-kftx3dmd","pgxcs-kftvwail",626539394,0.218,431714737,0.15,194824657,0.068,"PGX_AM_BS_MetSarc-tar-02","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.890000",,,,,,"P56Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b171a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma [metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxb","pgxind-kftx3dmf","pgxcs-kftvwaj3",626539394,0.218,431714737,0.15,194824657,0.068,"PGX_AM_BS_MetSarc-tar-02M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.891000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1723","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxq","pgxind-kftx3dmy","pgxcs-kftvwang",1300065920,0.452,0,0,1300065920,0.452,"PGX_AM_BS_MetSarc-tar-07","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.904000",,,,,,"P22Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1724","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor [metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxs","pgxind-kftx3dn0","pgxcs-kftvwany",1300065920,0.452,0,0,1300065920,0.452,"PGX_AM_BS_MetSarc-tar-07M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.905000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1727","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant    brous histiocytoma [myxoid, metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxx","pgxind-kftx3dn6","pgxcs-kftvwapf",277667722,0.097,98143080,0.034,179524642,0.062,"PGX_AM_BS_MetSarc-tar-09","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.909000",,,,,,"P34Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1728","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","malignant fibrous histiocytoma [myxoid, metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfxy","pgxind-kftx3dn8","pgxcs-kftvwapw",277667722,0.097,98143080,0.034,179524642,0.062,"PGX_AM_BS_MetSarc-tar-09M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.911000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1733","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS [metastasized]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfyh","pgxind-kftx3dnu","pgxcs-kftvwaxb",583361912,0.203,443229163,0.154,140132749,0.049,"PGX_AM_BS_MetSarc-tar-15","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.926000",,,,,,"P57Y",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1734","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS [metastasis]","PMID:10398425","Tarkkanen M, Huuhtanen R et al. (1999): Comparison of genetic changes in primary...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvhfyi","pgxind-kftx3dnw","pgxcs-kftvwaxt",583361912,0.203,443229163,0.154,140132749,0.049,"PGX_AM_BS_MetSarc-tar-15M","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:44.927000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b179a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [abdomen, recurrence]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgct","pgxind-kftx3dtm","pgxcs-kftvwcd8",539124728,0.188,393613875,0.137,145510853,0.051,"PGX_AM_BS_PNST-08","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.067000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b179c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [left thigh, metastasis]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgcw","pgxind-kftx3dtq","pgxcs-kftvwce6",937279680,0.326,0,0,937279680,0.326,"PGX_AM_BS_PNST-11","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.070000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [retroperitoneum, primary]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgd3","pgxind-kftx3dtx","pgxcs-kftvwcg4",728462652,0.253,395894047,0.138,332568605,0.116,"PGX_AM_BS_PNST-13","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.076000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [left thigh, primary]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgd4","pgxind-kftx3dtz","pgxcs-kftvwcgm",1219556648,0.424,174708261,0.061,1044848387,0.363,"PGX_AM_BS_PNST-14","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.077000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [lower belly, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgd9","pgxind-kftx3du5","pgxcs-kftvwci2",866281990,0.301,0,0,866281990,0.301,"PGX_AM_BS_PNST-16b","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.081000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [thorax wall, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdc","pgxind-kftx3du9","pgxcs-kftvwcj1",891849649,0.31,409464362,0.142,482385287,0.168,"PGX_AM_BS_PNST-16d","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.084000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [left lower arm, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgde","pgxind-kftx3duc","pgxcs-kftvwcjj",620336586,0.216,233066407,0.081,387270179,0.135,"PGX_AM_BS_PNST-17","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.086000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17a9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [right thorax wall, recurrence]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdh","pgxind-kftx3dug","pgxcs-kftvwckj",624360863,0.217,0,0,624360863,0.217,"PGX_AM_BS_PNST-19","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.088000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b17b0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","peripheral nerve sheath tumor [neck, primary, neurofibromatosis]","PMID:10379866","Schmidt H, Würl P et al. (1999): Genomic imbalances of 7p and 17q...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. Autonomous","pgxbs-kftvhgdt","pgxind-kftx3duu","pgxcs-kftvwcnx",836277516,0.291,51300051,0.018,784977465,0.273,"PGX_AM_BS_PNST-23d","{}",8.36,52.06,"Point","DEU","Halle","Germany","Halle, Germany",52.06,8.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:44:45.098000",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b192d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhgvb","pgxind-kftx3eg0","pgxcs-kftvwi06",495466689,0.172,61943043,0.022,433523646,0.151,"PGX_AM_BS_HG-Osarc-17","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.626000",,,,,,,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1935","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhgvp","pgxind-kftx3egg","pgxcs-kftvwi41",460382369,0.16,0,0,460382369,0.16,"PGX_AM_BS_HG-Osarc-29","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.637000",,,,,,,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1936","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhgvq","pgxind-kftx3egi","pgxcs-kftvwi4j",892714641,0.311,264343245,0.092,628371396,0.219,"PGX_AM_BS_HG-Osarc-30","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.638000",,,,,,,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5bab56ce727983b2e00b1937","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma [primary, high grade]","PMID:10096241","Tarkkanen M, Elomaa I et al. (1999): DNA sequence copy number increase at...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvhgvs","pgxind-kftx3egk","pgxcs-kftvwi50",1090717915,0.379,61943043,0.022,1028774872,0.358,"PGX_AM_BS_HG-Osarc-31","{}",24.94,60.17,"Point","FIN","Helsinki","Finland","Helsinki, Finland",60.17,24.94,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:44:45.639000",,,,,,,,,,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a059b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bf4fc4a5-ae1e-4363-a440-a841464ae81a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhhqv","pgxind-kftx3fi3","pgxcs-kftvwrk8",2453704512,0.853,1011275244,0.352,1442429268,0.502,"bf4fc4a5-ae1e-4363-a440-a841464ae81a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:46.574000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a093d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3d257887-d0f2-40d1-945b-a46db90e63df","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhixi","pgxind-kftx3gwf","pgxcs-kftvx4sa",2819661717,0.981,837341658,0.291,1982320059,0.69,"3d257887-d0f2-40d1-945b-a46db90e63df","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:48.216000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0947","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-0c5a0353-bf76-4a2b-a941-76bf24a8540f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhixz","pgxind-kftx3gwz","pgxcs-kftvx4x3",2179144028,0.758,1001213780,0.348,1177930248,0.41,"0c5a0353-bf76-4a2b-a941-76bf24a8540f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:48.230000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0958","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bedf1833-c215-49c8-84ff-49f84c192ffd","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C16.9","Stomach, NOS","pgxbs-kftvhiyr","pgxind-kftx3gxx","pgxcs-kftvx55a",2204904344,0.767,794792713,0.276,1410111631,0.49,"bedf1833-c215-49c8-84ff-49f84c192ffd","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000945","stomach","{}","2020-09-10 17:44:48.254000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a09cc","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-6245d97d-1af8-4c78-8bbf-840ee4e7bd44","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhj41","pgxind-kftx3h3q","pgxcs-kftvx6ro",2499486325,0.869,1431783459,0.498,1067702866,0.371,"6245d97d-1af8-4c78-8bbf-840ee4e7bd44","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:48.416000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0a7c","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a2679d7d-8c31-4caa-b310-33b627d7bab6","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvhjc1","pgxind-kftx3hd0","pgxcs-kftvx990",910398171,0.317,478014054,0.166,432384117,0.15,"a2679d7d-8c31-4caa-b310-33b627d7bab6","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:44:48.661000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0aee","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f854db6b-57cb-4da7-9252-b2ade22c2675","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhjh6","pgxind-kftx3hj6","pgxcs-kftvxawb",1717158895,0.597,519444469,0.181,1197714426,0.417,"f854db6b-57cb-4da7-9252-b2ade22c2675","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:48.827000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0b22","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f7e730b2-be2b-4b47-8a55-2c888758ed6a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhjjj","pgxind-kftx3hm2","pgxcs-kftvxblc",1852924407,0.644,890179015,0.31,962745392,0.335,"f7e730b2-be2b-4b47-8a55-2c888758ed6a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:48.901000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0d22","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d2165554-a30a-49e9-8038-c9539d487a22","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhk6y","pgxind-kftx3icb","pgxcs-kftvxivh",2662979373,0.926,754392318,0.262,1908587055,0.664,"d2165554-a30a-49e9-8038-c9539d487a22","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:49.624000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0d76","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-016886f1-1b40-422e-82cb-51307fca8cd4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvhkar","pgxind-kftx3igq","pgxcs-kftvxk2x",2285128979,0.795,1061363582,0.369,1223765397,0.426,"016886f1-1b40-422e-82cb-51307fca8cd4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:44:49.743000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0eae","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f035a57e-be4d-49ff-a96f-1ca75f4a6b92","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhkoy","pgxind-kftx3iw2","pgxcs-kftvxok4",2334310542,0.812,1070706803,0.372,1263603739,0.44,"f035a57e-be4d-49ff-a96f-1ca75f4a6b92","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:50.182000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0ec0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3d38f7c9-00dd-47c1-8649-c50574953aab","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhkpr","pgxind-kftx3iwx","pgxcs-kftvxoss",1934816375,0.673,872718418,0.304,1062097957,0.369,"3d38f7c9-00dd-47c1-8649-c50574953aab","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:50.207000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a0ece","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ab26b1f4-9062-49e4-b121-28d5f7fc61b6","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhkqf","pgxind-kftx3ixn","pgxcs-kftvxozj",2341318174,0.814,627694512,0.218,1713623662,0.596,"ab26b1f4-9062-49e4-b121-28d5f7fc61b6","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:50.227000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1000","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e84cc153-84e6-4a2f-93bd-082169b4fd5c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhl4b","pgxind-kftx3jd4","pgxcs-kftvxtba",2532578540,0.881,613839507,0.214,1918739033,0.667,"e84cc153-84e6-4a2f-93bd-082169b4fd5c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:50.657000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1100","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ccba79c4-8873-478a-ad99-0db99c034a91","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C48.0","Retroperitoneum","pgxbs-kftvhlfx","pgxind-kftx3jpf","pgxcs-kftvxwyd",1856577719,0.646,758072955,0.264,1098504764,0.382,"ccba79c4-8873-478a-ad99-0db99c034a91","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:51.015000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1428","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-18258ddc-34e3-4590-87e7-c11d7a41d0d3","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvhmgk","pgxind-kftx3l08","pgxcs-kftvy8kw",2109282403,0.734,1351543752,0.47,757738651,0.264,"18258ddc-34e3-4590-87e7-c11d7a41d0d3","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:44:52.155000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1597","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-29928748-9899-49b8-8830-da26ecd88e0e","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvhmx4","pgxind-kftx3ga2","pgxcs-kftvydsr",2507767300,0.872,1358335062,0.472,1149432238,0.4,"29928748-9899-49b8-8830-da26ecd88e0e","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:44:52.671000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a15b1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-08011518-9de2-4be0-b0eb-72f099bb7e9f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvhmyb","pgxind-kftx3liq","pgxcs-kftvye5d",1353698918,0.471,677700175,0.236,675998743,0.235,"08011518-9de2-4be0-b0eb-72f099bb7e9f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:44:52.708000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a15e7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ed0e5f9d-7df8-4af8-9916-d30139a9b807","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhn0s","pgxind-kftx3ll8","pgxcs-kftvyey5",781156377,0.272,429738676,0.149,351417701,0.122,"ed0e5f9d-7df8-4af8-9916-d30139a9b807","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:52.783000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a18ae","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-14cc693c-a747-470a-88b5-fff9eb3c250d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvhnx5","pgxind-kftx3mgt","pgxcs-kftvyp26",1538575017,0.535,787328313,0.274,751246704,0.261,"14cc693c-a747-470a-88b5-fff9eb3c250d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:44:53.779000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a198d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8549c8fa-ef3e-451a-8d20-f13249d8cc47","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvho7b","pgxind-kftx3mqf","pgxcs-kftvys7l",2198576404,0.765,686568928,0.239,1512007476,0.526,"8549c8fa-ef3e-451a-8d20-f13249d8cc47","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:54.102000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a19db","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1afcdb32-ae26-4747-a131-54e83dd84a46","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhoau","pgxind-kftx3mti","pgxcs-kftvytco",2042702262,0.711,826192237,0.287,1216510025,0.423,"1afcdb32-ae26-4747-a131-54e83dd84a46","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:54.216000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1bd3","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-467e7743-8c7e-4a22-ace1-492a9bc17a89","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhoxs","pgxind-kftx3ne8","pgxcs-kftvz0nn",1964219009,0.683,1155524307,0.402,808694702,0.281,"467e7743-8c7e-4a22-ace1-492a9bc17a89","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:54.927000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1c1f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-310b09b7-7762-40a9-aefa-b356c6341cf5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvhp19","pgxind-kftx3nhd","pgxcs-kftvz1r4",2255408622,0.784,1031103671,0.359,1224304951,0.426,"310b09b7-7762-40a9-aefa-b356c6341cf5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:44:55.038000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1c50","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e7e97623-5c8a-42b4-abc6-e7b424816713","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhp3h","pgxind-kftx3njb","pgxcs-kftvz2f8",2372709797,0.825,754953189,0.263,1617756608,0.563,"e7e97623-5c8a-42b4-abc6-e7b424816713","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:55.109000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1c6b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-80690d38-0d5c-4f52-8aad-110769f818c3","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhp4p","pgxind-kftx3nkh","pgxcs-kftvz2uu",1784459822,0.621,884900189,0.308,899559633,0.313,"80690d38-0d5c-4f52-8aad-110769f818c3","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:55.148000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1cc0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8faedd92-d7fa-452a-8210-741118e516f7","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C5234","Ovarian leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C56.9","Ovary","pgxbs-kftvhp8j","pgxind-kftx3nnv","pgxcs-kftvz42w",1079560707,0.375,672652421,0.234,406908286,0.142,"8faedd92-d7fa-452a-8210-741118e516f7","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000992","ovary","{}","2020-09-10 17:44:55.269000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a1efe","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f64f2f08-7f2a-44a2-a1a6-90a77dc43d06","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhpyp","pgxind-kftx3obp","pgxcs-kftvzc8n",1225271966,0.426,501218411,0.174,724053555,0.252,"f64f2f08-7f2a-44a2-a1a6-90a77dc43d06","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:56.085000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a200e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a60b467b-e29d-4ac0-a221-dae30011a183","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhqb4","pgxind-kftx3olq","pgxcs-kftvzg5o",1770340748,0.616,625626667,0.218,1144714081,0.398,"a60b467b-e29d-4ac0-a221-dae30011a183","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:56.464000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a201e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-892e17af-42c6-437a-8816-0441e56362a4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvhqbu","pgxind-kftx3omc","pgxcs-kftvzggl",2278794249,0.793,925742913,0.322,1353051336,0.471,"892e17af-42c6-437a-8816-0441e56362a4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:44:56.486000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2089","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-4421de00-0d62-42d7-a8ca-1c8ab38d1c57","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhqgs","pgxind-kftx3gid","pgxcs-kftvzhzs",2223101027,0.773,1179292380,0.41,1043808647,0.363,"4421de00-0d62-42d7-a8ca-1c8ab38d1c57","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:56.636000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2175","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-31eb46e1-aede-4ae4-ab2b-1f85b63da6c9","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhqrj","pgxind-kftx3oy5","pgxcs-kftvzld1",1925105540,0.67,843172252,0.293,1081933288,0.376,"31eb46e1-aede-4ae4-ab2b-1f85b63da6c9","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:56.968000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a21c0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ea02c527-63bd-4793-98c3-86025d2bf13d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhquw","pgxind-kftx3gbs","pgxcs-kftvzmgd",2015489359,0.701,1063566593,0.37,951922766,0.331,"ea02c527-63bd-4793-98c3-86025d2bf13d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:57.075000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2206","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-68f4a859-0be5-4e3f-898e-bcb9bd1b3827","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhqy1","pgxind-kftx3fgj","pgxcs-kftvznha",1306766918,0.455,872122882,0.303,434644036,0.151,"68f4a859-0be5-4e3f-898e-bcb9bd1b3827","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:57.174000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2254","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-2de5878a-85d4-4a26-9e7d-8d0834cb72ec","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhr1k","pgxind-kftx3p5u","pgxcs-kftvzom8",1144287858,0.398,470210650,0.164,674077208,0.234,"2de5878a-85d4-4a26-9e7d-8d0834cb72ec","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:57.288000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2466","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1857e1ed-2584-4b12-b889-791caf08dc5e","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhrpm","pgxind-kftx3jr9","pgxcs-kftvzw7l",2675995118,0.931,686011335,0.239,1989983783,0.692,"1857e1ed-2584-4b12-b889-791caf08dc5e","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:44:58.032000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a25b8","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-50906d74-4ce3-4e48-a0fd-605a80ed0f32","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhs51","pgxind-kftx3pjw","pgxcs-kftw015t",1527475518,0.531,889324684,0.309,638150834,0.222,"50906d74-4ce3-4e48-a0fd-605a80ed0f32","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:58.509000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2857","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-855f843c-4fad-46d8-b3c0-4cd45c6998df","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhszg","pgxind-kftx3qmx","pgxcs-kftw0aym",2121998861,0.738,1275165919,0.444,846832942,0.295,"855f843c-4fad-46d8-b3c0-4cd45c6998df","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:44:59.459000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2926","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5e76fe5b-24dc-4605-a5dc-5e06dd8620e4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvht8x","pgxind-kftx3qt0","pgxcs-kftw0dxz",585583182,0.204,255020168,0.089,330563014,0.115,"5e76fe5b-24dc-4605-a5dc-5e06dd8620e4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:44:59.750000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2a1a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1bd6b341-57ee-4a60-a69b-0822550ba6d1","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhtjx","pgxind-kftx3r0s","pgxcs-kftw0hic",1834673664,0.638,876187365,0.305,958486299,0.333,"1bd6b341-57ee-4a60-a69b-0822550ba6d1","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:00.092000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2a48","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3328fb12-bf55-4f73-87e8-902249996a62","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhtlz","pgxind-kftx3r2p","pgxcs-kftw0i8q",1653471568,0.575,783603744,0.273,869867824,0.303,"3328fb12-bf55-4f73-87e8-902249996a62","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:00.156000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2a58","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c9b51f86-b26b-4329-bb28-a1298d9b7142","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhtmq","pgxind-kftx3peq","pgxcs-kftw0igh",1508683658,0.525,805508232,0.28,703175426,0.245,"c9b51f86-b26b-4329-bb28-a1298d9b7142","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:00.179000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2b51","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-0f2659dc-b65f-440d-a0a8-aefa23363346","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhty1","pgxind-kftx3f7e","pgxcs-kftw0m2r",2369600549,0.824,612154060,0.213,1757446489,0.611,"0f2659dc-b65f-440d-a0a8-aefa23363346","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:00.529000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2bef","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-87e0c11a-cf75-4877-b4c8-23aa36631b4f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhu57","pgxind-kftx3rec","pgxcs-kftw0oc6",2125245185,0.739,1277636610,0.444,847608575,0.295,"87e0c11a-cf75-4877-b4c8-23aa36631b4f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:00.753000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2de0","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-254a48ae-81ee-4334-805c-3aa2a90d1c47","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhv12","pgxind-kftx3o6x","pgxcs-kftw0vkn",1985556902,0.691,909005905,0.316,1076550997,0.374,"254a48ae-81ee-4334-805c-3aa2a90d1c47","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:01.455000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2e08","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3f0974a2-b39b-4265-b1f9-e7d8c54cbac5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhv2v","pgxind-kftx3gso","pgxcs-kftw0w7d",2747302698,0.956,1708371712,0.594,1038930986,0.361,"3f0974a2-b39b-4265-b1f9-e7d8c54cbac5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:01.513000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a2e25","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-cb6ac223-425a-430b-b44b-4a127757621d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvhv46","pgxind-kftx3run","pgxcs-kftw0wlt",2023336423,0.704,1002227629,0.349,1021108794,0.355,"cb6ac223-425a-430b-b44b-4a127757621d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:01.555000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,
"5c06951772798368d51a330b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ceeba881-5a1d-4fdc-8c9d-d60b3facecf2","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhwp1","pgxind-kftx3sug","pgxcs-kftw1emx",2491265552,0.867,733481110,0.255,1757784442,0.611,"ceeba881-5a1d-4fdc-8c9d-d60b3facecf2","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:03.316000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a34c2","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-86ae3e79-5c03-480f-8a5a-35bac00cb89d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C40.2","Long bones of lower limb and associated joints","pgxbs-kftvhx8v","pgxind-kftx3t52","pgxcs-kftw1l1a",1958392849,0.681,1124066452,0.391,834326397,0.29,"86ae3e79-5c03-480f-8a5a-35bac00cb89d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003606","limb long bone","{}","2020-09-10 17:45:03.934000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a373a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-697bd072-f6bd-4545-9c30-2c61ade688fe","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhy1e","pgxind-kftx3tlu","pgxcs-kftw1u7i",515589334,0.179,333885806,0.116,181703528,0.063,"697bd072-f6bd-4545-9c30-2c61ade688fe","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:05.174000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a37a7","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Recurrent Tumor","TCGA-82bae7ab-9577-43ea-978b-d0d31fb5eca8","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhy6b","pgxind-kftx3obp","pgxcs-kftw1vqq",1012200121,0.352,470224515,0.164,541975606,0.189,"82bae7ab-9577-43ea-978b-d0d31fb5eca8","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:05.326000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3818","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-8c227ef2-2f70-4143-81d9-de2fb8ef9607","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhybg","pgxind-kftx3tqo","pgxcs-kftw1xc4",1938681113,0.674,1300282757,0.452,638398356,0.222,"8c227ef2-2f70-4143-81d9-de2fb8ef9607","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:05.485000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3951","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1d7c6c1d-8b93-48c4-9e7f-496331430a47","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhypj","pgxind-kftx3txf","pgxcs-kftw21wp",967767867,0.337,490394534,0.171,477373333,0.166,"1d7c6c1d-8b93-48c4-9e7f-496331430a47","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:05.925000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3a36","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e25b5088-a3d4-4f3c-8335-308c571f6a30","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhyzv","pgxind-kftx3gu3","pgxcs-kftw256n",580952988,0.202,290554282,0.101,290398706,0.101,"e25b5088-a3d4-4f3c-8335-308c571f6a30","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:06.246000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3a7e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5a51541c-b1f6-4e7e-aa59-e9c74e938138","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhz37","pgxind-kftx3h3y","pgxcs-kftw268s",1784347253,0.621,908721565,0.316,875625688,0.305,"5a51541c-b1f6-4e7e-aa59-e9c74e938138","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:06.348000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3abe","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-34b60937-76b3-401c-a8dd-3f78e2b20a38","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvhz63","pgxind-kftx3sjv","pgxcs-kftw277k",1835878933,0.639,848862528,0.295,987016405,0.343,"34b60937-76b3-401c-a8dd-3f78e2b20a38","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:06.438000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3aec","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f1e4a88f-57b5-4e29-bfb2-d6fc8fdbe209","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvhz87","pgxind-kftx3kb2","pgxcs-kftw27ww",722679843,0.251,419870818,0.146,302809025,0.105,"f1e4a88f-57b5-4e29-bfb2-d6fc8fdbe209","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:06.502000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3bbf","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c0327a7b-4afa-47b5-91b8-93162b16e144","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvhzhs","pgxind-kftx3qtc","pgxcs-kftw2aya",1883684534,0.655,770041072,0.268,1113643462,0.387,"c0327a7b-4afa-47b5-91b8-93162b16e144","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:06.801000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3d17","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d7fe16e1-e892-4a4c-a491-1a6cded8467a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhzxb","pgxind-kftx3rpf","pgxcs-kftw2fze",2072758031,0.721,1273000571,0.443,799757460,0.278,"d7fe16e1-e892-4a4c-a491-1a6cded8467a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:07.287000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3d32","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ddeae3ba-7bf7-42f1-879f-c4bec9e2d318","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvhzyj","pgxind-kftx3ugf","pgxcs-kftw2gch",1947776504,0.677,809602910,0.282,1138173594,0.396,"ddeae3ba-7bf7-42f1-879f-c4bec9e2d318","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:07.324000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3d99","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-0e5df0a8-ad22-4e91-9190-11d0ca9c86c1","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi037","pgxind-kftx3r5b","pgxcs-kftw2hsy",2074585435,0.722,1132804012,0.394,941781423,0.328,"0e5df0a8-ad22-4e91-9190-11d0ca9c86c1","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:07.472000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3edc","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ddc3d466-4e2b-4e0f-a123-3d7e7fb94508","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi0hs","pgxind-kftx3p8n","pgxcs-kftw2mhr",1572587273,0.547,448428576,0.156,1124158697,0.391,"ddc3d466-4e2b-4e0f-a123-3d7e7fb94508","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:07.924000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3f20","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e7ea9645-a60b-4b94-8746-31a7377687c4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C18.6","Descending colon","pgxbs-kftvi0kw","pgxind-kftx3fs9","pgxcs-kftw2nib",1832980392,0.638,695120494,0.242,1137859898,0.396,"e7ea9645-a60b-4b94-8746-31a7377687c4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0001158","descending colon","{}","2020-09-10 17:45:08.019000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a3fbb","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d22369d7-9f7a-4e54-badc-6c800eeb7e4c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvi0rx","pgxind-kftx3us1","pgxcs-kftw2pqp",2581050945,0.898,1346262572,0.468,1234788373,0.429,"d22369d7-9f7a-4e54-badc-6c800eeb7e4c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:45:08.234000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a405d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-15811e5d-9d25-4562-b902-ccb24a1a97cf","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi0za","pgxind-kftx3ijh","pgxcs-kftw2s3q",1482090267,0.516,421529663,0.147,1060560604,0.369,"15811e5d-9d25-4562-b902-ccb24a1a97cf","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:08.461000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a40bd","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5a234a83-b7e4-4282-a8c2-f74daf2c1d4d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvi13l","pgxind-kftx3uw3","pgxcs-kftw2th5",2576339639,0.896,1180880938,0.411,1395458701,0.485,"5a234a83-b7e4-4282-a8c2-f74daf2c1d4d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:45:08.595000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a40f4","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5ff35d01-c4ab-408a-92cb-422aa4b3b4b5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi162","pgxind-kftx3ux4","pgxcs-kftw2u8v",1808681213,0.629,863740766,0.3,944940447,0.329,"5ff35d01-c4ab-408a-92cb-422aa4b3b4b5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:08.671000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4242","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-96d18f04-a2c7-4f86-a648-c18b5796a2a8","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi1l7","pgxind-kftx3lg3","pgxcs-kftw2z58",2027103086,0.705,1049223633,0.365,977879453,0.34,"96d18f04-a2c7-4f86-a648-c18b5796a2a8","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:09.141000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a42ca","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-414e11c3-8430-49a2-b08c-0b496e336cd7","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C40.3","Short bones of lower limb and associated joints","pgxbs-kftvi1rc","pgxind-kftx3pj4","pgxcs-kftw315u",1496943656,0.521,1028040786,0.358,468902870,0.163,"414e11c3-8430-49a2-b08c-0b496e336cd7","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0013630","short bone","{}","2020-09-10 17:45:09.331000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a432e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a6bbee06-44bf-446a-8d21-550aa6e71960","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi1vv","pgxind-kftx3v62","pgxcs-kftw32l9",2583805977,0.899,1173546689,0.408,1410259288,0.491,"a6bbee06-44bf-446a-8d21-550aa6e71960","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:09.472000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a433a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-20f9b5a5-8c63-43be-9247-1ec3f2d07cea","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.6","Connective, Subcutaneous and other soft tissues of trunk, NOS","pgxbs-kftvi1we","pgxind-kftx3v66","pgxcs-kftw32r3",2633921377,0.916,1200513881,0.418,1433407496,0.499,"20f9b5a5-8c63-43be-9247-1ec3f2d07cea","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003586","trunk connective tissue","{}","2020-09-10 17:45:09.489000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4351","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-e36ce5cc-f8b6-47f8-8102-7a18053d3dfc","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvi1xg","pgxind-kftx3fpt","pgxcs-kftw332s",1763938100,0.614,655269016,0.228,1108669084,0.386,"e36ce5cc-f8b6-47f8-8102-7a18053d3dfc","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:45:09.522000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4359","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-3dd4532a-8cfe-4900-8d7e-af4303645705","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi1xt","pgxind-kftx3rck","pgxcs-kftw336o",2228582292,0.775,935651135,0.325,1292931157,0.45,"3dd4532a-8cfe-4900-8d7e-af4303645705","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:09.533000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a447d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-b0969599-1e56-489e-ad92-97fac0754a24","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi2b3","pgxind-kftx3hu0","pgxcs-kftw37fs",1622814874,0.564,549879572,0.191,1072935302,0.373,"b0969599-1e56-489e-ad92-97fac0754a24","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:09.943000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a453d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-ecbc891e-ed99-4541-bda5-ede1f28aba8a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi2jt","pgxind-kftx3vek","pgxcs-kftw3a70",1471574794,0.512,505148002,0.176,966426792,0.336,"ecbc891e-ed99-4541-bda5-ede1f28aba8a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:10.212000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4595","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-20ee01d8-ec14-45f8-a347-a36434fa13b3","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvi2nt","pgxind-kftx3gjs","pgxcs-kftw3bge",1185890202,0.412,652786547,0.227,533103655,0.185,"20ee01d8-ec14-45f8-a347-a36434fa13b3","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:10.334000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a45eb","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-05fc5924-07b1-422e-9d7c-7c0051f72368","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi2rn","pgxind-kftx3k28","pgxcs-kftw3cpn",1831364177,0.637,960897265,0.334,870466912,0.303,"05fc5924-07b1-422e-9d7c-7c0051f72368","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:10.454000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a470e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-673f7169-6924-42a2-b705-1815d4445044","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi34v","pgxind-kftx3rep","pgxcs-kftw3gx7",2722153331,0.947,824649460,0.287,1897503871,0.66,"673f7169-6924-42a2-b705-1815d4445044","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:10.862000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4796","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-84c516a9-e31e-486b-b6a6-15d6e2a6ce18","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi3b5","pgxind-kftx3no7","pgxcs-kftw3iys",2520073906,0.877,851657612,0.296,1668416294,0.58,"84c516a9-e31e-486b-b6a6-15d6e2a6ce18","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:11.053000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a48b1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-c91f6f45-ebfb-45cc-a0dd-9862b375336c","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi3nz","pgxind-kftx3vqj","pgxcs-kftw3n28",1924704644,0.669,1088360550,0.379,836344094,0.291,"c91f6f45-ebfb-45cc-a0dd-9862b375336c","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:11.450000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4920","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f0f372c1-849d-4209-9e50-2c7639626d85","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvi3t0","pgxind-kftx3imi","pgxcs-kftw3oq8",2027702913,0.705,1123157148,0.391,904545765,0.315,"f0f372c1-849d-4209-9e50-2c7639626d85","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:11.604000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4b08","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-5fe06294-b8b6-4e3f-a6ea-dc981cd9bb05","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi4f3","pgxind-kftx3rs2","pgxcs-kftw3vsf",2339964037,0.814,1280802642,0.445,1059161395,0.368,"5fe06294-b8b6-4e3f-a6ea-dc981cd9bb05","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:12.287000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4baa","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-83b89602-d430-4b8c-b29b-ebdecd9415a5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.5","Connective, Subcutaneous and other soft tissues of pelvis","pgxbs-kftvi4mf","pgxind-kftx3vza","pgxcs-kftw3y5x",2658144151,0.925,983499215,0.342,1674644936,0.582,"83b89602-d430-4b8c-b29b-ebdecd9415a5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003594","pelvis connective tissue","{}","2020-09-10 17:45:12.515000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4bbe","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-bcaea097-8911-4503-8af9-e7e0515d1529","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi4nb","pgxind-kftx3l4q","pgxcs-kftw3yfn",2198804728,0.765,811515192,0.282,1387289536,0.483,"bcaea097-8911-4503-8af9-e7e0515d1529","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:12.542000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4c9e","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-32f8354a-7d2f-467b-afed-e7f91369615f","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvi4xh","pgxind-kftx3nya","pgxcs-kftw41t2",1846789075,0.642,958849074,0.334,887940001,0.309,"32f8354a-7d2f-467b-afed-e7f91369615f","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:45:12.858000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4cfd","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a612b7da-1ddd-4a92-8d9a-674f26f98d8a","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi51s","pgxind-kftx3u6d","pgxcs-kftw437v",2242826857,0.78,892251375,0.31,1350575482,0.47,"a612b7da-1ddd-4a92-8d9a-674f26f98d8a","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:12.991000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4d4f","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-4c93c0a4-73c4-48ef-91e0-40b2143833bc","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi55h","pgxind-kftx3uww","pgxcs-kftw44gu",1807991295,0.629,692376126,0.241,1115615169,0.388,"4c93c0a4-73c4-48ef-91e0-40b2143833bc","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:13.106000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4d5d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-d49488be-65dd-419f-a768-e60d454417a5","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi564","pgxind-kftx3tch","pgxcs-kftw44np",1855867186,0.646,804469447,0.28,1051397739,0.366,"d49488be-65dd-419f-a768-e60d454417a5","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:13.126000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4ebb","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-46be2946-a6f4-426a-a589-3a616cb77eca","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi5lu","pgxind-kftx3sat","pgxcs-kftw49tj",1940428698,0.675,822175370,0.286,1118253328,0.389,"46be2946-a6f4-426a-a589-3a616cb77eca","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:13.613000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a4f12","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-80c1a2ac-afff-46c8-b4a6-8f2f46f32211","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi5pw","pgxind-kftx3ts9","pgxcs-kftw4b3a",2099979925,0.73,789924984,0.275,1310054941,0.456,"80c1a2ac-afff-46c8-b4a6-8f2f46f32211","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:13.735000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a50e5","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-96403ba9-28a3-4bfd-a53c-6d9ecd05ebb4","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.3","Connective, Subcutaneous and other soft tissues of thorax","pgxbs-kftvi6b4","pgxind-kftx3ueq","pgxcs-kftw4hzf",1633487118,0.568,948924216,0.33,684562902,0.238,"96403ba9-28a3-4bfd-a53c-6d9ecd05ebb4","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003837","thoracic segment connective tissue","{}","2020-09-10 17:45:14.389000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5166","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-b6852026-f3ff-4830-b9d6-a998adce6fdd","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.1","Connective, Subcutaneous and other soft tissues of upper limb and shoulder","pgxbs-kftvi6gz","pgxind-kftx3iit","pgxcs-kftw4jtt",1970578710,0.685,911526178,0.317,1059052532,0.368,"b6852026-f3ff-4830-b9d6-a998adce6fdd","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003579","shoulder connective tissue","{}","2020-09-10 17:45:14.570000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a517d","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-40bbddf9-5d42-4d41-991b-60ea008e5e37","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi6i1","pgxind-kftx3ovs","pgxcs-kftw4k61",1884870283,0.656,1007395055,0.35,877475228,0.305,"40bbddf9-5d42-4d41-991b-60ea008e5e37","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:14.603000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a52f1","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-7254c2ac-d8ac-4d6e-b444-4cb5f8a6eb36","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi6yv","pgxind-kftx3icq","pgxcs-kftw4ppx",2524011527,0.878,1030425828,0.358,1493585699,0.52,"7254c2ac-d8ac-4d6e-b444-4cb5f8a6eb36","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:15.141000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5435","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-06990702-c200-403c-ad6f-5cb78a15bf55","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvi7dg","pgxind-kftx3i5l","pgxcs-kftw4ufg",1747299411,0.608,693243041,0.241,1054056370,0.367,"06990702-c200-403c-ad6f-5cb78a15bf55","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:45:15.591000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a553a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-a4a04cce-6a96-44b2-bf26-ba558afef381","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi7pc","pgxind-kftx3wci","pgxcs-kftw4y9n",1950841325,0.679,1122541502,0.39,828299823,0.288,"a4a04cce-6a96-44b2-bf26-ba558afef381","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:15.956000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5637","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-f53143de-2704-4638-94e2-3661c1dbb3b9","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi80v","pgxind-kftx3n5l","pgxcs-kftw51yk",2179057948,0.758,901534015,0.314,1277523933,0.444,"f53143de-2704-4638-94e2-3661c1dbb3b9","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:16.310000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a566a","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-30c8f2c5-9aac-4c5b-b621-31e6c5f3c84d","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi83a","pgxind-kftx3spo","pgxcs-kftw52rb",1618952613,0.563,527548684,0.183,1091403929,0.38,"30c8f2c5-9aac-4c5b-b621-31e6c5f3c84d","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:16.380000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a57ca","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-1c323559-f2d0-480b-9dab-9ac014fa9c41","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C48.0","Retroperitoneum","pgxbs-kftvi8j8","pgxind-kftx3t5i","pgxcs-kftw57w0",1066954044,0.371,347971391,0.121,718982653,0.25,"1c323559-f2d0-480b-9dab-9ac014fa9c41","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:16.869000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5839","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-980d8a35-44ef-415f-b7b2-89a4bc18515b","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.2","Connective, Subcutaneous and other soft tissues of lower limb and hip","pgxbs-kftvi8o8","pgxind-kftx3pnl","pgxcs-kftw59gp",1705807032,0.593,791809429,0.275,913997603,0.318,"980d8a35-44ef-415f-b7b2-89a4bc18515b","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003576","hip connective tissue","{}","2020-09-10 17:45:17.024000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a58ad","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-988185cf-a54c-4335-a4ab-f59ce3a470ea","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C54.9","Corpus uteri","pgxbs-kftvi8tg","pgxind-kftx3vbs","pgxcs-kftw5b7f",2429697265,0.845,636302559,0.221,1793394706,0.624,"988185cf-a54c-4335-a4ab-f59ce3a470ea","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:45:17.189000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5a3c","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-784f6b88-9046-4fff-b061-81ee0bb27392","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma","icdot-C48.0","Retroperitoneum","pgxbs-kftvi9kx","pgxind-kftx3m0j","pgxcs-kftw5gyv",2151668254,0.748,1083826448,0.377,1067841806,0.371,"784f6b88-9046-4fff-b061-81ee0bb27392","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003693","retroperitoneal space","{}","2020-09-10 17:45:17.750000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c06951872798368d51a5b1b","pgxcohort-TCGA","TCGA samples","DUO:0000004","no restriction","Primary Tumor","TCGA-44a95fa6-eb07-4d7f-aa82-a0146f782d53","TCGA biosample id","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C49.0","Connective, Subcutaneous and other soft tissues of head, face, and neck","pgxbs-kftvi9v2","pgxind-kftx3tyn","pgxcs-kftw5k9g",2123646874,0.739,909508774,0.316,1214138100,0.422,"44a95fa6-eb07-4d7f-aa82-a0146f782d53","{}",0,0,"Point","XXX",,,,0,0,,"Feature","EFO:0009656","neoplastic sample","UBERON:0003566","head connective tissue","{}","2020-09-10 17:45:18.064000",,,,,,,"TCGA-SARC","TCGA-SARC project",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-TCGAcancers","TCGA Cancer samples","TCGA UUID","TCGA project ID","TCGA collection","TCGA-ALL-SAMPLES","TCGA collection","not reported",,,,,,,,,,,,,,,,,,,,,,
"5c865cb309d374f2dc2fb445","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievq","pgxind-kftx42ok","pgxcs-kftw749p",940263124,0.327,378705952,0.132,561557172,0.195,"PGX_AM_BS_GSM197635","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.088000",,,,,,"P66Y","geo:GSE8046","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,"geo:gsm","geo:GSM197635","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.9,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c865cb309d374f2dc2fb448","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievv","pgxind-kftx42oq","pgxcs-kftw74b5",1679511679,0.584,663457338,0.231,1016054341,0.353,"PGX_AM_BS_GSM198510","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.092000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE8046","",,,,"geo:gsm","geo:GSM198510","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c865cb309d374f2dc2fb449","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievx","pgxind-kftx42os","pgxcs-kftw74bn",1559887469,0.543,722728318,0.251,837159151,0.291,"PGX_AM_BS_GSM198600","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.094000",,,,,,,"geo:GSE8046","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,"geo:gsm","geo:GSM198600","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c865cb309d374f2dc2fb44a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvievy","pgxind-kftx42ou","pgxcs-kftw74c5",1675245781,0.583,844253896,0.294,830991885,0.289,"PGX_AM_BS_GSM198601","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.095000",,,,,,"P72Y","geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE8046","",,,,"geo:gsm","geo:GSM198601","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c865cb309d374f2dc2fb44f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSM198668","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftview7","pgxind-kftx42p4","pgxcs-kftw74ek",1534475541,0.534,617963022,0.215,916512519,0.319,"PGX_AM_BS_GSM198668","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.102000",,,,,,,"PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE8046","",,,,"geo:gpl","geo:GPL2005","","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c865cb309d374f2dc2fb456","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSM198675","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewi","pgxind-kftx42pi","pgxcs-kftw74hy",1479605977,0.515,561919327,0.195,917686650,0.319,"PGX_AM_BS_GSM198675","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.112000",,,,,,"P44Y","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE8046","",,,,"geo:gpl","geo:GPL2005","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c865cb309d374f2dc2fb458","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSE8046","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewm","pgxind-kftx42pn","pgxcs-kftw74iw",810088207,0.282,296183381,0.103,513904826,0.179,"PGX_AM_BS_GSM198677","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.115000",,,,,,"P60Y","geo:GPL2005","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,"geo:gsm","geo:GSM198677","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c865cb309d374f2dc2fb45a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviewp","pgxind-kftx42pr","pgxcs-kftw74jv",1171231880,0.407,504390290,0.175,666841590,0.232,"PGX_AM_BS_GSM198679","{}",-81.1,32.08,"Point","USA","Savannah","United States of America","Savannah, United States",32.08,-81.1,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:24.118000",,,,,,"P69Y","geo:GSE8046","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:17909028","Johnson JE, Gettings EJ et al. (2007): Whole-genome profiling in liposarcomas reveals genetic...",,,,"geo:gsm","geo:GSM198679","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c865da009d374f2dc31626f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6e","pgxind-kftx46q8","pgxcs-kftw84lp",2122922120,0.738,1455589607,0.506,667332513,0.232,"PGX_AM_BS_GSM312349","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.795000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,"geo:gsm","geo:GSM312349","","arraymap import",,,,,,,,,,,,,,,,
"5c865da009d374f2dc316274","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312354","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6m","pgxind-kftx46qi","pgxcs-kftw84o3",634980010,0.221,463458840,0.161,171521170,0.06,"PGX_AM_BS_GSM312354","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.802000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,,
"5c865da009d374f2dc316275","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312355","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6o","pgxind-kftx46qk","pgxcs-kftw84ol",705515286,0.245,289640598,0.101,415874688,0.145,"PGX_AM_BS_GSM312355","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.804000",,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,,
"5c865da009d374f2dc316278","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GPL4723","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6t","pgxind-kftx46qq","pgxcs-kftw84q0",1806171104,0.628,731301668,0.254,1074869436,0.374,"PGX_AM_BS_GSM312358","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.808000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,"geo:gsm","geo:GSM312358","","arraymap import",,,,,,,,,,,,,,,,
"5c865da009d374f2dc316279","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6v","pgxind-kftx46qs","pgxcs-kftw84qi",1628029635,0.566,1128501297,0.393,499528338,0.174,"PGX_AM_BS_GSM312359","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.810000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,"geo:gsm","geo:GSM312359","","arraymap import",,,,,,,,,,,,,,,,
"5c865da009d374f2dc31627b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii6y","pgxind-kftx46qw","pgxcs-kftw84tb",2125269965,0.739,1265520484,0.44,859749481,0.299,"PGX_AM_BS_GSM312361","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.813000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,"geo:gsm","geo:GSM312361","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc31627f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312365","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii74","pgxind-kftx46r4","pgxcs-kftw84va",561122110,0.195,145817058,0.051,415305052,0.144,"PGX_AM_BS_GSM312365","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.818000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE12439","",,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc316281","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GPL4723","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii77","pgxind-kftx46r8","pgxcs-kftw84w9",447662691,0.156,302836039,0.105,144826652,0.05,"PGX_AM_BS_GSM312367","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.821000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,"geo:gsm","geo:GSM312367","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc316288","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312374","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii7j","pgxind-kftx46rm","pgxcs-kftw84zm",2429798533,0.845,1492887556,0.519,936910977,0.326,"PGX_AM_BS_GSM312374","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.831000",,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc31628f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312381","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii7u","pgxind-kftx46s0","pgxcs-kftw8530",1461382828,0.508,922115360,0.321,539267468,0.188,"PGX_AM_BS_GSM312381","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.841000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE12439","",,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc316290","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii7w","pgxind-kftx46s2","pgxcs-kftw853i",1813458566,0.631,783031554,0.272,1030427012,0.358,"PGX_AM_BS_GSM312382","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.842000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE12439","",,,,"geo:gsm","geo:GSM312382","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc316294","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312386","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii83","pgxind-kftx46sa","pgxcs-kftw855f",752604429,0.262,686347787,0.239,66256642,0.023,"PGX_AM_BS_GSM312386","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.848000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8q","pgxind-kftx46t3","pgxcs-kftw85cb",697001109,0.242,572592960,0.199,124408149,0.043,"PGX_AM_BS_GSM312400","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.867000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,"geo:gsm","geo:GSM312400","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM312403","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8v","pgxind-kftx46t9","pgxcs-kftw85dt",1003196336,0.349,490138598,0.17,513057738,0.178,"PGX_AM_BS_GSM312403","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.871000",,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM315235","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii8y","pgxind-kftx46td","pgxcs-kftw85er",1448904201,0.504,718746350,0.25,730157851,0.254,"PGX_AM_BS_GSM315235","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.874000",,,,,,,"geo:GSE12439","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL7203","",,,,"pubmed","PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...","arraymap import",,,,,,,,,,,,,,,,
"5c865da109d374f2dc3162a8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM315236","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii90","pgxind-kftx46tf","pgxcs-kftw85f9",681664575,0.237,401486331,0.14,280178244,0.097,"PGX_AM_BS_GSM315236","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.876000",,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL7203","",,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,,
"5c865da209d374f2dc3162ab","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","chondrosarcoma","geo:GSM315239","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvii95","pgxind-kftx46tl","pgxcs-kftw85gq",2699662705,0.939,1014365662,0.353,1685297043,0.586,"PGX_AM_BS_GSM315239","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:27.880000",,,,,,,"PMID:19336518","Hallor KH, Staaf J et al. (2009): Genomic profiling of chondrosarcoma: chromosomal patterns...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL7203","",,,,"geo:gse","geo:GSE12439","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d22","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviim5","pgxind-kftx479m","pgxcs-kftw89gh",1486175803,0.517,860328301,0.299,625847502,0.218,"PGX_AM_BS_GSM322076","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.287000",,,,,,,"geo:GSE12830","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM322076","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d25","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322079","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviima","pgxind-kftx479s","pgxcs-kftw89hy",1511156054,0.526,875068180,0.304,636087874,0.221,"PGX_AM_BS_GSM322079","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.292000",,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE12830","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL4091","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d26","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL4091","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimc","pgxind-kftx479u","pgxcs-kftw89ig",1584602300,0.551,869442765,0.302,715159535,0.249,"PGX_AM_BS_GSM322086","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.293000",,,,,,,"geo:GSE12830","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM322086","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d27","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322087","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimd","pgxind-kftx479w","pgxcs-kftw89iy",1356898124,0.472,1010844155,0.352,346053969,0.12,"PGX_AM_BS_GSM322087","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.295000",,,,,,,"PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE12830","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL4091","","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d28","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM322088","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimf","pgxind-kftx479y","pgxcs-kftw89jf",1473578856,0.513,1044495155,0.363,429083701,0.149,"PGX_AM_BS_GSM322088","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.296000",,,,,,,"geo:GSE12830","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","arraymap import",,,,,,,,,,,,,,,,
"5c865dbf09d374f2dc318d2d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:19286668","Sadikovic B, Yoshimoto M et al. (2009): Identification of interactive networks of gene...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftviimn","pgxind-kftx47a8","pgxcs-kftw89md",1729726793,0.602,927149153,0.322,802577640,0.279,"PGX_AM_BS_GSM322094","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:28.304000",,,,,,,"geo:GSE12830","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM322094","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a452","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GPL4723","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviip5","pgxind-kftx47db","pgxcs-kftw8aez",841628626,0.293,609552330,0.212,232076296,0.081,"PGX_AM_BS_GSM346706","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.381000",,,,,,,"geo:GSE13775","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,"geo:gsm","geo:GSM346706","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a461","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","geo:GSM346721","","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipu","pgxind-kftx47e5","pgxcs-kftw8amg",1664421599,0.579,1557819036,0.542,106602563,0.037,"PGX_AM_BS_GSM346721","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.402000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,,,"pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a462","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346722","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipv","pgxind-kftx47e8","pgxcs-kftw8amy",892759797,0.311,862145667,0.3,30614130,0.011,"PGX_AM_BS_GSM346722","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.403000",,,,,,,"PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL4723","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:GSE13775","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a464","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviipz","pgxind-kftx47ec","pgxcs-kftw8anx",690685514,0.24,52041419,0.018,638644095,0.222,"PGX_AM_BS_GSM346724","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.406000",,,,,,,"geo:GSE13775","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM346724","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc809d374f2dc31a46f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346735","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqg","pgxind-kftx47ey","pgxcs-kftw8at9",882390650,0.307,120617942,0.042,761772708,0.265,"PGX_AM_BS_GSM346735","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.422000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a472","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","undifferentiated pleomorphic sarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C27096","Undifferentiated (Embryonal) Sarcoma","icdom-88053","Undifferentiated sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqm","pgxind-kftx47f4","pgxcs-kftw8aup",836545678,0.291,683552322,0.238,152993356,0.053,"PGX_AM_BS_GSM346738","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.426000",,,,,,,"geo:GSE13775","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4723","",,,,"geo:gsm","geo:GSM346738","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a474","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqp","pgxind-kftx47f8","pgxcs-kftw8avo",1683322260,0.586,295768307,0.103,1387553953,0.483,"PGX_AM_BS_GSM346740","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.429000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","geo:gpl","geo:gse","geo:GSE13775","",,,,"geo:gsm","geo:GSM346740","","arraymap import",,,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a477","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346743","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqu","pgxind-kftx47fe","pgxcs-kftw8ax5",1655178645,0.576,1452049150,0.505,203129495,0.071,"PGX_AM_BS_GSM346743","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.434000",,,,,,,"geo:GPL4723","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE13775","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865dc909d374f2dc31a478","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","leiomyosarcoma","geo:GSM346744","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviiqv","pgxind-kftx47fg","pgxcs-kftw8aze",1104219917,0.384,844066867,0.294,260153050,0.09,"PGX_AM_BS_GSM346744","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:28.435000",,,,,,,"geo:GSE13775","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4723","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:19290004","Carneiro A, Francis P et al. (2009): Indistinguishable genomic profiles and shared prognostic...","arraymap import",,,,,,,,,,,,,,,,
"5c865ead09d374f2dc32eeba","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondroblastic osteosarcoma","geo:GSM185261","","pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma","icdot-C41.9","bone, NOS","pgxbs-kftvim3m","pgxind-kftx4b6y","pgxcs-kftw98y2",412127656,0.143,222719595,0.077,189408061,0.066,"PGX_AM_BS_GSM185261","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:31.849000",,,,,,,"PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","pubmed","geo:gse","geo:GSE7692","",,,,"geo:gpl","geo:GPL4894","","arraymap import",,,,,,,,,,,,,,,,
"5c865eb109d374f2dc32ef94","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma [cell line Rh18c]","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvimdm","pgxind-kftx4bj8","pgxcs-kftw9c1h",1537631620,0.535,860854338,0.299,676777282,0.235,"PGX_AM_BS_GSM186447","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:32.156000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE7692","",,,,"cellosaurus","cellosaurus:CVCL_DG02","","arraymap import",,,,,,,,,"geo:gsm","geo:GSM186447","",,,,,
"5c865eb109d374f2dc32ef95","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma [cell line Rh18c]","cellosaurus:CVCL_DG02","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvimdo","pgxind-kftx4bja","pgxcs-kftw9c1z",1869065666,0.65,1038104689,0.361,830960977,0.289,"PGX_AM_BS_GSM186448","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:32.158000",,,,,,,"geo:GSM186448","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,"geo:gpl","geo:GPL4894","","arraymap import",,,,,,,,,"geo:gse","geo:GSE7692","",,,,,
"5c865eb109d374f2dc32ef96","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Rhabdomyosarcoma [cell line Rh30]","cellosaurus:CVCL_0041","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvimdq","pgxind-kftx4bjc","pgxcs-kftw9c2h",515625954,0.179,291871002,0.102,223754952,0.078,"PGX_AM_BS_GSM186449","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:32.159000",,,,,,,"geo:GSM186449","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,"geo:gse","geo:GSE7692","","arraymap import",,,,,,,,,"geo:gpl","geo:GPL4894","",,,,,
"5c865eb309d374f2dc32efcf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM186529","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C76.2","abdomen, NOS","pgxbs-kftvimga","pgxind-kftx4bmk","pgxcs-kftw9cub",392935497,0.137,247039608,0.086,145895889,0.051,"PGX_AM_BS_GSM186529","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000916","abdomen","{}","2020-09-10 17:45:32.243000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gpl","geo:gse","geo:GSE7692","",,,,"pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","arraymap import",,,,,,,,,,,,,,,,
"5c865eb409d374f2dc32efff","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C64.9","kidney","pgxbs-kftvimih","pgxind-kftx4bpb","pgxcs-kftw9djh",343581316,0.12,250069282,0.087,93512034,0.033,"PGX_AM_BS_GSM186581","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002113","kidney","{}","2020-09-10 17:45:32.310000",,,,,,,"geo:GSE7692","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"pubmed","geo:gse","geo:gpl","geo:GPL4894","",,,,"geo:gsm","geo:GSM186581","","arraymap import",,,,,,,,,,,,,,,,
"5c865eb409d374f2dc32f00c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSE7692","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C64.9","kidney","pgxbs-kftvimj2","pgxind-kftx4bq1","pgxcs-kftw9dpt",654466399,0.228,540100799,0.188,114365600,0.04,"PGX_AM_BS_GSM186597","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002113","kidney","{}","2020-09-10 17:45:32.328000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,"geo:gsm","geo:GSM186597","","arraymap import",,,,,,,,,,,,,,,,
"5c865eb509d374f2dc32f03c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSM186645","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C64.9","kidney","pgxbs-kftviml8","pgxind-kftx4bsr","pgxcs-kftw9eda",240581874,0.084,18358391,0.006,222223483,0.077,"PGX_AM_BS_GSM186645","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002113","kidney","{}","2020-09-10 17:45:32.395000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gpl","geo:gse","geo:GSE7692","",,,,"pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...","arraymap import",,,,,,,,,,,,,,,,
"5c865eb509d374f2dc32f03d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSE7692","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C64.9","kidney","pgxbs-kftvimla","pgxind-kftx4bst","pgxcs-kftw9eds",339812170,0.118,0,0,339812170,0.118,"PGX_AM_BS_GSM186646","{}",-75.4,40.09,"Point","USA","King of Prussia","United States of America","King of Prussia, United States",40.09,-75.4,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002113","kidney","{}","2020-09-10 17:45:32.396000",,,,,,,"geo:GPL4894","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","pubmed","PMID:17440070","Greshock J, Nathanson K et al. (2007): Cancer cell lines as genetic models...",,,,"geo:gsm","geo:GSM186646","","arraymap import",,,,,,,,,,,,,,,,
"5c865f1a09d374f2dc33da6c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GPL2879","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinoi","pgxind-kftx4d4z","pgxcs-kftw9qo1",272880734,0.095,118044460,0.041,154836274,0.054,"PGX_AM_BS_GSM475469","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.608000",,,,,,,"geo:GSE19180","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:24330824","Yang J, Zhao L, Tian W et al. (2013): Correlation of WWOX, RUNX2 and VEGFA...",,,,"geo:gsm","geo:GSM475469","","arraymap import",,,,,,,,,,,,,,,,
"5c865f1f09d374f2dc33e2fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U2OS]","geo:GSE11411","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinqr","pgxind-kftx4d7r","pgxcs-kftw9rd0",1655331216,0.576,686401728,0.239,968929488,0.337,"PGX_AM_BS_GSM287989","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.677000",,,,,,,"geo:GPL4091","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:18698372","Sadikovic B, Yoshimoto M et al. (2008): In vitro analysis of integrated global...",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM287989","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0042","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c865f1f09d374f2dc33e2fe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U2OS]","geo:GSM287990","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvinqt","pgxind-kftx4d7u","pgxcs-kftw9rdi",1865776283,0.649,725469507,0.252,1140306776,0.397,"PGX_AM_BS_GSM287990","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:33.678000",,,,,,,"cellosaurus:CVCL_0042","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","pubmed","PMID:18698372","Sadikovic B, Yoshimoto M et al. (2008): In vitro analysis of integrated global...",,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE11411","","arraymap import",,,,,,,,,"geo:gpl","geo:GPL4091","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c865fd909d374f2dc35ed04","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GSM484745","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviq2h","pgxind-kftx4g3k","pgxcs-kftwah3v",598387269,0.208,121321974,0.042,477065295,0.166,"PGX_AM_BS_GSM484745","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:36.691000",,,,,,,"PMID:20197395","Mitchell MA, Johnson JE et al. (2010): Doxorubicin resistance in a novel in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL2005","",,,,"geo:gse","geo:GSE19449","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c865fd909d374f2dc35ed05","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviq2i","pgxind-kftx4g3m","pgxcs-kftwah4c",1446761250,0.503,628127728,0.218,818633522,0.285,"PGX_AM_BS_GSM484746","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:36.693000",,,,,,,"geo:GSE19449","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20197395","Mitchell MA, Johnson JE et al. (2010): Doxorubicin resistance in a novel in...",,,,"geo:gsm","geo:GSM484746","","arraymap import",0.68,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aa1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwk","pgxind-kftx4m24","pgxcs-kftwbync",276927144,0.096,69503698,0.024,207423446,0.072,"PGX_AM_BS_GSM528891","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.117000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,"geo:gsm","geo:GSM528891","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aa2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwm","pgxind-kftx4m26","pgxcs-kftwbynu",159773033,0.056,92712400,0.032,67060633,0.023,"PGX_AM_BS_GSM528892","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.119000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM528892","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aa3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwo","pgxind-kftx4m28","pgxcs-kftwbyob",520390337,0.181,401613683,0.14,118776654,0.041,"PGX_AM_BS_GSM528893","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.120000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,"geo:gsm","geo:GSM528893","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aa4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528894","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwp","pgxind-kftx4m2a","pgxcs-kftwbyos",475419851,0.165,195924110,0.068,279495741,0.097,"PGX_AM_BS_GSM528894","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.122000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.36,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aa5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528895","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwr","pgxind-kftx4m2c","pgxcs-kftwbypa",53407673,0.019,2728838,0.001,50678835,0.018,"PGX_AM_BS_GSM528895","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.123000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,"geo:gse","geo:GSE21123","","arraymap import",0.24,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aaa","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528900","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuwz","pgxind-kftx4m2n","pgxcs-kftwbytz",558287817,0.194,290667184,0.101,267620633,0.093,"PGX_AM_BS_GSM528900","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.130000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,"geo:gpl","geo:GPL3720","","arraymap import",0.36,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.44,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aac","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviux2","pgxind-kftx4m2r","pgxcs-kftwbyuz",1256721844,0.437,672245684,0.234,584476160,0.203,"PGX_AM_BS_GSM528902","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.133000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,"geo:gsm","geo:GSM528902","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7aaf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528905","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviux7","pgxind-kftx4m2x","pgxcs-kftwbywf",407930050,0.142,358868276,0.125,49061774,0.017,"PGX_AM_BS_GSM528905","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.137000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7ab1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528907","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxb","pgxind-kftx4m32","pgxcs-kftwbyxe",869174276,0.302,506158240,0.176,363016036,0.126,"PGX_AM_BS_GSM528907","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.140000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,"geo:gpl","geo:GPL3720","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7ab4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxf","pgxind-kftx4m38","pgxcs-kftwbyyu",799829315,0.278,376057846,0.131,423771469,0.147,"PGX_AM_BS_GSM528910","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.145000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM528910","","arraymap import",0.24,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7ab7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxk","pgxind-kftx4m3e","pgxcs-kftwbz0a",1438950868,0.501,746550317,0.26,692400551,0.241,"PGX_AM_BS_GSM528913","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.149000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,"geo:gsm","geo:GSM528913","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7ab9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxo","pgxind-kftx4m3i","pgxcs-kftwbz19",364377066,0.127,300222129,0.104,64154937,0.022,"PGX_AM_BS_GSM528915","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.152000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM528915","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7abb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxr","pgxind-kftx4m3m","pgxcs-kftwbz28",1246886353,0.434,593623791,0.206,653262562,0.227,"PGX_AM_BS_GSM528917","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.155000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM528917","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618709d374f2dc3b7abc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuxt","pgxind-kftx4m3o","pgxcs-kftwbz2p",650159485,0.226,424194664,0.148,225964821,0.079,"PGX_AM_BS_GSM528918","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.156000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,"geo:gsm","geo:GSM528918","","arraymap import",0.44,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5c86618709d374f2dc3b7aca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GSM528932","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuyh","pgxind-kftx4m4h","pgxcs-kftwbz9f",371625461,0.129,254548366,0.089,117077095,0.041,"PGX_AM_BS_GSM528932","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.176000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7acd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuym","pgxind-kftx4m4n","pgxcs-kftwbzav",1397122176,0.486,621179273,0.216,775942903,0.27,"PGX_AM_BS_GSM528935","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.181000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM528935","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7acf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuyp","pgxind-kftx4m4r","pgxcs-kftwbzbv",669202016,0.233,344125390,0.12,325076626,0.113,"PGX_AM_BS_GSM528937","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.184000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,"geo:gsm","geo:GSM528937","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7ad1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma,Dedifferentiated","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuys","pgxind-kftx4m4v","pgxcs-kftwbzcu",40722459,0.014,1185942,0,39536517,0.014,"PGX_AM_BS_GSM528939","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.187000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,"geo:gsm","geo:GSM528939","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7ae9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviuzw","pgxind-kftx4m68","pgxcs-kftwbzoi",819166493,0.285,674781520,0.235,144384973,0.05,"PGX_AM_BS_GSM528963","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.221000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528963","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7aef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM528993","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv07","pgxind-kftx4m6k","pgxcs-kftwc05f",1209459183,0.421,273152361,0.095,936306822,0.326,"PGX_AM_BS_GSM528993","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.230000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.44,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618809d374f2dc3b7af4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528974","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0f","pgxind-kftx4m6u","pgxcs-kftwbztx",1795577072,0.625,1309712400,0.456,485864672,0.169,"PGX_AM_BS_GSM528974","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.237000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL3720","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7af6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528976","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0i","pgxind-kftx4m6y","pgxcs-kftwbzuw",702466648,0.244,414945925,0.144,287520723,0.1,"PGX_AM_BS_GSM528976","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.240000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618809d374f2dc3b7afb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528981","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0r","pgxind-kftx4m78","pgxcs-kftwbzxc",2186446171,0.761,970786114,0.338,1215660057,0.423,"PGX_AM_BS_GSM528981","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.248000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:GSE21123","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7afe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528984","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv0w","pgxind-kftx4m7e","pgxcs-kftwbzys",660765058,0.23,438506435,0.153,222258623,0.077,"PGX_AM_BS_GSM528984","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.252000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b06","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv19","pgxind-kftx4m7v","pgxcs-kftwbzrg",1355785207,0.472,618306950,0.215,737478257,0.257,"PGX_AM_BS_GSM528969","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.263000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM528969","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b07","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM528994","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1b","pgxind-kftx4m7x","pgxcs-kftwc05w",1750658560,0.609,856190758,0.298,894467802,0.311,"PGX_AM_BS_GSM528994","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.265000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,"geo:gse","geo:GSE21123","","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b08","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1c","pgxind-kftx4m7z","pgxcs-kftwc06e",2306120958,0.802,886774093,0.308,1419346865,0.494,"PGX_AM_BS_GSM528995","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.266000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM528995","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b09","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1e","pgxind-kftx4m81","pgxcs-kftwc06w",497948141,0.173,1557173,0.001,496390968,0.173,"PGX_AM_BS_GSM528996","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.268000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,"geo:gsm","geo:GSM528996","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b0a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM528997","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1f","pgxind-kftx4m83","pgxcs-kftwc07d",1867043815,0.649,976176364,0.34,890867451,0.31,"PGX_AM_BS_GSM528997","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.269000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b0b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1h","pgxind-kftx4m85","pgxcs-kftwc07v",2117571983,0.737,1080698475,0.376,1036873508,0.361,"PGX_AM_BS_GSM528998","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.271000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM528998","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b0d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1k","pgxind-kftx4m89","pgxcs-kftwc08u",1095778207,0.381,540899245,0.188,554878962,0.193,"PGX_AM_BS_GSM529000","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.274000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529000","","arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b0e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529001","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1m","pgxind-kftx4m8b","pgxcs-kftwc09c",1220876441,0.425,613073042,0.213,607803399,0.211,"PGX_AM_BS_GSM529001","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.275000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,"geo:gpl","geo:GPL3720","","arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b10","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1p","pgxind-kftx4m8f","pgxcs-kftwc0aa",1727542646,0.601,903488830,0.314,824053816,0.287,"PGX_AM_BS_GSM529003","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.278000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,"geo:gsm","geo:GSM529003","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b11","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1r","pgxind-kftx4m8h","pgxcs-kftwc0as",763078032,0.265,577236138,0.201,185841894,0.065,"PGX_AM_BS_GSM529004","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.280000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529004","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b12","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529005","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1s","pgxind-kftx4m8j","pgxcs-kftwc0b9",1420449301,0.494,809528213,0.282,610921088,0.212,"PGX_AM_BS_GSM529005","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.281000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,"geo:gpl","geo:GPL3720","","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b14","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1w","pgxind-kftx4m8n","pgxcs-kftwc0c8",1504605533,0.523,865879366,0.301,638726167,0.222,"PGX_AM_BS_GSM529007","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.284000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529007","","arraymap import",0.44,"SNP2pop 1000 Genomes population","HANCESTRO:0502","Vietnamese",0.76,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5c86618909d374f2dc3b7b15","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529008","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1y","pgxind-kftx4m8p","pgxcs-kftwc0cq",1102318230,0.383,550560076,0.191,551758154,0.192,"PGX_AM_BS_GSM529008","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.286000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b16","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529009","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv1z","pgxind-kftx4m8s","pgxcs-kftwc0d7",380770712,0.132,194061548,0.067,186709164,0.065,"PGX_AM_BS_GSM529009","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.287000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,"geo:gpl","geo:GPL3720","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b18","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv23","pgxind-kftx4m8w","pgxcs-kftwc0e6",1576923678,0.548,889411666,0.309,687512012,0.239,"PGX_AM_BS_GSM529011","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.290000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,"geo:gsm","geo:GSM529011","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b19","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529012","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv24","pgxind-kftx4m8y","pgxcs-kftwc0eo",211515776,0.074,103331701,0.036,108184075,0.038,"PGX_AM_BS_GSM529012","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.291000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,"geo:gse","geo:GSE21123","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.7,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b1a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv26","pgxind-kftx4m90","pgxcs-kftwc0f5",358235206,0.125,237422329,0.083,120812877,0.042,"PGX_AM_BS_GSM529013","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.293000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529013","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b1b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv28","pgxind-kftx4m92","pgxcs-kftwc0fn",1231986880,0.429,514741341,0.179,717245539,0.249,"PGX_AM_BS_GSM529014","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.295000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529014","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b1e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2d","pgxind-kftx4m98","pgxcs-kftwc0h3",1471986858,0.512,642194969,0.223,829791889,0.289,"PGX_AM_BS_GSM529017","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.299000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529017","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b1f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2e","pgxind-kftx4m9a","pgxcs-kftwc0hm",1054925764,0.367,593703640,0.207,461222124,0.16,"PGX_AM_BS_GSM529018","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.301000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,"geo:gsm","geo:GSM529018","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b20","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529019","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2g","pgxind-kftx4m9c","pgxcs-kftwc0i3",1794934108,0.624,978942926,0.341,815991182,0.284,"PGX_AM_BS_GSM529019","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.302000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,"geo:gse","geo:GSE21123","","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.32,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b23","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSM529022","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2l","pgxind-kftx4m9i","pgxcs-kftwc0jk",2044828919,0.711,1075418942,0.374,969409977,0.337,"PGX_AM_BS_GSM529022","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.307000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,"geo:gpl","geo:GPL3720","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618909d374f2dc3b7b26","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2q","pgxind-kftx4m9o","pgxcs-kftwc0l2",785575096,0.273,355971277,0.124,429603819,0.149,"PGX_AM_BS_GSM529025","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.311000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529025","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b27","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Myxofibrosarcoma","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2r","pgxind-kftx4m9q","pgxcs-kftwc0lj",979023009,0.341,464615561,0.162,514407448,0.179,"PGX_AM_BS_GSM529026","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.313000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,"geo:gsm","geo:GSM529026","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618909d374f2dc3b7b28","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, myxoid","geo:GSM529027","","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv2t","pgxind-kftx4m9s","pgxcs-kftwc0m0",320218539,0.111,958649,0,319259890,0.111,"PGX_AM_BS_GSM529027","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.314000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,"geo:gpl","geo:GPL3720","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b30","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, myxoid","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv36","pgxind-kftx4ma8","pgxcs-kftwc0pv",486690960,0.169,348899174,0.121,137791786,0.048,"PGX_AM_BS_GSM529035","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.326000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,"geo:gsm","geo:GSM529035","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b34","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, myxoid","geo:GSM529039","","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3c","pgxind-kftx4mag","pgxcs-kftwc0rs",308372997,0.107,235456573,0.082,72916424,0.025,"PGX_AM_BS_GSM529039","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.331000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,,,"geo:gpl","geo:GPL3720","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b37","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, myxoid","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3h","pgxind-kftx4mam","pgxcs-kftwc0t8",203348431,0.071,191937784,0.067,11410647,0.004,"PGX_AM_BS_GSM529042","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.335000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529042","","arraymap import",0.36,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b39","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, myxoid","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3l","pgxind-kftx4maq","pgxcs-kftwc0u7",118018434,0.041,116286521,0.04,1731913,0.001,"PGX_AM_BS_GSM529044","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.338000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,"geo:gsm","geo:GSM529044","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618a09d374f2dc3b7b3d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529048","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3r","pgxind-kftx4may","pgxcs-kftwc0w4",957599876,0.333,412481912,0.143,545117964,0.19,"PGX_AM_BS_GSM529048","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.344000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b3e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3t","pgxind-kftx4mb0","pgxcs-kftwc0wm",1257349209,0.437,528934984,0.184,728414225,0.253,"PGX_AM_BS_GSM529049","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.345000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529049","","arraymap import",0.58,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.92,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b3f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529050","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3v","pgxind-kftx4mb2","pgxcs-kftwc0x3",1864720773,0.649,956500278,0.333,908220495,0.316,"PGX_AM_BS_GSM529050","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.347000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b40","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3w","pgxind-kftx4mb4","pgxcs-kftwc0xl",1769689043,0.616,914620537,0.318,855068506,0.297,"PGX_AM_BS_GSM529051","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.348000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529051","","arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b41","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3y","pgxind-kftx4mb6","pgxcs-kftwc0y2",1544310096,0.537,694726706,0.242,849583390,0.296,"PGX_AM_BS_GSM529052","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.350000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,"geo:gsm","geo:GSM529052","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b42","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv3z","pgxind-kftx4mb9","pgxcs-kftwc0yk",1677421117,0.583,843284351,0.293,834136766,0.29,"PGX_AM_BS_GSM529053","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.351000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529053","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b43","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv41","pgxind-kftx4mbb","pgxcs-kftwc0z2",865325437,0.301,414715579,0.144,450609858,0.157,"PGX_AM_BS_GSM529054","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.353000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529054","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b44","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529055","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv43","pgxind-kftx4mbd","pgxcs-kftwc0zk",1483840337,0.516,710264537,0.247,773575800,0.269,"PGX_AM_BS_GSM529055","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.354000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,"geo:gse","geo:GSE21123","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.34,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b45","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv44","pgxind-kftx4mbf","pgxcs-kftwc102",948980411,0.33,426337091,0.148,522643320,0.182,"PGX_AM_BS_GSM529056","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.356000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,,,"geo:gsm","geo:GSM529056","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b46","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv46","pgxind-kftx4mbh","pgxcs-kftwc10k",1806463114,0.628,960237666,0.334,846225448,0.294,"PGX_AM_BS_GSM529057","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.357000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529057","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.64,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618a09d374f2dc3b7b48","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv49","pgxind-kftx4mbl","pgxcs-kftwc11k",1448360581,0.504,760231374,0.264,688129207,0.239,"PGX_AM_BS_GSM529059","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.360000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529059","","arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b4b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529062","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4e","pgxind-kftx4mbr","pgxcs-kftwc131",1857847184,0.646,845218192,0.294,1012628992,0.352,"PGX_AM_BS_GSM529062","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.364000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3720","",,,,"geo:gse","geo:GSE21123","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.7,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618a09d374f2dc3b7b4f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4l","pgxind-kftx4mbz","pgxcs-kftwc14y",777998145,0.271,305368680,0.106,472629465,0.164,"PGX_AM_BS_GSM529066","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.370000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529066","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b50","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529067","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4m","pgxind-kftx4mc1","pgxcs-kftwc15g",1123131640,0.391,557475960,0.194,565655680,0.197,"PGX_AM_BS_GSM529067","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.371000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b51","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529068","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4o","pgxind-kftx4mc3","pgxcs-kftwc15z",594029668,0.207,472652016,0.164,121377652,0.042,"PGX_AM_BS_GSM529068","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.373000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86618a09d374f2dc3b7b53","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529070","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4r","pgxind-kftx4mc7","pgxcs-kftwc16y",1919288457,0.668,1016722052,0.354,902566405,0.314,"PGX_AM_BS_GSM529070","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.376000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b54","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma, pleomorphic","geo:GSM529071","","pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphic liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4t","pgxind-kftx4mc9","pgxcs-kftwc17g",742449237,0.258,695996398,0.242,46452839,0.016,"PGX_AM_BS_GSM529071","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.377000",,,,,,,"geo:GSE21123","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3720","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618a09d374f2dc3b7b57","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, monophasic","geo:GSM529074","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv4y","pgxind-kftx4mcg","pgxcs-kftwc1au",1269612963,0.442,607640439,0.211,661972524,0.23,"PGX_AM_BS_GSM529074","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.382000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618b09d374f2dc3b7b5c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, monophasic","geo:GSM529079","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv56","pgxind-kftx4mcq","pgxcs-kftwc1d9",491676060,0.171,349661092,0.122,142014968,0.049,"PGX_AM_BS_GSM529079","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.389000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21123","",,,,"pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.44,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618b09d374f2dc3b7b64","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma, monophasic","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv5j","pgxind-kftx4md6","pgxcs-kftwc1h3",117951157,0.041,63721838,0.022,54229319,0.019,"PGX_AM_BS_GSM529087","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.400000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE21123","",,,,"geo:gsm","geo:GSM529087","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.3,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618b09d374f2dc3b7b6c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovial sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv5x","pgxind-kftx4mdn","pgxcs-kftwc1ky",2293915996,0.798,820846179,0.286,1473069817,0.512,"PGX_AM_BS_GSM529095","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.411000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,"geo:gsm","geo:GSM529095","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86618b09d374f2dc3b7b6f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dedifferentiated Liposarcoma [cell line LPS141]","geo:GSE21123","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftviv62","pgxind-kftx4mdt","pgxcs-kftwc1mf",1256656465,0.437,679637434,0.236,577019031,0.201,"PGX_AM_BS_GSM529098","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.416000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM529098","","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_M823","",,,,,
"5c86618f09d374f2dc3b7c3c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM528988","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivfh","pgxind-kftx4mpd","pgxcs-kftwc02y",360502068,0.125,352864441,0.123,7637627,0.003,"PGX_AM_BS_GSM528988","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.700000",,,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE21123","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL3720","","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8661b209d374f2dc3c3629","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","geo:GSM537763","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivk9","pgxind-kftx4mv8","pgxcs-kftwc607",1452887708,0.505,635875243,0.221,817012465,0.284,"PGX_AM_BS_GSM537763","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.850000",,,,,,,"geo:GPL4091","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE21530","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","arraymap import",,,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c362b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivkc","pgxind-kftx4mvc","pgxcs-kftwc5z6",1593367841,0.554,877305721,0.305,716062120,0.249,"PGX_AM_BS_GSM537761","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.852000",,,,,,,"geo:GSE21530","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM537761","","arraymap import",,,,,,,,,,,,,,,,
"5c8661b209d374f2dc3c3630","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pulmonary artery intimal sarcoma","geo:GSM537767","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvivkk","pgxind-kftx4mvm","pgxcs-kftwc626",1667728431,0.58,1001873803,0.348,665854628,0.232,"PGX_AM_BS_GSM537767","{}",4.7,50.88,"Point","BEL","Leuven","Belgium","Leuven, Belgium",50.88,4.7,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:42.860000",,,,,,,"geo:GSE21530","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL4091","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:20685895","Dewaele B, Floris G et al. (2010): Coactivated platelet-derived growth factor receptor {alpha}...","arraymap import",,,,,,,,,,,,,,,,
"5c86639c09d374f2dc42ed03","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677364","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1a6","pgxind-kftx4tkb","pgxcs-kftwdufu",2125696396,0.739,1233723893,0.429,891972503,0.31,"PGX_AM_BS_GSM677364","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.938000",,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed05","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677366","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1aa","pgxind-kftx4tkg","pgxcs-kftwdugu",1591269714,0.553,1103626877,0.384,487642837,0.17,"PGX_AM_BS_GSM677366","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.941000",,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed07","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ad","pgxind-kftx4tkk","pgxcs-kftwduhu",1696105330,0.59,891839745,0.31,804265585,0.28,"PGX_AM_BS_GSM677368","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.944000",,,,,,,"geo:GPL13190","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE27392","",,,,"geo:gsm","geo:GSM677368","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed08","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1af","pgxind-kftx4tkm","pgxcs-kftwduib",1219957412,0.424,645592566,0.225,574364846,0.2,"PGX_AM_BS_GSM677369","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.946000",,,,,,,"geo:GSE27392","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL13190","",,,,"geo:gsm","geo:GSM677369","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed0a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677371","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ai","pgxind-kftx4tkq","pgxcs-kftwduja",1229907143,0.428,666964591,0.232,562942552,0.196,"PGX_AM_BS_GSM677371","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.949000",,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed0e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677376","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1ao","pgxind-kftx4tky","pgxcs-kftwdul9",1560438883,0.543,907409587,0.316,653029296,0.227,"PGX_AM_BS_GSM677376","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.955000",,,,,,,"geo:GPL13190","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE27392","",,,,"pubmed","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed16","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1b2","pgxind-kftx4tle","pgxcs-kftwdur5",298931399,0.104,42696128,0.015,256235271,0.089,"PGX_AM_BS_GSM677384","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.967000",,,,,,,"geo:GSE27392","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL13190","",,,,"geo:gsm","geo:GSM677384","","arraymap import",,,,,,,,,,,,,,,,
"5c86639d09d374f2dc42ed1a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Embryonal rhabdomyosarcoma","geo:GSM677388","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj1b8","pgxind-kftx4tlm","pgxcs-kftwdut7",1590521397,0.553,1181046780,0.411,409474617,0.142,"PGX_AM_BS_GSM677388","{}",-96.81,32.78,"Point","USA","Dallas","United States of America","Dallas, United States",32.78,-96.81,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:48.973000",,,,,,,"PMID:21412928","Paulson V, Chandler G et al. (2011): High-resolution array CGH identifies common mechanisms...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE27392","",,,,"geo:gpl","geo:GPL13190","","arraymap import",,,,,,,,,,,,,,,,
"5c86647809d374f2dc47586c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma [p53mut, Li-Fraumeni syndrome]","PMID:22265402","Rausch T, Jones DT et al. (2012): Genome sequencing of pediatric medulloblastoma links...","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj37y","pgxind-kftx4vxz","pgxcs-kftwefjj",1175721932,0.409,857167544,0.298,318554388,0.111,"PGX_AM_BS_GSM847446","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:51.447000",,,,,,,"geo:GSE34323","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6801","",,,,"geo:gsm","geo:GSM847446","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c86647809d374f2dc47586d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma [p53mut, Li-Fraumeni syndrome]","geo:GSM847447","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvj380","pgxind-kftx4vy1","pgxcs-kftwefk1",1426916231,0.496,1020634935,0.355,406281296,0.141,"PGX_AM_BS_GSM847447","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:51.449000",,,,,,,"PMID:22265402","Rausch T, Jones DT et al. (2012): Genome sequencing of pediatric medulloblastoma links...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE34323","",,,,"geo:gpl","geo:GPL6801","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c86649c09d374f2dc478e08","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SK-NEP-1]","cellosaurus:CVCL_0631","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj3hr","pgxind-kftx4wa4","pgxcs-kftwej6j",1623257343,0.565,961787230,0.335,661470113,0.23,"PGX_AM_BS_GSM827180","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:51.752000",,,,,,,"geo:GSM827180","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE20306","",,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3720","","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,,,
"5c86649c09d374f2dc478e27","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","uterine corpus sarcoma [cell line SKN]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvj3j6","pgxind-kftx4wbv","pgxcs-kftwejnv",981668300,0.341,757265608,0.263,224402692,0.078,"PGX_AM_BS_GSM827211","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000995","uterus","{}","2020-09-10 17:45:51.798000",,,,,,,"geo:GSE20306","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_3167","","arraymap import",0.42,"SNP2pop 1000 Genomes population","HANCESTRO:0502","Vietnamese",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","geo:gsm","geo:GSM827211","",,,,,
"5c86649c09d374f2dc478e29","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","ovarian leiomyosarcoma [cell line RKN]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C5234","Ovarian leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C56.9","ovary","pgxbs-kftvj3j9","pgxind-kftx4wbz","pgxcs-kftwejov",1029523749,0.358,531386605,0.185,498137144,0.173,"PGX_AM_BS_GSM827213","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000992","ovary","{}","2020-09-10 17:45:51.801000",,,,,,,"geo:GSE20306","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM827213","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","cellosaurus","cellosaurus:CVCL_3156","",,,,,
"5c86649e09d374f2dc478e83","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line A-673]","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj3ne","pgxind-kftx4ws7","pgxcs-kftwekz9",306994337,0.107,162022146,0.056,144972191,0.05,"PGX_AM_BS_GSM827304","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:45:51.936000",,,,,,,"geo:GSE20306","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3720","",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM827304","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.42,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0080","",,,,,
"5c86649f09d374f2dc478ea9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line G-292 clone A141B1]","geo:GSM827342","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3p5","pgxind-kftx4wuc","pgxcs-kftwelhr",1094428347,0.381,414193396,0.144,680234951,0.237,"PGX_AM_BS_GSM827342","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:51.991000",,,,,,,"cellosaurus:CVCL_2909","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE20306","",,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3720","","arraymap import",0.42,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.48,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c86649f09d374f2dc478eaf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine corpus sarcoma [cell line MES-SA/Dx5]","geo:GSM827348","","pgxfus-0002","no followup status","NCIT:C6339","Uterine corpus sarcoma","icdom-88003","Sarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvj3pf","pgxind-kftx4wup","pgxcs-kftwelkn",987949337,0.344,321359483,0.112,666589854,0.232,"PGX_AM_BS_GSM827348","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000995","uterus","{}","2020-09-10 17:45:52",,,,,,,"cellosaurus:CVCL_2598","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3720","","arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gse","geo:GSE20306","",,,,,
"5c8664a009d374f2dc478ed4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line KHOS/NP]","geo:GSE20306","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj3r5","pgxind-kftx4wws","pgxcs-kftwem4u",1429204012,0.497,722386547,0.251,706817465,0.246,"PGX_AM_BS_GSM827385","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.055000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_2546","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM827385","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c8664a009d374f2dc478ed8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","uterus sarcoma [cell line MES-SA]","cellosaurus:CVCL_1404","","pgxfus-0002","no followup status","NCIT:C6339","Uterine corpus sarcoma","icdom-88003","Sarcoma, NOS","icdot-C55.9","uterus, nos","pgxbs-kftvj3rc","pgxind-kftx4wx0","pgxcs-kftwem6u",334289523,0.116,212809192,0.074,121480331,0.042,"PGX_AM_BS_GSM827389","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000995","uterus","{}","2020-09-10 17:45:52.060000",,,,,,,"geo:GSM827389","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE20306","",,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3720","","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,,,,
"5c8664a409d374f2dc478f9a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U2OS]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj40b","pgxind-kftx4x80","pgxcs-kftweoyp",1233236019,0.429,564067198,0.196,669168821,0.233,"PGX_AM_BS_GSM827583","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.347000",,,,,,,"geo:GSE20306","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM827583","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.36,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0042","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c8664a509d374f2dc478f9f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line Saos-2]","geo:GSE20306","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvj40j","pgxind-kftx4x8a","pgxcs-kftwep15",1009270471,0.351,324106722,0.113,685163749,0.238,"PGX_AM_BS_GSM827588","{}",-71.06,42.38,"Point","USA","Charlestown","United States of America","Charlestown, United States",42.38,-71.06,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:45:52.354000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20215515","Rothenberg SM, Mohapatra G et al. (2010): A genome-wide screen for microdeletions reveals...",,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_0548","","arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.48,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM827588","","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5c8665b209d374f2dc4c82e6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM820998","","pgxfus-0002","no followup status","NCIT:C3902","Telangiectatic Osteosarcoma","icdom-91833","Telangiectatic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6b7","pgxind-kftx501p","pgxcs-kftwfej5",1454098868,0.506,755225823,0.263,698873045,0.243,"PGX_AM_BS_GSM820998","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.920000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33153","",,,,"geo:gpl","geo:GPL6801","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82e8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6ba","pgxind-kftx501t","pgxcs-kftwfek5",1166836154,0.406,728889313,0.254,437946841,0.152,"PGX_AM_BS_GSM821000","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.923000",,,,,,,"geo:GSE33153","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6801","",,,,"geo:gsm","geo:GSM821000","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82e9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821001","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bc","pgxind-kftx501v","pgxcs-kftwfekn",861053227,0.299,353838660,0.123,507214567,0.176,"PGX_AM_BS_GSM821001","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.924000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,"geo:gse","geo:GSE33153","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.2,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82eb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821003","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bf","pgxind-kftx501z","pgxcs-kftwfeln",589656292,0.205,262148622,0.091,327507670,0.114,"PGX_AM_BS_GSM821003","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.928000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,"geo:gse","geo:GSE33153","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82ec","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821004","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bh","pgxind-kftx5021","pgxcs-kftwfem5",1545453001,0.538,681388132,0.237,864064869,0.301,"PGX_AM_BS_GSM821004","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.929000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,"geo:gse","geo:GSE33153","","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c8665b209d374f2dc4c82ed","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GPL6801","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bj","pgxind-kftx5023","pgxcs-kftwfemn",1479507226,0.515,755430311,0.263,724076915,0.252,"PGX_AM_BS_GSM821005","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.931000",,,,,,,"geo:GSE33153","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,"geo:gsm","geo:GSM821005","","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821007","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bm","pgxind-kftx5027","pgxcs-kftwfenn",1700213083,0.591,1010095393,0.351,690117690,0.24,"PGX_AM_BS_GSM821007","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.934000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33153","",,,,"geo:gpl","geo:GPL6801","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82f1","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6bp","pgxind-kftx502c","pgxcs-kftwfeon",1317597971,0.458,822576285,0.286,495021686,0.172,"PGX_AM_BS_GSM821009","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.937000",,,,,,,"geo:GSE33153","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6801","",,,,"geo:gsm","geo:GSM821009","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82f2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSE33153","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6br","pgxind-kftx502e","pgxcs-kftwfep5",1296956651,0.451,757060822,0.263,539895829,0.188,"PGX_AM_BS_GSM821010","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.938000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,"geo:gsm","geo:GSM821010","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82f5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821014","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bw","pgxind-kftx502k","pgxcs-kftwfer6",1367169807,0.476,740326730,0.258,626843077,0.218,"PGX_AM_BS_GSM821014","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.943000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,"geo:gse","geo:GSE33153","","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82f6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821013","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6by","pgxind-kftx502m","pgxcs-kftwfeqo",1453663675,0.506,792739413,0.276,660924262,0.23,"PGX_AM_BS_GSM821013","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.944000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33153","",,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82f7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821015","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6bz","pgxind-kftx502o","pgxcs-kftwfero",1695513145,0.59,1062693124,0.37,632820021,0.22,"PGX_AM_BS_GSM821015","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.946000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33153","",,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c8665b209d374f2dc4c82f9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSE33153","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6c2","pgxind-kftx502s","pgxcs-kftwfeso",1231975786,0.429,859858366,0.299,372117420,0.129,"PGX_AM_BS_GSM821017","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.949000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,"geo:gsm","geo:GSM821017","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5c8665b209d374f2dc4c82fa","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821018","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6c4","pgxind-kftx502u","pgxcs-kftwfet8",1384166344,0.481,839545129,0.292,544621215,0.189,"PGX_AM_BS_GSM821018","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.950000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6801","",,,,"geo:gse","geo:GSE33153","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82fb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM820997","","pgxfus-0002","no followup status","NCIT:C3902","Telangiectatic Osteosarcoma","icdom-91833","Telangiectatic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6c6","pgxind-kftx502w","pgxcs-kftwfein",1422511490,0.495,704680099,0.245,717831391,0.25,"PGX_AM_BS_GSM820997","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.951000",,,,,,,"geo:GPL6801","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33153","",,,,"pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8665b209d374f2dc4c82fc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GPL6801","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvj6c8","pgxind-kftx502y","pgxcs-kftwfeu9",699441604,0.243,501658311,0.174,197783293,0.069,"PGX_AM_BS_GSM821020","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.953000",,,,,,,"geo:GSE33153","",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,,"geo:gsm","geo:GSM821020","","arraymap import",0.3,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.58,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5c8665b209d374f2dc4c82fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [high-grade, pre-chemotherapy]","geo:GSM821021","","pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma","icdot-C40.0","bones and joints","pgxbs-kftvj6c9","pgxind-kftx5030","pgxcs-kftwfeus",2184453077,0.76,1151587048,0.401,1032866029,0.359,"PGX_AM_BS_GSM821021","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element",,"2020-09-10 17:45:54.954000",,,,,,,"PMID:22454324","Kuijjer ML, Rydbeck H et al. (2012): Identification of osteosarcoma driver genes by...",,,"NCITgrade-C14158","High Grade","pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33153","",,,,"geo:gpl","geo:GPL6801","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675409d374f2dc538641","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqe","pgxind-kftx554l","pgxcs-kftwgot0",623126720,0.217,409501098,0.142,213625622,0.074,"PGX_AM_BS_GSM1109929","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.558000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE45573","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109929","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538643","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqh","pgxind-kftx554q","pgxcs-kftwgoty",615708632,0.214,375677617,0.131,240031015,0.083,"PGX_AM_BS_GSM1109931","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.561000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE45573","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109931","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538646","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GPL8841","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqm","pgxind-kftx554w","pgxcs-kftwgove",1472262854,0.512,917644303,0.319,554618551,0.193,"PGX_AM_BS_GSM1109934","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.565000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109934","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538649","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM1109937","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqr","pgxind-kftx5552","pgxcs-kftwgowv",2235406600,0.778,1116267871,0.388,1119138729,0.389,"PGX_AM_BS_GSM1109937","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.569000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL8841","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc53864d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM1109941","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaqx","pgxind-kftx555b","pgxcs-kftwgoyx",1479362867,0.515,940304325,0.327,539058542,0.187,"PGX_AM_BS_GSM1109941","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.575000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL8841","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538650","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSE45573","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjar2","pgxind-kftx555h","pgxcs-kftwgp0f",1509656304,0.525,937840710,0.326,571815594,0.199,"PGX_AM_BS_GSM1109944","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.579000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109944","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538652","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjar5","pgxind-kftx555l","pgxcs-kftwgoj3",502206885,0.175,395125650,0.137,107081235,0.037,"PGX_AM_BS_GSM1109909","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.582000",,,,,,,"geo:GPL8841","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE45573","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109909","","arraymap import",,,,,,,,,,,,,,,,
"5c86675409d374f2dc538655","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GSM1109912","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjara","pgxind-kftx555r","pgxcs-kftwgokl",999637834,0.348,561120227,0.195,438517607,0.153,"PGX_AM_BS_GSM1109912","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.586000",,,,,,,"PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL8841","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gse","geo:GSE45573","","arraymap import",,,,,,,,,,,,,,,,
"5c86675509d374f2dc538660","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GSM1109923","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjars","pgxind-kftx556e","pgxcs-kftwgoq0",195145926,0.068,179890358,0.063,15255568,0.005,"PGX_AM_BS_GSM1109923","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.602000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL8841","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...","arraymap import",,,,,,,,,,,,,,,,
"5c86675509d374f2dc538661","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GSM1109924","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaru","pgxind-kftx556g","pgxcs-kftwgoqh",1899622852,0.661,985887199,0.343,913735653,0.318,"PGX_AM_BS_GSM1109924","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.603000",,,,,,,"PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE45573","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:GPL8841","","arraymap import",,,,,,,,,,,,,,,,
"5c86675509d374f2dc538664","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma","geo:GPL8841","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjarz","pgxind-kftx556m","pgxcs-kftwgory",1537867147,0.535,870367630,0.303,667499517,0.232,"PGX_AM_BS_GSM1109927","{}",-46.64,-23.55,"Point","BRA","Sao Paulo","Brazil","Sao Paulo, Brazil",-23.55,-46.64,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.608000",,,,,,,"geo:GSE45573","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:23825676","Silveira SM, Villacis RA et al. (2013): Genomic signatures predict poor outcome in...",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1109927","","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d5e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197411","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjas5","pgxind-kftx556u","pgxcs-kftwgp2d",1271015117,0.442,904887969,0.315,366127148,0.127,"PGX_AM_BS_GSM1197411","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.613000",,,,,,,"PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE49324","",,,,"geo:gpl","geo:GPL9777","","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d64","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197418","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasf","pgxind-kftx5577","pgxcs-kftwgp5w",464150309,0.161,51665870,0.018,412484439,0.143,"PGX_AM_BS_GSM1197418","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.622000",,,,,,,"geo:GPL9777","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE49324","",,,,"pubmed","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d65","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197421","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasg","pgxind-kftx5579","pgxcs-kftwgp7e",1729490435,0.602,1257902651,0.438,471587784,0.164,"PGX_AM_BS_GSM1197421","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.623000",,,,,,,"geo:GSE49324","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL9777","",,,,"pubmed","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d67","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197419","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjask","pgxind-kftx557d","pgxcs-kftwgp6e",1654212713,0.575,1091514020,0.38,562698693,0.196,"PGX_AM_BS_GSM1197419","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.626000",,,,,,,"PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL9777","",,,,"geo:gse","geo:GSE49324","","arraymap import",,,,,,,,,,,,,,,,
"5c86675709d374f2dc538d68","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar soft part sarcoma","geo:GSM1197420","","pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjasl","pgxind-kftx557f","pgxcs-kftwgp6v",1241237875,0.432,347069585,0.121,894168290,0.311,"PGX_AM_BS_GSM1197420","{}",-91.53,41.66,"Point","USA","Iowa City","United States of America","Iowa City, United States",41.66,-91.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.627000",,,,,,,"geo:GSE49324","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL9777","",,,,"pubmed","PMID:24493828","Selvarajah S, Pyne S et al. (2014): High-resolution array CGH and gene expression...","arraymap import",,,,,,,,,,,,,,,,
"5c86675909d374f2dc539d50","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dedifferentiated Liposarcoma [cell line LPS141]","geo:GPL9128","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjass","pgxind-kftx557n","pgxcs-kftwgp9e",1455001119,0.506,664176160,0.231,790824959,0.275,"PGX_AM_BS_GSM1228009","{}",0.12,52.2,"Point","GBR","Cambridge","United Kingdom","Cambridge, United Kingdom",52.2,0.12,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.633000",,,,,,,"geo:GSE50750","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:24065146","Miller ML, Molinelli EJ et al. (2013): Drug synergy screen and network modeling...",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM1228009","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_M823","",,,,,
"5c86675c09d374f2dc53a00c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma [cell line LMS]","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjau5","pgxind-kftx559c","pgxcs-kftwgpv4",1541090236,0.536,859765918,0.299,681324318,0.237,"PGX_AM_BS_GSM1280506","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.676000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE53021","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:GSM1280506","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675c09d374f2dc53a010","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Leiomyosarcoma","geo:GSM1280505","","pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaub","pgxind-kftx559k","pgxcs-kftwgpum",1140237001,0.397,416848373,0.145,723388628,0.252,"PGX_AM_BS_GSM1280505","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.682000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE53021","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675c09d374f2dc53a019","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Gastrointestinal stromal tumor [cell line eRMS]","geo:GSM1280499","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjauq","pgxind-kftx55a2","pgxcs-kftwgprn",1925479044,0.67,1249812987,0.435,675666057,0.235,"PGX_AM_BS_GSM1280499","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.694000",,,,,,,"PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL3718","",,,,"geo:gse","geo:GSE53021","","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675c09d374f2dc53a01a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Gastrointestinal stromal tumor [cell line eRMS]","geo:GSE53021","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaus","pgxind-kftx55a4","pgxcs-kftwgps5",711510898,0.247,401570603,0.14,309940295,0.108,"PGX_AM_BS_GSM1280500","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.696000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...",,,,"geo:gsm","geo:GSM1280500","","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.16,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c86675c09d374f2dc53a01b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Rhabdomyosarcoma","PMID:24793134","Wang Y, Marino-Enriquez A et al. (2014): Dystrophin is a tumor suppressor in...","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjaut","pgxind-kftx55a6","pgxcs-kftwgpr6",1385110960,0.482,1022498046,0.356,362612914,0.126,"PGX_AM_BS_GSM1280498","{}",-71.06,42.36,"Point","USA","Boston","United States of America","Boston, United States",42.36,-71.06,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:45:59.697000",,,,,,,"geo:GSE53021","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL3718","",,,,"geo:gsm","geo:GSM1280498","","arraymap import",0.42,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5c8668e809d374f2dc5998bc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509942","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjeu3","pgxind-kftx5a6g","pgxcs-kftwhyd9",1695146944,0.59,1053183823,0.366,641963121,0.223,"PGX_AM_BS_GSM509942","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.549000",,,,,,,"geo:GSE20355","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL8634","",,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998be","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GPL8634","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjeu6","pgxind-kftx5a6k","pgxcs-kftwhye8",1712354640,0.596,843815603,0.294,868539037,0.302,"PGX_AM_BS_GSM509944","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.551000",,,,,,,"geo:GSE20355","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gpl","geo:gse","pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,"geo:gsm","geo:GSM509944","","arraymap import",,,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998ca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE20355","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjeuq","pgxind-kftx5a77","pgxcs-kftwhyk7",1189060137,0.414,670929817,0.233,518130320,0.18,"PGX_AM_BS_GSM509956","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.568000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gse","geo:gpl","pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,"geo:gsm","geo:GSM509956","","arraymap import",,,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998cd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509959","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjeuv","pgxind-kftx5a7d","pgxcs-kftwhyln",1966658940,0.684,1192975345,0.415,773683595,0.269,"PGX_AM_BS_GSM509959","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.572000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gpl","geo:gse","geo:GSE20355","",,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998dd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509975","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjevn","pgxind-kftx5a8a","pgxcs-kftwhytn",2424088286,0.843,1502341088,0.523,921747198,0.321,"PGX_AM_BS_GSM509975","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.594000",,,,,,,"geo:GSE20355","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL8634","",,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,,
"5c8668e809d374f2dc5998df","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509977","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjevq","pgxind-kftx5a8e","pgxcs-kftwhyum",1678159991,0.584,1075313524,0.374,602846467,0.21,"PGX_AM_BS_GSM509977","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.597000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gpl","geo:gse","geo:GSE20355","",,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,,,,,,,,
"5c8668e909d374f2dc5998e7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SK-ES-1]","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjew4","pgxind-kftx5a8u","pgxcs-kftwhz9u",1562972259,0.544,758362335,0.264,804609924,0.28,"PGX_AM_BS_GSM510008","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.609000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,"geo:gsm","geo:GSM510008","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0627","",,,,,
"5c8668e909d374f2dc5998ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSM509993","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjewi","pgxind-kftx5a9b","pgxcs-kftwhz2j",1547477920,0.538,1045848029,0.364,501629891,0.174,"PGX_AM_BS_GSM509993","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.620000",,,,,,,"PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","pubmed","geo:gse","geo:GSE20355","",,,,"geo:gpl","geo:GPL8634","","arraymap import",,,,,,,,,,,,,,,,
"5c8668e909d374f2dc5998f8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line A-673]","geo:GPL8634","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjewx","pgxind-kftx5a9t","pgxcs-kftwhz6v",275966020,0.096,147376050,0.051,128589970,0.045,"PGX_AM_BS_GSM510002","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.632000",,,,,,,"geo:GSE20355","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:gse","pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,"cellosaurus","cellosaurus:CVCL_0080","","arraymap import",,,,,,,,,"geo:gsm","geo:GSM510002","",,,,,
"5c8668e909d374f2dc5998fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line RM-82]","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjex5","pgxind-kftx5aa3","pgxcs-kftwhz9d",1713906666,0.596,1223377249,0.426,490529417,0.171,"PGX_AM_BS_GSM510007","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.640000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,"geo:gsm","geo:GSM510007","","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_9714","",,,,,
"5c8668e909d374f2dc599901","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line STA-ET-2.1]","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjexc","pgxind-kftx5aab","pgxcs-kftwhzbb",1405392856,0.489,938298021,0.326,467094835,0.162,"PGX_AM_BS_GSM510011","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.645000",,,,,,,"geo:GPL8634","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","pubmed","geo:gpl","geo:gse","geo:GSE20355","",,,,"cellosaurus","cellosaurus:CVCL_9686","","arraymap import",,,,,,,,,"geo:gsm","geo:GSM510011","",,,,,
"5c8668e909d374f2dc599902","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing Sarcoma [Cell Line TC71]","geo:GSM510013","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjexd","pgxind-kftx5aad","pgxcs-kftwhzca",1146741527,0.399,512406323,0.178,634335204,0.221,"PGX_AM_BS_GSM510013","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.647000",,,,,,,"cellosaurus:CVCL_2213","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","cellosaurus","pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,"geo:gpl","geo:GPL8634","","arraymap import",,,,,,,,,"geo:gse","geo:GSE20355","",,,,,
"5c8668e909d374f2dc599903","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line TTC-466]","geo:GSM510014","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjexf","pgxind-kftx5aaf","pgxcs-kftwhzcu",1612282662,0.561,800165144,0.278,812117518,0.282,"PGX_AM_BS_GSM510014","{}",-3.68,40.43,"Point","ESP","Salamanca","Spain","Salamanca, Spain",40.43,-3.68,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:04.648000",,,,,,,"cellosaurus:CVCL_A444","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","cellosaurus","pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...",,,,"geo:gse","geo:GSE20355","","arraymap import",,,,,,,,,"geo:gpl","geo:GPL8634","",,,,,
"5c86690609d374f2dc59e8c3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSE25985","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf8z","pgxind-kftx5aoq","pgxcs-kftwi2yl",2629816976,0.915,0,0,2629816976,0.915,"PGX_AM_BS_GSM637930","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.011000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...",,,,"geo:gsm","geo:GSM637930","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf90","pgxind-kftx5aos","pgxcs-kftwi2z2",2629095210,0.914,0,0,2629095210,0.914,"PGX_AM_BS_GSM637931","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.012000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE25985","",,,,"geo:gsm","geo:GSM637931","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSE25985","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf92","pgxind-kftx5aou","pgxcs-kftwi2zj",2629322510,0.915,0,0,2629322510,0.915,"PGX_AM_BS_GSM637932","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.014000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...",,,,"geo:gsm","geo:GSM637932","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSM637933","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf94","pgxind-kftx5aow","pgxcs-kftwi301",2629701416,0.915,0,0,2629701416,0.915,"PGX_AM_BS_GSM637933","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.015000",,,,,,,"PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL6985","",,,,"geo:gse","geo:GSE25985","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSE25985","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf95","pgxind-kftx5aoy","pgxcs-kftwi30i",2629785586,0.915,0,0,2629785586,0.915,"PGX_AM_BS_GSM637935","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.017000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...",,,,"geo:gsm","geo:GSM637935","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf97","pgxind-kftx5ap0","pgxcs-kftwi310",2629768603,0.915,0,0,2629768603,0.915,"PGX_AM_BS_GSM637936","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.018000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE25985","",,,,"geo:gsm","geo:GSM637936","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8c9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf98","pgxind-kftx5ap2","pgxcs-kftwi31i",2629768983,0.915,0,0,2629768983,0.915,"PGX_AM_BS_GSM637938","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.020000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE25985","",,,,"geo:gsm","geo:GSM637938","","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8ca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","geo:GSM637940","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf9a","pgxind-kftx5ap4","pgxcs-kftwi31z",2629502545,0.915,0,0,2629502545,0.915,"PGX_AM_BS_GSM637940","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.021000",,,,,,,"geo:GSE25985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL6985","",,,,"pubmed","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","arraymap import",,,,,,,,,,,,,,,,
"5c86690609d374f2dc59e8cb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma","PMID:21949816","Olsson L, Paulsson K et al. (2011): Clonal evolution through loss of chromosomes...","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjf9c","pgxind-kftx5ap7","pgxcs-kftwi32h",2628994443,0.914,0,0,2628994443,0.914,"PGX_AM_BS_GSM637942","{}",13.19,55.71,"Point","SWE","Lund","Sweden","Lund, Sweden",55.71,13.19,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:05.023000",,,,,,,"geo:GSE25985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL6985","",,,,"geo:gsm","geo:GSM637942","","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bab","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816448","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1y","pgxind-kftx5cxn","pgxcs-kftwin7y",700842594,0.244,311241370,0.108,389601224,0.136,"PGX_AM_BS_GSM816448","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.049000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE32964","",,,,"pubmed","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bac","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816449","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh1z","pgxind-kftx5cxp","pgxcs-kftwin8g",685989812,0.239,258901845,0.09,427087967,0.149,"PGX_AM_BS_GSM816449","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.050000",,,,,,,"PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE32964","",,,,"geo:gpl","geo:GPL6985","","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bb2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh2a","pgxind-kftx5cy1","pgxcs-kftwinbx",719174518,0.25,511250169,0.178,207924349,0.072,"PGX_AM_BS_GSM816456","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.059000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE32964","",,,,"geo:gsm","geo:GSM816456","","arraymap import",,,,,,,,,,,,,,,,
"5c86699d09d374f2dc5b8bb6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816460","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh2g","pgxind-kftx5cy9","pgxcs-kftwindy",508762398,0.177,189794558,0.066,318967840,0.111,"PGX_AM_BS_GSM816460","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.065000",,,,,,,"geo:GSE32964","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL6985","",,,,"pubmed","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","arraymap import",,,,,,,,,,,,,,,,
"5c86699e09d374f2dc5b8bbe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM816468","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C40.0","bones and joints","pgxbs-kftvjh2u","pgxind-kftx5cyp","pgxcs-kftwinhw",232468647,0.081,169934662,0.059,62533985,0.022,"PGX_AM_BS_GSM816468","{}",4.89,52.37,"Point","NLD","Amsterdam","Netherlands","Amsterdam, Netherlands",52.37,4.89,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:07.077000",,,,,,,"geo:GPL6985","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE32964","",,,,"pubmed","PMID:22292074","Both J, Wu T, Bras J et al. (2012): Identification of novel candidate oncogenes in...","arraymap import",,,,,,,,,,,,,,,,
"5c8669e809d374f2dc5ca29c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838288","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhtf","pgxind-kftx5dvh","pgxcs-kftwivqp",1557266809,0.542,869258204,0.302,688008605,0.239,"PGX_AM_BS_GSM838288","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.901000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL5477","",,,,"pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2a0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhtm","pgxind-kftx5dvp","pgxcs-kftwivso",2207386370,0.768,855361762,0.298,1352024608,0.47,"PGX_AM_BS_GSM838292","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.907000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gse","geo:gpl","geo:GPL5477","",,,,"geo:gsm","geo:GSM838292","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2aa","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhu2","pgxind-kftx5dwb","pgxcs-kftwivxh",2174141379,0.756,878621119,0.306,1295520260,0.451,"PGX_AM_BS_GSM838302","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.921000",,,,,,,"geo:GPL5477","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE33881","",,,,"geo:gsm","geo:GSM838302","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838310","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuf","pgxind-kftx5dwr","pgxcs-kftwiw1d",1217255385,0.423,494446512,0.172,722808873,0.251,"PGX_AM_BS_GSM838310","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.932000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL5477","",,,,"pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838314","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhum","pgxind-kftx5dwz","pgxcs-kftwiw3b",803491173,0.279,503139226,0.175,300351947,0.104,"PGX_AM_BS_GSM838314","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.938000",,,,,,,"geo:GPL5477","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE33881","",,,,"pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838315","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhun","pgxind-kftx5dx1","pgxcs-kftwiw3t",1949940043,0.678,829235467,0.288,1120704576,0.39,"PGX_AM_BS_GSM838315","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.939000",,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gse","geo:GSE33881","",,,,"geo:gpl","geo:GPL5477","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838316","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhup","pgxind-kftx5dx3","pgxcs-kftwiw4b",2191537374,0.762,1482831148,0.516,708706226,0.247,"PGX_AM_BS_GSM838316","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.941000",,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2b9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuq","pgxind-kftx5dx5","pgxcs-kftwiw4s",179815380,0.063,12333646,0.004,167481734,0.058,"PGX_AM_BS_GSM838317","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.942000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,"geo:gsm","geo:GSM838317","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2bb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhuu","pgxind-kftx5dx9","pgxcs-kftwiw5r",2171575610,0.755,1080120127,0.376,1091455483,0.38,"PGX_AM_BS_GSM838319","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.945000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,"geo:gsm","geo:GSM838319","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838324","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv2","pgxind-kftx5dxj","pgxcs-kftwiw87",2092793055,0.728,621405298,0.216,1471387757,0.512,"PGX_AM_BS_GSM838324","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.952000",,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv5","pgxind-kftx5dxn","pgxcs-kftwiw96",1149236628,0.4,471284130,0.164,677952498,0.236,"PGX_AM_BS_GSM838326","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.955000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,"geo:gsm","geo:GSM838326","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838327","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv7","pgxind-kftx5dxp","pgxcs-kftwiw9o",1406974910,0.489,1087086744,0.378,319888166,0.111,"PGX_AM_BS_GSM838327","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.957000",,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GSM838328","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhv8","pgxind-kftx5dxs","pgxcs-kftwiwa6",1801923850,0.627,658414221,0.229,1143509629,0.398,"PGX_AM_BS_GSM838328","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.958000",,,,,,,"PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","pubmed","geo:gpl","geo:GPL5477","",,,,"geo:gse","geo:GSE33881","","arraymap import",,,,,,,,,,,,,,,,
"5c8669e909d374f2dc5ca2c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Malignant peripheral nerve sheath tumor","geo:GPL5477","","pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor","icdot-C47.9","peripheral nervs incl. autonomous","pgxbs-kftvjhvd","pgxind-kftx5dxy","pgxcs-kftwiwbm",1416736312,0.493,522630883,0.182,894105429,0.311,"PGX_AM_BS_GSM838331","{}",23.79,61.5,"Point","FIN","Tampere","Finland","Tampere, Finland",61.5,23.79,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001780","spinal nerve","{}","2020-09-10 17:46:07.963000",,,,,,,"geo:GSE33881","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:22042973","Yang J, Ylipää A et al. (2011): Genomic and molecular characterization of malignant...",,,,"geo:gsm","geo:GSM838331","","arraymap import",,,,,,,,,,,,,,,,
"5dc17b5f09d374f6dd77341c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U2OS]","cellosaurus:CVCL_0042","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjtr5","pgxind-kftx5s7q","pgxcs-kftwmffm",1549575741,0.539,918057270,0.319,631518471,0.22,"PGX_AM_BS_GSM170250","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.183000",,,,,,,"geo:GSM170250","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gpl","geo:GPL2879","",,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE7077","","arraymap import",,,,,,,,,"pubmed","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5dc17b5f09d374f6dd773585","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line U-2 OS]","geo:GSM879223","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjtr6","pgxind-kftx5s7s","pgxcs-kftwmfg0",1356867660,0.472,720797339,0.251,636070321,0.221,"PGX_AM_BS_GSM879223","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.185000",,,,,,"P15Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0042","",,,"U-2 OS","cell line",
"5dc17be709d374f6dd794833","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSE10132","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjudl","pgxind-kftx5szi","pgxcs-kftwmkfk",1474530670,0.513,845233049,0.294,629297621,0.219,"PGX_AM_BS_GSM256076","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.791000",,,,,,,"geo:GPL6359","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_0317","",,,,"geo:gsm","geo:GSM256076","","arraymap import",,,,,,,,,,,,,,,,
"5dc17be709d374f6dd794834","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSE10132","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjudm","pgxind-kftx5szk","pgxcs-kftwmkfv",1321785373,0.46,739532302,0.257,582253071,0.203,"PGX_AM_BS_GSM256077","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.792000",,,,,,,"geo:GPL6359","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_0317","",,,,"geo:gsm","geo:GSM256077","","arraymap import",,,,,,,,,,,,,,,,
"5dc17be709d374f6dd79483f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSM256088","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjue4","pgxind-kftx5t06","pgxcs-kftwmkjd",706015692,0.246,580210060,0.202,125805632,0.044,"PGX_AM_BS_GSM256088","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.803000",,,,,,,"cellosaurus:CVCL_0317","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","cellosaurus","geo:gse","geo:GSE10132","",,,,"geo:gpl","geo:GPL6359","","arraymap import",,,,,,,,,,,,,,,,
"5dc17be709d374f6dd794845","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","geo:GSM256094","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjuee","pgxind-kftx5t0i","pgxcs-kftwmkla",996046253,0.346,553408494,0.192,442637759,0.154,"PGX_AM_BS_GSM256094","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.810000",,,,,,,"cellosaurus:CVCL_0317","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","cellosaurus","geo:gpl","geo:GPL6359","",,,,"geo:gse","geo:GSE10132","","arraymap import",,,,,,,,,,,,,,,,
"5dc17be709d374f6dd79484d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Fibrosarcoma [cell line HT-1080, modified]","cellosaurus:CVCL_0317","","pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjues","pgxind-kftx5t0y","pgxcs-kftwmknt",524994351,0.183,173630114,0.06,351364237,0.122,"PGX_AM_BS_GSM256102","{}",-122.42,37.77,"Point","USA","San Francisco","United States of America","San Francisco, United States",37.77,-122.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:21.818000",,,,,,,"geo:GSM256102","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","cellosaurus","geo:gsm","geo:gpl","geo:GPL6359","",,,,"geo:gse","geo:GSE10132","","arraymap import",,,,,,,,,,,,,,,,
"5dc17bf209d374f6dd796459","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma [cell line MG-63]","cellosaurus:CVCL_0426","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjugt","pgxind-kftx5t3g","pgxcs-kftwml3a",1729284741,0.601,1110759283,0.386,618525458,0.215,"PGX_AM_BS_GSM170251","{}",-79.42,43.7,"Point","CAN","Toronto","Canada","Toronto, Canada",43.7,-79.42,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.870000",,,,,,,"geo:GSM170251","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","cellosaurus","geo:gsm","geo:gse","geo:GSE7077","",,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL2879","","arraymap import",,,,,,,,,"pubmed","PMID:17981215","Selvarajah S, Yoshimoto M et al. (2007): Identification of cryptic microaberrations in osteosarcoma...","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,
"5dc17c0109d374f6dd797070","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-3]","geo:GSM393031","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjujv","pgxind-kftx5t76","pgxcs-kftwmm0e",626214146,0.218,489713123,0.17,136501023,0.047,"PGX_AM_BS_GSM393031","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.952000",,,,,,,"cellosaurus:CVCL_5170","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE15696","",,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3718","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.0800000000000001,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797077","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuk6","pgxind-kftx5t7k","pgxcs-kftwmlxf",951438749,0.331,803594307,0.28,147844442,0.051,"PGX_AM_BS_GSM393023","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.960000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM393023","",,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17c0109d374f6dd797078","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuk8","pgxind-kftx5t7m","pgxcs-kftwmlxq",2575077376,0.896,1351409861,0.47,1223667515,0.426,"PGX_AM_BS_GSM393024","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.961000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM393024","",,,,,,,"arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17c0109d374f6dd79707a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SCMS-ES1]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukb","pgxind-kftx5t7r","pgxcs-kftwmlye",986003667,0.343,176946065,0.062,809057602,0.281,"PGX_AM_BS_GSM393026","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.963000",,,,,,,"geo:GSE15696","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","cellosaurus","cellosaurus:CVCL_7123","",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM393026","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.56,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17c0109d374f6dd79707b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SK-ES-1]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukd","pgxind-kftx5t7t","pgxcs-kftwmlys",881818415,0.307,201062203,0.07,680756212,0.237,"PGX_AM_BS_GSM393027","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.964000",,,,,,,"geo:GSE15696","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","cellosaurus","cellosaurus:CVCL_0627","",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM393027","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17c0109d374f6dd79707c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line ES-1-OT]","geo:GSM393028","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukf","pgxind-kftx5t7v","pgxcs-kftwmlz7",1350344004,0.47,884383305,0.308,465960699,0.162,"PGX_AM_BS_GSM393028","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.966000",,,,,,,"cellosaurus:CVCL_5122","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE15696","",,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3718","","arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0019","Japanese",0.66,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17c0109d374f6dd79707e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-2]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuki","pgxind-kftx5t7z","pgxcs-kftwmm00",1437160405,0.5,17510813,0.006,1419649592,0.494,"PGX_AM_BS_GSM393030","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.968000",,,,,,,"geo:GSE15696","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM393030","",,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_5169","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.0800000000000001,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd79707f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-5]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukk","pgxind-kftx5t81","pgxcs-kftwmm0t",1306982442,0.455,805612779,0.28,501369663,0.174,"PGX_AM_BS_GSM393032","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.969000",,,,,,,"geo:GSE15696","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","cellosaurus","cellosaurus:CVCL_5171","",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM393032","","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797080","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-6]","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukm","pgxind-kftx5t83","pgxcs-kftwmm18",963224119,0.335,479778139,0.167,483445980,0.168,"PGX_AM_BS_GSM393033","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.971000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_5172","",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM393033","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797081","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-7]","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjuko","pgxind-kftx5t85","pgxcs-kftwmm1n",475944807,0.166,122300287,0.043,353644520,0.123,"PGX_AM_BS_GSM393034","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.972000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM393034","",,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_5173","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797082","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SJES-8]","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukp","pgxind-kftx5t87","pgxcs-kftwmm21",769415114,0.268,280959333,0.098,488455781,0.17,"PGX_AM_BS_GSM393035","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.973000",,,,,,,"geo:GSE15696","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM393035","",,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_5174","","arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797083","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line SK-N-PI]","geo:GSM393036","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukr","pgxind-kftx5t89","pgxcs-kftwmm2g",658585294,0.229,307150604,0.107,351434690,0.122,"PGX_AM_BS_GSM393036","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.975000",,,,,,,"cellosaurus:CVCL_S664","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gpl","geo:GPL3718","",,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE15696","","arraymap import",0.48,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0109d374f6dd797087","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line KP-PN-TTBm2]","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjukx","pgxind-kftx5t8h","pgxcs-kftwmm3z",611637757,0.213,284270731,0.099,327367026,0.114,"PGX_AM_BS_GSM393040","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.979000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM393040","",,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_5147","","arraymap import",0.2,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.18,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17c0109d374f6dd79708a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing sarcoma [cell line UTP-ES1]","geo:GSE15696","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C40.0","bones and joints","pgxbs-kftvjul2","pgxind-kftx5t8n","pgxcs-kftwmm54",1395484188,0.485,754856400,0.263,640627788,0.223,"PGX_AM_BS_GSM393043","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0004765","skeletal element","{}","2020-09-10 17:46:21.983000",,,,,,,"geo:GPL2004","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_DH85","",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM393043","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.6,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17c0509d374f6dd797881","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line Saos-2]","geo:GSM879222","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjull","pgxind-kftx5t9b","pgxcs-kftwmm82",1797249074,0.625,913787260,0.318,883461814,0.307,"PGX_AM_BS_GSM879222","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:21.998000",,,,,,,"geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_0548","",,,"Saos-2","cell line",
"5dc17c0a09d374f6dd7980f0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing's Sarcoma [cell line SKES1]","geo:GSM510017","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","EWING SARCOMA","icdot-C41.9","Bone, NOS","pgxbs-kftvjumd","pgxind-kftx5ta9","pgxcs-kftwmme1",986126033,0.343,161579938,0.056,824546095,0.287,"PGX_AM_BS_GSM510017","{}",-101.19,20.57,"Point","MEX","Salamanca","Mexico","Salamanca, Mexico",20.57,-101.19,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.018000",,,,,,,"geo:GSE20356","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,"pubmed","PMID:21822310","Mackintosh C, Ordóñez JL et al. (2012): 1q gain and CDT2 overexpression underlie...","arraymap import",,,,,,,,,"cellosaurus","cellosaurus:CVCL_0627","",,,"SKES1","cell line",
"5dc17c3f09d374f6dd79dc81","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Liposarcoma [cell line SW872]","geo:GPL3720","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjuxh","pgxind-kftx5tnu","pgxcs-kftwmp5u",1006134071,0.35,474415118,0.165,531718953,0.185,"PGX_AM_BS_GSM482514","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.327000",,,,,,,"geo:GSE19399","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","pubmed","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...",,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_1730","","arraymap import",0.5,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.46,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM482514","",,,,,
"5dc17c7b09d374f6dd7a432e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Monophasic synovial sarcoma [cell line HS-SY-2]","geo:GSM482569","","pgxfus-0002","no followup status","NCIT:C4277","Spindle Cell Synovial Sarcoma","icdom-90413","Synovial sarcoma, spindle cell","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjva7","pgxind-kftx5u3c","pgxcs-kftwms1o",1300272173,0.452,175824597,0.061,1124447576,0.391,"PGX_AM_BS_GSM482569","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.667000",,,,,,,"cellosaurus:CVCL_8719","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE19399","",,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL3720","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian","pubmed","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...",,,,,
"5dc17c8209d374f6dd7a5509","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line ZK-58]","geo:GSM879224","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbn","pgxind-kftx5u55","pgxcs-kftwms5n",0,0,0,0,0,0,"PGX_AM_BS_GSM879224","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.712000",,,,,,"P21Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.14,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_9920","",,,"ZK-58","cell line",
"5dc17c8309d374f6dd7a5b5e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/OS14]","geo:GSM879211","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbs","pgxind-kftx5u5b","pgxcs-kftwms72",0,0,0,0,0,0,"PGX_AM_BS_GSM879211","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.717000",,,,,,"P13Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American","cellosaurus","cellosaurus:CVCL_9990","",,,"IOR/OS14","cell line",
"5dc17c8409d374f6dd7a5e46","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line IOR/OS18]","geo:GSM879213","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvbw","pgxind-kftx5u5f","pgxcs-kftwms82",2113352049,0.735,951924865,0.331,1161427184,0.404,"PGX_AM_BS_GSM879213","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.720000",,,,,,"P33Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_9993","",,,"IOR/OS18","metastasis",
"5dc17c9009d374f6dd7a6e78","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line MHM]","geo:GSM879218","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvf0","pgxind-kftx5u9b","pgxcs-kftwmsrc",1865160594,0.649,923077315,0.321,942083279,0.328,"PGX_AM_BS_GSM879218","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.803000",,,,,,"P41Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_B426","",,,"MHM","metastasis",
"5dc17c9109d374f6dd7a711c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line OHS]","geo:GSM879220","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvf2","pgxind-kftx5u9d","pgxcs-kftwmsru",0,0,0,0,0,0,"PGX_AM_BS_GSM879220","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.804000",,,,,,"P14Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.18,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_B450","",,,"OHS","cell line",
"5dc17c9209d374f6dd7a741f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell line HAL]","geo:GSM879207","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvjvfa","pgxind-kftx5u9n","pgxcs-kftwmstx",1669041877,0.581,757383055,0.263,911658822,0.317,"PGX_AM_BS_GSM879207","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:22.811000",,,,,,"P15Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","cellosaurus","cellosaurus:CVCL_D788","",,,"HAL","cell line",
"5dc17ca709d374f6dd7a97c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Pleomorphic liposarcoma [cell line LiSa-2]","geo:GSE19399","","pgxfus-0002","no followup status","NCIT:C3194","Liposarcoma","icdom-88503","Liposarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvjp","pgxind-kftx5uf1","pgxcs-kftwmu3j",903906771,0.314,451447221,0.157,452459550,0.157,"PGX_AM_BS_GSM482515","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.943000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","pubmed","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...",,"pgxcohort-celllines","Cancer cell lines","cellosaurus","cellosaurus:CVCL_M821","","arraymap import",0.44,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African","geo:gsm","geo:GSM482515","",,,,,
"5dc17cab09d374f6dd7aa40b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GSE41263","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkc","pgxind-kftx5uft","pgxcs-kftwmuaa",1581196569,0.55,652082017,0.227,929114552,0.323,"PGX_AM_BS_GSM1012753","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.964000",,,,,,,"geo:GPL2004","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","cellosaurus","cellosaurus:CVCL_W527","",,"pgxcohort-celllines","Cancer cell lines","geo:gsm","geo:GSM1012753","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.82,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17cab09d374f6dd7aa40e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GSM1012755","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkh","pgxind-kftx5ufz","pgxcs-kftwmub3",1675555505,0.583,957514844,0.333,718040661,0.25,"PGX_AM_BS_GSM1012755","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.967000",,,,,,,"cellosaurus:CVCL_W527","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gpl","geo:GPL2004","",,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE41263","","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.78,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17cab09d374f6dd7aa40f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GSM1012756","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkj","pgxind-kftx5ug1","pgxcs-kftwmubh",1137546644,0.396,531096468,0.185,606450176,0.211,"PGX_AM_BS_GSM1012756","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.969000",,,,,,,"cellosaurus:CVCL_W527","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gse","geo:GSE41263","",,"pgxcohort-celllines","Cancer cell lines","geo:gpl","geo:GPL2004","","arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.76,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17cab09d374f6dd7aa410","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma [cell line RMS]","geo:GSM1012757","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkk","pgxind-kftx5ug3","pgxcs-kftwmubw",1726870012,0.601,843776113,0.293,883093899,0.307,"PGX_AM_BS_GSM1012757","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.970000",,,,,,,"cellosaurus:CVCL_W527","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","cellosaurus","geo:gpl","geo:GPL2004","",,"pgxcohort-celllines","Cancer cell lines","geo:gse","geo:GSE41263","","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.78,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17cb009d374f6dd7aa59c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GPL3718","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkm","pgxind-kftx5ug5","pgxcs-kftwmurp",939920384,0.327,441476206,0.154,498444178,0.173,"PGX_AM_BS_GSM1012758","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.971000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM1012758","",,,,,,,"arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17cb009d374f6dd7aa59e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSE41263","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkp","pgxind-kftx5ug9","pgxcs-kftwmucm",588552243,0.205,246543151,0.086,342009092,0.119,"PGX_AM_BS_GSM1012714","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.973000",,,,,,,"geo:GPL2004","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM1012714","",,,,,,,"arraymap import",0.12,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.78,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17cb009d374f6dd7aa5a2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012718","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvkw","pgxind-kftx5ugh","pgxcs-kftwmudv",1507400129,0.524,713119926,0.248,794280203,0.276,"PGX_AM_BS_GSM1012718","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.978000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE41263","",,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.34,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17cb009d374f6dd7aa5aa","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSE41263","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvl9","pgxind-kftx5ugx","pgxcs-kftwmuge",506894762,0.176,344681358,0.12,162213404,0.056,"PGX_AM_BS_GSM1012726","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.987000",,,,,,,"geo:GPL3718","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM1012726","",,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.28,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17cb009d374f6dd7aa5ad","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012729","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvle","pgxind-kftx5uh3","pgxcs-kftwmuhd",446167129,0.155,3163250,0.001,443003879,0.154,"PGX_AM_BS_GSM1012729","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:22.990000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17cb009d374f6dd7aa5c2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pediatric rhabdomyosarcoma","geo:GSM1012750","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjvmd","pgxind-kftx5ui9","pgxcs-kftwmur2",1634918613,0.569,956575905,0.333,678342708,0.236,"PGX_AM_BS_GSM1012750","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.012000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.32,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17cb009d374f6dd7aa5c5","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1528055","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvmi","pgxind-kftx5uif","pgxcs-kftwmusi",1489799079,0.518,911176883,0.317,578622196,0.201,"PGX_AM_BS_GSM1528055","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.016000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17cb009d374f6dd7aa5cb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1528061","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvms","pgxind-kftx5uis","pgxcs-kftwmuvg",1843936398,0.641,1299154444,0.452,544781954,0.189,"PGX_AM_BS_GSM1528061","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.025000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,"arraymap import",0.02,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17cb009d374f6dd7aa5cc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","embryonal rhabdomyosarcoma","geo:GSM1530028","","pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjvmu","pgxind-kftx5uiu","pgxcs-kftwmuvx",1847510121,0.643,1323358464,0.46,524151657,0.182,"PGX_AM_BS_GSM1530028","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:23.026000",,,,,,,"geo:GSE41263","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.24,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17d2609d374f6dd7c37bd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Ewing tumor","geo:GSM2087500","","pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvjw9s","pgxind-kftx5vbd","pgxcs-kftwryqn",253838415,0.088,241942759,0.084,11895656,0.004,"PGX_AM_BS_GSM2087500","{}",16.37,48.21,"Point","AUT","Vienna","Austria","Vienna, Austria",48.21,16.37,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:23.635000",,,,,,,"geo:GSE79187","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL16131","",,,,,,,"arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.4,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"primary","23000"
"5dc17d2609d374f6dd7c37bf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma","geo:GSM2087503","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvjw9v","pgxind-kftx5vbh","pgxcs-kftwrys3",1057650576,0.368,638475163,0.222,419175413,0.146,"PGX_AM_BS_GSM2087503","{}",16.37,48.21,"Point","AUT","Vienna","Austria","Vienna, Austria",48.21,16.37,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:23.638000",,,,,,,"geo:GSE79187","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL16131","",,,,,,,"arraymap import",0.48,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.5,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"primary","23000"
"5dc17dcb09d374f6dd7ce3ee","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559551","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxe8","pgxind-kftx5woq","pgxcs-kftwn9tp",1436214339,0.5,1129135551,0.393,307078788,0.107,"PGX_AM_BS_GSM1559551","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.871000",,,,,,,"geo:GSE63891","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17dcb09d374f6dd7ce3ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559552","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxe9","pgxind-kftx5wos","pgxcs-kftwn9u7",2174000976,0.756,1272532144,0.443,901468832,0.314,"PGX_AM_BS_GSM1559552","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.873000",,,,,,,"geo:GSE63891","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17dcb09d374f6dd7ce3f6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559559","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxel","pgxind-kftx5wp7","pgxcs-kftwn9xn",435718785,0.152,155522425,0.054,280196360,0.097,"PGX_AM_BS_GSM1559559","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.883000",,,,,,,"geo:GSE63891","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL3718","",,,,,,,"arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17dcb09d374f6dd7ce3fe","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","rhabdomyosarcoma","geo:GSM1559567","","pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS","icdot-C49.9","Connective, Subcutaneous and other soft tissues, NOS","pgxbs-kftvjxey","pgxind-kftx5wpn","pgxcs-kftwna1l",0,0,0,0,0,0,"PGX_AM_BS_GSM1559567","{}",139.69,35.69,"Point","JPN","Tokyo","Japan","Tokyo, Japan",35.69,139.69,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:24.894000",,,,,,,"geo:GSE63891","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL16131","",,,,,,,"arraymap import",0,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.58,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,"primary",
"5dc17eda09d374f6dd7e598e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzdw","pgxind-kftx5yq9","pgxcs-kftwnoe2",1783807328,0.62,599786745,0.209,1184020583,0.412,"PGX_AM_BS_GSM608959","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.502000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608959","",,,,,,,"arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17eda09d374f6dd7e598f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608960","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzdy","pgxind-kftx5yqb","pgxcs-kftwnoee",1195435624,0.416,406243304,0.141,789192320,0.275,"PGX_AM_BS_GSM608960","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.503000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE24715","",,,,,,,"arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e5991","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze1","pgxind-kftx5yqf","pgxcs-kftwnof1",733751159,0.255,290028001,0.101,443723158,0.154,"PGX_AM_BS_GSM608962","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.505000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608962","",,,,,,,"arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.48,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e5992","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze3","pgxind-kftx5yqh","pgxcs-kftwnofc",1935794411,0.673,884834173,0.308,1050960238,0.366,"PGX_AM_BS_GSM608963","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.506000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608963","",,,,,,,"arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.92,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17eda09d374f6dd7e5993","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze5","pgxind-kftx5yqj","pgxcs-kftwnofo",1297643359,0.451,802834612,0.279,494808747,0.172,"PGX_AM_BS_GSM608964","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.508000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608964","",,,,,,,"arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0567","Afro-Caribbean",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17eda09d374f6dd7e5995","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608966","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze8","pgxind-kftx5yqn","pgxcs-kftwnogb",1604494403,0.558,792098610,0.276,812395793,0.283,"PGX_AM_BS_GSM608966","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.510000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE24715","",,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.26,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e5996","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608967","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjze9","pgxind-kftx5yqp","pgxcs-kftwnogn",1918270231,0.667,700571035,0.244,1217699196,0.424,"PGX_AM_BS_GSM608967","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.511000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,"arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0567","Afro-Caribbean",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17eda09d374f6dd7e5998","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzed","pgxind-kftx5yqt","pgxcs-kftwnoh9",1559601901,0.542,813233208,0.283,746368693,0.26,"PGX_AM_BS_GSM608969","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.513000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608969","",,,,,,,"arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e5999","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzef","pgxind-kftx5yqv","pgxcs-kftwnohl",1339383050,0.466,880786230,0.306,458596820,0.16,"PGX_AM_BS_GSM608970","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.514000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608970","",,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0392","Spanish",0.04,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e599c","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzek","pgxind-kftx5yr1","pgxcs-kftwnoij",1759834960,0.612,598991883,0.208,1160843077,0.404,"PGX_AM_BS_GSM608973","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.518000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608973","",,,,,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e599d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzem","pgxind-kftx5yr3","pgxcs-kftwnoiu",1790941184,0.623,676384805,0.235,1114556379,0.388,"PGX_AM_BS_GSM608974","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.519000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608974","",,,,,,,"arraymap import",0.1,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.02,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e59a0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzer","pgxind-kftx5yra","pgxcs-kftwnojs",1109201625,0.386,463889212,0.161,645312413,0.224,"PGX_AM_BS_GSM608977","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.522000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608977","",,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0392","Spanish",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e59a4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzex","pgxind-kftx5yri","pgxcs-kftwnol3",738160412,0.257,529067508,0.184,209092904,0.073,"PGX_AM_BS_GSM608981","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.527000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608981","",,,,,,,"arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0027","Han Chinese",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0009","East Asian",,,,,,,,
"5dc17eda09d374f6dd7e59a7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzf2","pgxind-kftx5yro","pgxcs-kftwnom3",753070838,0.262,393080578,0.137,359990260,0.125,"PGX_AM_BS_GSM608984","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.530000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM608984","",,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e59a8","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608985","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzf4","pgxind-kftx5yrt","pgxcs-kftwnomf",1674322512,0.582,897573908,0.312,776748604,0.27,"PGX_AM_BS_GSM608985","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.531000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,"arraymap import",0.58,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17eda09d374f6dd7e59a9","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608986","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzf5","pgxind-kftx5yrv","pgxcs-kftwnomr",672308124,0.234,395935376,0.138,276372748,0.096,"PGX_AM_BS_GSM608986","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.532000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,"arraymap import",0.34,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc17eda09d374f6dd7e59ac","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GPL2005","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzfa","pgxind-kftx5ys1","pgxcs-kftwnonp",2261001252,0.786,1467837725,0.511,793163527,0.276,"PGX_AM_BS_GSM608989","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.535000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM608989","",,,,,,,"arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.54,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e59b4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM608997","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzfn","pgxind-kftx5ysi","pgxcs-kftwnoq9",1112901848,0.387,222443980,0.077,890457868,0.31,"PGX_AM_BS_GSM608997","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.545000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,"arraymap import",0.78,"SNP2pop 1000 Genomes population","HANCESTRO:0485","Bangladesh",0.9,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0006","South Asian",,,,,,,,
"5dc17eda09d374f6dd7e59bb","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzfy","pgxind-kftx5ysw","pgxcs-kftwnosh",1028129069,0.358,522461419,0.182,505667650,0.176,"PGX_AM_BS_GSM609004","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.552000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM609004","",,,,,,,"arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e59bf","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSE24715","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzg5","pgxind-kftx5yt4","pgxcs-kftwnotq",1488233682,0.518,615794708,0.214,872438974,0.303,"PGX_AM_BS_GSM609008","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.557000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM609008","",,,,,,,"arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0392","Spanish",0.1,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17eda09d374f6dd7e59c7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM609017","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzgi","pgxind-kftx5ytl","pgxcs-kftwnowl",1461377903,0.508,852389186,0.296,608988717,0.212,"PGX_AM_BS_GSM609017","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.565000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE24715","",,,,,,,"arraymap import",0.16,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.86,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17eda09d374f6dd7e59cd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Alveolar rhabdomyosarcoma","geo:GSM609009","","pgxfus-0002","no followup status","NCIT:C3749","Alveolar Rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzgs","pgxind-kftx5ytx","pgxcs-kftwnou2",852235381,0.296,312794509,0.109,539440872,0.188,"PGX_AM_BS_GSM609009","{}",-75.16,39.95,"Point","USA","Philadelphia","United States of America","Philadelphia, United States",39.95,-75.16,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.572000",,,,,,,"geo:GSE24715","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL2005","",,,,,,,"arraymap import",0.38,"SNP2pop 1000 Genomes population","HANCESTRO:0415","Mexican",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17ee409d374f6dd7e73ed","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","soft tissue sarcoma","geo:GPL5750","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzhc","pgxind-kftx5yum","pgxcs-kftwnp1x",330780385,0.115,91309933,0.032,239470452,0.083,"PGX_AM_BS_GSM218576","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.584000",,,,,,,"geo:GSE8798","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gpl","geo:gse","geo:gsm","geo:GSM218576","",,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc17ee409d374f6dd7e73ef","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM218578","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhf","pgxind-kftx5yuq","pgxcs-kftwnp2j",876140936,0.305,249713331,0.087,626427605,0.218,"PGX_AM_BS_GSM218578","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.586000",,,,,,,"geo:GSE8798","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL5750","",,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc17ee409d374f6dd7e73f6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSM218657","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhq","pgxind-kftx5yv3","pgxcs-kftwnp4r",1809939295,0.63,736652836,0.256,1073286459,0.373,"PGX_AM_BS_GSM218657","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.594000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE8798","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"arraymap import",0.04,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc17ee409d374f6dd7e73f7","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma","geo:GSE8798","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","bone, NOS","pgxbs-kftvjzhs","pgxind-kftx5yv5","pgxcs-kftwnp52",2028442631,0.706,907661240,0.316,1120781391,0.39,"PGX_AM_BS_GSM218658","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:26.595000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM218658","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"arraymap import",0.32,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.96,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17ee409d374f6dd7e73fc","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","soft tissue sarcoma","geo:GSE8798","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzi0","pgxind-kftx5yvf","pgxcs-kftwnp6n",1633794853,0.568,962321481,0.335,671473372,0.234,"PGX_AM_BS_GSM218663","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.600000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM218663","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"arraymap import",0.28,"SNP2pop 1000 Genomes population","HANCESTRO:0421","Puerto Rican",0.72,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc17ee409d374f6dd7e73fd","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","soft tissue sarcoma","geo:GSM218664","","pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvjzi2","pgxind-kftx5yvh","pgxcs-kftwnp92",1803714502,0.627,995367446,0.346,808347056,0.281,"PGX_AM_BS_GSM218664","{}",-95.36,29.76,"Point","USA","Houston","United States of America","Houston, United States",29.76,-95.36,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:26.602000",,,,,,,"geo:GPL2005","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE8798","",,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0005","European",0.38,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0005","European",,,,,,,,
"5dc1831f09d374f6dd8260ca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Synovial sarcoma","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...","pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovial sarcoma, NOS","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvk6ja","pgxind-kftx67hq","pgxcs-kftwpdk2",46514,0,46514,0,0,0,"PGX_AM_BS_GSM482571","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:33.614000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","pubmed","geo:gpl","geo:gse","geo:GSE19399","",,,,"geo:gsm","geo:GSM482571","","arraymap import",0.4,"SNP2pop 1000 Genomes population","HANCESTRO:0420","Peruvian",0.92,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,,
"5dc1834709d374f6dd8293ae","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dedifferentiated liposarcoma","geo:GSM486220","","pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma","icdot-C49.9","connective and soft tissue, NOS","pgxbs-kftvk6qs","pgxind-kftx67qy","pgxcs-kftwpf1f",889374804,0.309,585131482,0.204,304243322,0.106,"PGX_AM_BS_GSM486220","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States",42.38,-71.11,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:46:33.792000",,,,,,,"geo:GPL3720","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE19399","",,,,"pubmed","PMID:20164920","Beroukhim R, Mermel CH et al. (2010): The landscape of somatic copy-number alteration...","arraymap import",0.26,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.22,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,,
"5dc1840b09d374f6dd83794b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSM108568","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82j","pgxind-kftx69du","pgxcs-kftwpo9l",2670545460,0.929,1855508262,0.645,815037198,0.283,"PGX_AM_BS_GSM108568","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.167000",,,,,,,"geo:GSE4838","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gse","geo:gpl","geo:GPL3749","",,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1840b09d374f6dd83794d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GPL3749","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82n","pgxind-kftx69dy","pgxcs-kftwpoae",2525485061,0.878,2166551894,0.754,358933167,0.125,"PGX_AM_BS_GSM108972","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.170000",,,,,,,"geo:GSE4838","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM108972","",,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1840b09d374f6dd83794e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GPL3749","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82o","pgxind-kftx69e0","pgxcs-kftwpoat",1077208590,0.375,575979661,0.2,501228929,0.174,"PGX_AM_BS_GSM108973","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.171000",,,,,,,"geo:GSE4838","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gpl","geo:gse","geo:gsm","geo:GSM108973","",,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1840b09d374f6dd83794f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSM108975","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82q","pgxind-kftx69e2","pgxcs-kftwpobk",1948950785,0.678,1706491972,0.594,242458813,0.084,"PGX_AM_BS_GSM108975","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.172000",,,,,,,"geo:GPL3749","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gsm","geo:gpl","geo:gse","geo:GSE4838","",,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1840b09d374f6dd837950","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Dendritic cell tumour","geo:GSE4838","","pgxfus-0002","no followup status","NCIT:C9282","Interdigitating Dendritic Cell Sarcoma","icdom-97573","Interdigitating dendritic cell sarcoma","icdot-C42.4","Hematopoietic system, NOS","pgxbs-kftvk82r","pgxind-kftx69e4","pgxcs-kftwpobz",1664430584,0.579,1411035072,0.491,253395512,0.088,"PGX_AM_BS_GSM109004","{}",13.41,52.52,"Point","DEU","Berlin","Germany","Berlin, Germany",52.52,13.41,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002390","hematopoietic system","{}","2020-09-10 17:46:35.173000",,,,,,,"geo:GPL3749","",,,,,"pgxcohort-gao2021signatures","Gao and Baudis - Cancer CNV Signatures (2021)","pgxcohort-2021progenetix","Version at Progenetix Update 2021","geo:gse","geo:gpl","geo:gsm","geo:GSM109004","",,,,,,,"arraymap import",,,,,,,,,,,,,,,,
"5dc1878d09d374f6dd897985","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade II [Ollier patient]","geo:GSM567027","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke6z","pgxind-kftx6gvc","pgxcs-kftwqrlw",458953597,0.16,303733123,0.106,155220474,0.054,"PGX_AM_BS_GSM567027","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.660000",,,,,,"P23Y","geo:GSE22965","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.06,"SNP2pop 1000 Genomes population","HANCESTRO:0403","Colombian",0.06,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0014","Hispanic or Latin American",,,,,,,"primary",
"5dc1878d09d374f6dd89798b","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade I [Ollier patient]","geo:GSM567056","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke79","pgxind-kftx6gvo","pgxcs-kftwqru1",186190203,0.065,186169258,0.065,20945,0,"PGX_AM_BS_GSM567056","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.668000",,,,,,"P18Y","geo:GSE22965","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.22,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.72,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"primary",
"5dc1878d09d374f6dd897995","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade I [Ollier patient]","geo:GSM567334","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke7p","pgxind-kftx6gw8","pgxcs-kftwqs59",501146596,0.174,324760613,0.113,176385983,0.061,"PGX_AM_BS_GSM567334","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.682000",,,,,,"P48Y","geo:GSE22965","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.12,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"primary",
"5dc1878d09d374f6dd897997","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Chondrosarcoma grade II [Ollier patient]","geo:GSM567338","","pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvke7t","pgxind-kftx6gwd","pgxcs-kftwqs76",1717566648,0.597,983636526,0.342,733930122,0.255,"PGX_AM_BS_GSM567338","{}",4.49,52.16,"Point","NLD","Leiden","Netherlands","Leiden, Netherlands",52.16,4.49,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:40.685000",,,,,,"P68Y","geo:GSE22965","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,"geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,"pubmed","PMID:21235737","Pansuriya TC, Oosting J et al. (2011): Genome-wide analysis of Ollier disease: Is...","arraymap import",0.08,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.0399999999999999,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"primary",
"5dc1890909d374660e5075e3","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Osteosarcoma [cell lineI OR/MOS]","geo:GSM879214","","pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bones, NOS","pgxbs-kftvkg3y","pgxind-kftx6j8a","pgxcs-kftwrczu",0,0,0,0,0,0,"PGX_AM_BS_GSM879214","{}",10.75,59.91,"Point","NOR","Oslo","Norway","Oslo, Norway",59.91,10.75,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:42.791000",,,,,,"P13Y","geo:GSE36003","",,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)","geo:gsm","geo:gse","geo:gpl","geo:GPL6801","",,,,"pubmed","PMID:23144859","Kresse SH, Rydbeck H et al. (2012): Integrative analysis reveals relationships of genetic...","arraymap import",0.14,"SNP2pop 1000 Genomes population","HANCESTRO:0568","African American",0.08,"SNP2pop 1000 Genomes superpopulation","HANCESTRO:0010","African",,,,,,,"cell line",
"5f5a354582925370d25adf94","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1638950",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkij3","pgxind-kftx6m7t","pgxcs-kftwsi4p",2061338509,0.717,1254446105,0.436,806892404,0.281,"PGX_AM_BS_GSM1638950",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.382000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding","P39Y","geo:GPL18602",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Müllerian...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a354582925370d25adf9f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1917699",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkijl","pgxind-kftx6m8g","pgxcs-kftwsia1",793272664,0.276,654852486,0.228,138420178,0.048,"PGX_AM_BS_GSM1917699",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.398000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding","P64Y","geo:GPL18602",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Müllerian...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a354582925370d25adfa0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","Uterine adenosarcoma","geo:GSM1917700",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C55.9","Uterus, NOS","pgxbs-kftvkijn","pgxind-kftx6m8i","pgxcs-kftwsiai",1081760010,0.376,770934553,0.268,310825457,0.108,"PGX_AM_BS_GSM1917700",,121.53,25.05,"Point","TWN","Taipei","Taiwan","Taipei, Taiwan",25.05,121.53,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000995","uterus","{}","2020-09-10 17:46:45.399000","T1","NCITstage-C27966","Stage I","TNM-C48720","T1 Stage Finding","P38Y","geo:GPL18602",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021",,,,,,"PMID:27255164","Lee JC, Lu TP, Changou CA et al. (2016): Genomewide copy number analysis of Müllerian...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2ca","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma;reponse to chemotherapy: good responder","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvklhu","pgxind-kftx6pxp","pgxcs-kftwyfkl",1225293726,0.426,521578076,0.181,703715650,0.245,"PGX_AM_BS_AE-MTAB_3034-OS011-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.761000",,,,,,,"geo:GPL6801",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2ce","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma;reponse to chemotherapy: good responder","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkli1","pgxind-kftx6pxx","pgxcs-kftwyfoe",810235454,0.282,554996647,0.193,255238807,0.089,"PGX_AM_BS_AE-MTAB_3034-OS022-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.766000",,,,,,,"geo:GPL6801",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2d2","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","reponse to chemotherapy: poor responder;osteosarcoma","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkli7","pgxind-kftx6py5","pgxcs-kftwyfs9",1044352754,0.363,853224776,0.297,191127978,0.066,"PGX_AM_BS_AE-MTAB_3034-OS034-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.772000",,,,,,,"geo:GPL6801",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a362e5667b527f2dbe2ed","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","osteosarcoma;reponse to chemotherapy: good responder","arrayexpress:E-MTAB-3034",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkljf","pgxind-kftx6pzo","pgxcs-kftwygkr",1244469140,0.433,1087970187,0.378,156498953,0.054,"PGX_AM_BS_AE-MTAB_3034-OS124-SNP6","{}",7.63,51.96,"Point","DEU","Muenster","Germany","Muenster, Germany",51.96,7.63,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:48.811000",,,,,,,"geo:GPL6801",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36305667b527f2dbe7e4","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn4q","pgxind-kftx6rzp","pgxcs-kftwzgwe",1250648244,0.435,892496897,0.31,358151347,0.125,"PGX_AM_BS_AE-MTAB_3998-OS001-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.614000",,,,,,"P4Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7e6","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn4t","pgxind-kftx6rzt","pgxcs-kftwzgyc",1452430035,0.505,856295894,0.298,596134141,0.207,"PGX_AM_BS_AE-MTAB_3998-OS007-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.617000",,,,,,"P74Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7ed","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn55","pgxind-kftx6s07","pgxcs-kftwzh53",470561835,0.164,146851775,0.051,323710060,0.113,"PGX_AM_BS_AE-MTAB_3998-OS027-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.627000",,,,,,"P17Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7f0","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn59","pgxind-kftx6s0d","pgxcs-kftwzh80",1050326417,0.365,923114737,0.321,127211680,0.044,"PGX_AM_BS_AE-MTAB_3998-OS034-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.631000",,,,,,"P19Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe7ff","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn5y","pgxind-kftx6s18","pgxcs-kftwzhmj",1376534989,0.479,567435649,0.197,809099340,0.281,"PGX_AM_BS_AE-MTAB_3998-OS063-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.653000",,,,,,"P17Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe800","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn60","pgxind-kftx6s1a","pgxcs-kftwzhni",1117857699,0.389,405731127,0.141,712126572,0.248,"PGX_AM_BS_AE-MTAB_3998-OS065-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.654000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe803","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn65","pgxind-kftx6s1g","pgxcs-kftwzhqf",959662412,0.334,464953418,0.162,494708994,0.172,"PGX_AM_BS_AE-MTAB_3998-OS075-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.659000",,,,,,"P3Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe807","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6c","pgxind-kftx6s1o","pgxcs-kftwzhub",1273978166,0.443,862027184,0.3,411950982,0.143,"PGX_AM_BS_AE-MTAB_3998-OS083-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.664000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe80d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6l","pgxind-kftx6s20","pgxcs-kftwzi05",1230579822,0.428,558066072,0.194,672513750,0.234,"PGX_AM_BS_AE-MTAB_3998-OS097-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.673000",,,,,,"P36Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe80e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6n","pgxind-kftx6s22","pgxcs-kftwzi14",1225136346,0.426,924501509,0.322,300634837,0.105,"PGX_AM_BS_AE-MTAB_3998-OS099-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.675000",,,,,,"P9Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe810","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn6q","pgxind-kftx6s26","pgxcs-kftwzi5h",1723982010,0.6,996068054,0.346,727913956,0.253,"PGX_AM_BS_AE-MTAB_3998-OS102-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.677000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe818","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn73","pgxind-kftx6s2n","pgxcs-kftwzids",1790600121,0.623,1022849220,0.356,767750901,0.267,"PGX_AM_BS_AE-MTAB_3998-OS115-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.689000",,,,,,"P16Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe81e","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7d","pgxind-kftx6s2z","pgxcs-kftwzijn",905650500,0.315,798020445,0.278,107630055,0.037,"PGX_AM_BS_AE-MTAB_3998-OS124-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.698000",,,,,,"P16Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe824","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7n","pgxind-kftx6s3b","pgxcs-kftwzipk",1359643815,0.473,937314940,0.326,422328875,0.147,"PGX_AM_BS_AE-MTAB_3998-OS130-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.707000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe825","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7o","pgxind-kftx6s3d","pgxcs-kftwziqj",2022437717,0.703,1058790381,0.368,963647336,0.335,"PGX_AM_BS_AE-MTAB_3998-OS131-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.708000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe826","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7q","pgxind-kftx6s3f","pgxcs-kftwziri",1630741384,0.567,824795485,0.287,805945899,0.28,"PGX_AM_BS_AE-MTAB_3998-OS133-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.710000",,,,,,"P18Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe828","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7t","pgxind-kftx6s3j","pgxcs-kftwziti",1095968672,0.381,220797229,0.077,875171443,0.304,"PGX_AM_BS_AE-MTAB_3998-OS136-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.713000",,,,,,"P16Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe829","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7v","pgxind-kftx6s3l","pgxcs-kftwziui",1573414274,0.547,864294486,0.301,709119788,0.247,"PGX_AM_BS_AE-MTAB_3998-OS137-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.714000",,,,,,"P17Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe82a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn7w","pgxind-kftx6s3n","pgxcs-kftwzivh",975392020,0.339,719134148,0.25,256257872,0.089,"PGX_AM_BS_AE-MTAB_3998-OS139-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.715000",,,,,,"P23Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe831","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn88","pgxind-kftx6s42","pgxcs-kftwzj29",1468541077,0.511,836241903,0.291,632299174,0.22,"PGX_AM_BS_AE-MTAB_3998-OS149-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.725000",,,,,,"P26Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe838","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8j","pgxind-kftx6s4g","pgxcs-kftwzj93",1221524598,0.425,756731002,0.263,464793596,0.162,"PGX_AM_BS_AE-MTAB_3998-OS160-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.735000",,,,,,"P15Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe83a","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn8n","pgxind-kftx6s4k","pgxcs-kftwzjd6",1839278122,0.64,708389104,0.246,1130889018,0.393,"PGX_AM_BS_AE-MTAB_3998-OS162-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.738000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe84d","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9h","pgxind-kftx6s5n","pgxcs-kftwzjvq",1369076948,0.476,549061263,0.191,820015685,0.285,"PGX_AM_BS_AE-MTAB_3998-OS234-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.765000",,,,,,"P17Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe84f","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9k","pgxind-kftx6s5r","pgxcs-kftwzjxo",1820158210,0.633,947832897,0.33,872325313,0.303,"PGX_AM_BS_AE-MTAB_3998-OS236-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.767000",,,,,,"P19Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36315667b527f2dbe850","pgxcohort-arraymap","arrayMap collection","DUO:0000004","no restriction","pre-therapeutic biopsy of tumor tissue;osteosarcoma","arrayexpress:E-MTAB-3998",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkn9m","pgxind-kftx6s5t","pgxcs-kftwzjyn",1111398034,0.387,741346099,0.258,370051935,0.129,"PGX_AM_BS_AE-MTAB_3998-OS237-CytoScanHD","{}",7.57,47.56,"Point","CHE","Basel","Switzerland","Basel, Switzerland",47.56,7.57,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:46:50.769000",,,,,,"P14Y","geo:GPL16131",,,,,,"pgxcohort-2021progenetix","Version at Progenetix Update 2021","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:26632267","Kovac M, Blattmann C et al. (2015): Exome sequencing of osteosarcoma reveals mutation...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a366e6b8c1d6d377c1950","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvks9n","pgxind-kftx6y0u","pgxcs-kftwtxem",409584369,0.142,271033702,0.094,138550667,0.048,"PGX_AM_BS_CELLLINE_CCLE_BROAD-A673_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.090000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_0080",,,,,,,,,,,,,,,,"A-673",,
"5f5a366e6b8c1d6d377c1988","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C6476","Dedifferentiated chondrosarcoma","icdom-92433","Dedifferentiated chondrosarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvksc5","pgxind-kftx6y40","pgxcs-kftwty8b",2093850697,0.728,1037719312,0.361,1056131385,0.367,"PGX_AM_BS_CELLLINE_CCLE_BROAD-CAL78_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.174000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_1809",,,,,,,,,,,,,,,,"CAL-78",,
"5f5a366e6b8c1d6d377c19f9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvksha","pgxind-kftx6yaf","pgxcs-kftwtztv",1634468367,0.569,750845233,0.261,883623134,0.307,"PGX_AM_BS_CELLLINE_CCLE_BROAD-G292CLONEA141B1_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.342000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_2909",,,,,,,,,,,,,,,,"G-292 clone A141B1",,
"5f5a366e6b8c1d6d377c1a64","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.4","Skeletal muscle","pgxbs-kftvksm5","pgxind-kftx6ygg","pgxcs-kftwu1ci",2110019958,0.734,1082596507,0.377,1027423451,0.357,"PGX_AM_BS_CELLLINE_CCLE_BROAD-HS729_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0003567","abdomen connective tissue","{}","2020-09-10 17:46:56.502000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_0871",,,,,,,,,,,,,,,,"Hs 729.T",,
"5f5a366f6b8c1d6d377c1b31","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine corpus sarcoma","icdom-88003","Sarcoma, NOS","icdot-C55.9","Uterus, NOS","pgxbs-kftvksve","pgxind-kftx6ys2","pgxcs-kftwu4cg",377050915,0.131,275781918,0.096,101268997,0.035,"PGX_AM_BS_CELLLINE_CCLE_BROAD-MESSA_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0000995","uterus","{}","2020-09-10 17:46:56.815000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_1404",,,,,,,,,,,,,,,,"MES-SA",,
"5f5a366f6b8c1d6d377c1b36","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvksvm","pgxind-kftx6ysd","pgxcs-kftwu4ex",1690368393,0.588,788482463,0.274,901885930,0.314,"PGX_AM_BS_CELLLINE_CCLE_BROAD-MG63_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.822000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_0426",,,,,,,,,,,,,,,,"MG-63",,
"5f5a366f6b8c1d6d377c1b3a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvksvt","pgxind-kftx6ysl","pgxcs-kftwu4gv",1129739330,0.393,294730470,0.103,835008860,0.29,"PGX_AM_BS_CELLLINE_CCLE_BROAD-MHHES1_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:56.827000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_1411",,,,,,,,,,,,,,,,"MHH-ES-1",,
"5f5a366f6b8c1d6d377c1be8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C7155","Primary central chondrosarcoma","icdom-92203","Chondrosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkt3o","pgxind-kftx6z2f","pgxcs-kftwu6zn",1462636362,0.509,692769954,0.241,769866408,0.268,"PGX_AM_BS_CELLLINE_CCLE_BROAD-OUMS27_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.089000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_3090",,,,,,,,,,,,,,,,"OUMS-27",,
"5f5a366f6b8c1d6d377c1c1a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS","icdot-C49.4","Skeletal muscle","pgxbs-kftvkt5w","pgxind-kftx6z57","pgxcs-kftwu7qs",1388670803,0.483,517763740,0.18,870907063,0.303,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RD_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0003567","abdomen connective tissue","{}","2020-09-10 17:46:57.163000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_1649",,,,,,,,,,,,,,,,"RD",,
"5f5a366f6b8c1d6d377c1c25","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C3749","Alveolar rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C34.9","Lung and bronchus, NOS","pgxbs-kftvkt6e","pgxind-kftx6z5t","pgxcs-kftwu7w7",1860803474,0.647,888995865,0.309,971807609,0.338,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RH30_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002048","lung","{}","2020-09-10 17:46:57.179000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_0041",,,,,,,,,,,,,,,,"Rh30",,
"5f5a366f6b8c1d6d377c1c26","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C3749","Alveolar rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C34.9","Lung and bronchus, NOS","pgxbs-kftvkt6g","pgxind-kftx6z5v","pgxcs-kftwu7wo",1658654654,0.577,549769474,0.191,1108885180,0.386,"PGX_AM_BS_CELLLINE_CCLE_BROAD-RH41_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002048","lung","{}","2020-09-10 17:46:57.181000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_2176",,,,,,,,,,,,,,,,"Rh41",,
"5f5a366f6b8c1d6d377c1c36","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C6041","Thyroid gland sarcoma","icdom-88003","Sarcoma, NOS","icdot-C73.9","Thyroid gland","pgxbs-kftvkt76","pgxind-kftx6z6s","pgxcs-kftwu84h",1761557134,0.613,823388269,0.286,938168865,0.326,"PGX_AM_BS_CELLLINE_CCLE_BROAD-S117_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002046","thyroid gland","{}","2020-09-10 17:46:57.204000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_1674",,,,,,,,,,,,,,,,"S-117",,
"5f5a366f6b8c1d6d377c1c4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C3749","Alveolar rhabdomyosarcoma","icdom-89203","Alveolar rhabdomyosarcoma","icdot-C34.9","Lung and bronchus, NOS","pgxbs-kftvkt82","pgxind-kftx6z7x","pgxcs-kftwu8e9",1939688127,0.675,973563105,0.339,966125022,0.336,"PGX_AM_BS_CELLLINE_CCLE_BROAD-SJRH30_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0002048","lung","{}","2020-09-10 17:46:57.234000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_0041",,,,,,,,,,,,,,,,"Rh30",,
"5f5a366f6b8c1d6d377c1c4b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS","icdot-C41.9","Bone, NOS","pgxbs-kftvkt84","pgxind-kftx6z80","pgxcs-kftwu8eq",937702424,0.326,680057691,0.237,257644733,0.09,"PGX_AM_BS_CELLLINE_CCLE_BROAD-SJSA1_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.235000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines","pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_1697",,,,,,,,,,,,,,,,"SJSA-1",,
"5f5a366f6b8c1d6d377c1c4e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvkt89","pgxind-kftx6z86","pgxcs-kftwu8g7",1950528912,0.678,1198120853,0.417,752408059,0.262,"PGX_AM_BS_CELLLINE_CCLE_BROAD-SKES1_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.240000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_0627",,,,,,,,,,,,,,,,"SK-ES-1",,
"5f5a366f6b8c1d6d377c1c50","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C40318","Vulvar leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS","icdot-C51.9","Vulva","pgxbs-kftvkt8c","pgxind-kftx6z8a","pgxcs-kftwu8h7",1913263435,0.665,867342681,0.302,1045920754,0.364,"PGX_AM_BS_CELLLINE_CCLE_BROAD-SKLMS1_SOFT_TISSUE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0011387","constrictor vulvae muscle","{}","2020-09-10 17:46:57.243000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_0628",,,,,,,,,,,,,,,,"SK-LMS-1",,
"5f5a366f6b8c1d6d377c1cce","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Mixed Cancer Types","cBP-CELLLINE_CCLE_BROAD",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing sarcoma","icdom-92603","Ewing sarcoma","icdot-C41.9","Bone, NOS","pgxbs-kftvkte0","pgxind-kftx6zff","pgxcs-kftwuabg",1295110436,0.45,674157989,0.234,620952447,0.216,"PGX_AM_BS_CELLLINE_CCLE_BROAD-TC71_BONE","{}",-71.11,42.38,"Point","USA","Cambridge","United States of America","Cambridge, United States of America",42.38,-71.11,"city","Feature","EFO:0001639","cancer cell line","UBERON:0001474","bone element","{}","2020-09-10 17:46:57.432000",,,,,,"P69Y","geo:GPL6801",,,,,,"pgxcohort-celllines","Cancer cell lines",,,,,,"PMID:22460905","Barretina J, Caponigro G et al. (2012): The Cancer Cell Line Encyclopedia enables...",,,,,"cellosaurus:CVCL_2213",,,,,,,,,,,,,,,,"TC-71",,
"5f5a36746b8c1d6d377c2773","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkwr5","pgxind-kftx73pa","pgxcs-kftwvcfp",1842109576,0.641,1347610038,0.469,494499538,0.172,"PGX_AM_BS_MSK_IMPACT_2017-P_0000257_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:01.270000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c277e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkwrn","pgxind-kftx73pw","pgxcs-kftwvcky",990912319,0.345,647290873,0.225,343621446,0.12,"PGX_AM_BS_MSK_IMPACT_2017-P_0000271_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:01.286000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c28a5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkx4z","pgxind-kftx746l","pgxcs-kftwvgqq",1835690915,0.639,713051364,0.248,1122639551,0.39,"PGX_AM_BS_MSK_IMPACT_2017-P_0000576_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:02.076000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c28dc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkx7h","pgxind-kftx749p","pgxcs-kftwvhiy",1971481480,0.686,1011896313,0.352,959585167,0.334,"PGX_AM_BS_MSK_IMPACT_2017-P_0000629_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.154000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c28fe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Follicular Dendritic Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9281","Follicular Dendritic Cell Sarcoma","icdom-97583","Follicular dendritic cell sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkx90","pgxind-kftx74bm","pgxcs-kftwvi1a",970970780,0.338,418199698,0.145,552771082,0.192,"PGX_AM_BS_MSK_IMPACT_2017-P_0000660_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:02.200000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2932","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvkxbc","pgxind-kftx74ek","pgxcs-kftwviqa",953444543,0.332,496826315,0.173,456618228,0.159,"PGX_AM_BS_MSK_IMPACT_2017-P_0000708_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:02.274000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2935","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkxbh","pgxind-kftx74eq","pgxcs-kftwvitn",1639024541,0.57,807986700,0.281,831037841,0.289,"PGX_AM_BS_MSK_IMPACT_2017-P_0000711_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:02.278000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c2996","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondroblastic Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkxft","pgxind-kftx74k7","pgxcs-kftwvk6g",2244284503,0.781,951329041,0.331,1292955462,0.45,"PGX_AM_BS_MSK_IMPACT_2017-P_0000815_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:02.414000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36746b8c1d6d377c29b9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Alveolar Soft Part Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3750","Alveolar Soft Part Sarcoma","icdom-95813","Alveolar soft part sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxhd","pgxind-kftx74m6","pgxcs-kftwvkn6",130915372,0.046,51413,0,130863959,0.046,"PGX_AM_BS_MSK_IMPACT_2017-P_0000851_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:02.463000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a37","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4303","Myxoid Chondrosarcoma","icdom-92313","Myxoid chondrosarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkxn0","pgxind-kftx74tb","pgxcs-kftwvmdq",1826663761,0.635,867344061,0.302,959319700,0.334,"PGX_AM_BS_MSK_IMPACT_2017-P_0000972_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:02.641000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a52","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvkxo8","pgxind-kftx74uv","pgxcs-kftwvmsu",1786926410,0.622,826241231,0.287,960685179,0.334,"PGX_AM_BS_MSK_IMPACT_2017-P_0001002_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:02.679000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a62","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxoy","pgxind-kftx74vr","pgxcs-kftwvn0i",1614701731,0.562,874062447,0.304,740639284,0.258,"PGX_AM_BS_MSK_IMPACT_2017-P_0001016_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:02.702000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a9b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Epithelioid Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3714","Epithelioid Sarcoma","icdom-88043","Epithelioid sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxrj","pgxind-kftx74yz","pgxcs-kftwvntw",611227334,0.213,282008678,0.098,329218656,0.115,"PGX_AM_BS_MSK_IMPACT_2017-P_0001083_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:02.781000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2a9f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxrp","pgxind-kftx74z7","pgxcs-kftwvnvt",1547408929,0.538,909092070,0.316,638316859,0.222,"PGX_AM_BS_MSK_IMPACT_2017-P_0001087_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.787000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2ae3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","High-Grade Endometrial Stromal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8973","Endometrioid Stromal Sarcoma","icdom-89303","Endometrial stromal sarcoma, NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkxut","pgxind-kftx7532","pgxcs-kftwvosq",255421582,0.089,165741335,0.058,89680247,0.031,"PGX_AM_BS_MSK_IMPACT_2017-P_0001164_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium",,"2020-09-10 17:47:02.883000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2aeb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Intimal Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C53677","Intimal Sarcoma","icdom-91373","Intimal sarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxv6","pgxind-kftx753i","pgxcs-kftwvoyw",1650395188,0.574,1041742335,0.362,608652853,0.212,"PGX_AM_BS_MSK_IMPACT_2017-P_0001173_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:02.894000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2b17","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkxx5","pgxind-kftx7560","pgxcs-kftwvpk1",988167851,0.344,687425175,0.239,300742676,0.105,"PGX_AM_BS_MSK_IMPACT_2017-P_0001217_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:02.958000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2b97","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvky2w","pgxind-kftx75d7","pgxcs-kftwvrds",2662660842,0.926,1571680810,0.547,1090980032,0.379,"PGX_AM_BS_MSK_IMPACT_2017-P_0001343_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:03.138000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2bf6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvky76","pgxind-kftx75ik","pgxcs-kftwvspo",2219447370,0.772,1171196058,0.407,1048251312,0.365,"PGX_AM_BS_MSK_IMPACT_2017-P_0001439_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.272000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c00","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvky7m","pgxind-kftx75j4","pgxcs-kftwvsuj",1765639897,0.614,1144803350,0.398,620836547,0.216,"PGX_AM_BS_MSK_IMPACT_2017-P_0001448_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.286000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36756b8c1d6d377c2c3f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkyag","pgxind-kftx75mo","pgxcs-kftwvtow",1109989470,0.386,888138005,0.309,221851465,0.077,"PGX_AM_BS_MSK_IMPACT_2017-P_0001513_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.375000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c7f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkydb","pgxind-kftx75qb","pgxcs-kftwvum3",1971605805,0.686,861247457,0.3,1110358348,0.386,"PGX_AM_BS_MSK_IMPACT_2017-P_0001572_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.466000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2c91","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkye3","pgxind-kftx75rc","pgxcs-kftwvuus",872011022,0.303,553238004,0.192,318773018,0.111,"PGX_AM_BS_MSK_IMPACT_2017-P_0001596_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.491000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2ca2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyev","pgxind-kftx75sa","pgxcs-kftwvv55",2056552603,0.715,1392860870,0.484,663691733,0.231,"PGX_AM_BS_MSK_IMPACT_2017-P_0001612_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.514000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2cca","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sclerosing Epithelioid Fibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C49027","Sclerosing Epithelioid Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkygn","pgxind-kftx75uk","pgxcs-kftwvvoe",1204118760,0.419,900681765,0.313,303436995,0.106,"PGX_AM_BS_MSK_IMPACT_2017-P_0001652_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:03.570000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d14","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkyjz","pgxind-kftx75yr","pgxcs-kftwvwqd",1875053770,0.652,1226334481,0.427,648719289,0.226,"PGX_AM_BS_MSK_IMPACT_2017-P_0001725_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:03.674000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d4b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkymf","pgxind-kftx761v","pgxcs-kftwvxis",1875049386,0.652,1170841945,0.407,704207441,0.245,"PGX_AM_BS_MSK_IMPACT_2017-P_0001781_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:03.752000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2d79","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkyoh","pgxind-kftx764f","pgxcs-kftwvy4w",2392857986,0.832,1369311414,0.476,1023546572,0.356,"PGX_AM_BS_MSK_IMPACT_2017-P_0001827_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:03.817000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e15","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyvn","pgxind-kftx76da","pgxcs-kftww0c1",1068617821,0.372,306060009,0.106,762557812,0.265,"PGX_AM_BS_MSK_IMPACT_2017-P_0001983_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:04.037000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e1b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkyvw","pgxind-kftx76dm","pgxcs-kftww0ex",1559064860,0.542,848055290,0.295,711009570,0.247,"PGX_AM_BS_MSK_IMPACT_2017-P_0001989_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.046000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e25","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkywd","pgxind-kftx76e6","pgxcs-kftww0jp",1081446648,0.376,490293583,0.171,591153065,0.206,"PGX_AM_BS_MSK_IMPACT_2017-P_0001999_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.061000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e2f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkywt","pgxind-kftx76eq","pgxcs-kftww0oh",1884098681,0.655,1149095090,0.4,735003591,0.256,"PGX_AM_BS_MSK_IMPACT_2017-P_0002008_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.075000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e3d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkyxg","pgxind-kftx76fj","pgxcs-kftww0v8",2017618406,0.702,840379847,0.292,1177238559,0.409,"PGX_AM_BS_MSK_IMPACT_2017-P_0002020_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.095000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvkyy0","pgxind-kftx76g9","pgxcs-kftww13i",2446428671,0.851,1498163839,0.521,948264832,0.33,"PGX_AM_BS_MSK_IMPACT_2017-P_0002034_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:04.113000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e68","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4258","Pleomorphic Rhabdomyosarcoma","icdom-89013","Pleomorphic rhabdomyosarcoma, adult type ","icdot-C49.4","Connective, subcutaneous and other soft tissues of abdomen","pgxbs-kftvkyzd","pgxind-kftx76hy","pgxcs-kftww1hx",1665399234,0.579,919344898,0.32,746054336,0.259,"PGX_AM_BS_MSK_IMPACT_2017-P_0002066_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0003567","abdomen connective tissue","{}","2020-09-10 17:47:04.155000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2e8a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkz0x","pgxind-kftx76jw","pgxcs-kftww1y8",1277349756,0.444,826218832,0.287,451130924,0.157,"PGX_AM_BS_MSK_IMPACT_2017-P_0002100_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.202000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2eaa","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvkz2f","pgxind-kftx76lp","pgxcs-kftww2fq",1522946498,0.53,543757502,0.189,979188996,0.341,"PGX_AM_BS_MSK_IMPACT_2017-P_0002134_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:04.247000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2eab","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvkz2h","pgxind-kftx76lr","pgxcs-kftww2g7",1618761304,0.563,1015319262,0.353,603442042,0.21,"PGX_AM_BS_MSK_IMPACT_2017-P_0002134_T02_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:04.249000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36766b8c1d6d377c2ed7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkz4i","pgxind-kftx76o9","pgxcs-kftww319",2026595829,0.705,1336535102,0.465,690060727,0.24,"PGX_AM_BS_MSK_IMPACT_2017-P_0002179_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:04.310000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f2d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvkz8e","pgxind-kftx76t4","pgxcs-kftww48s",1273894921,0.443,647566473,0.225,626328448,0.218,"PGX_AM_BS_MSK_IMPACT_2017-P_0002256_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:04.431000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f39","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondroblastic Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4021","Chondroblastic Osteosarcoma","icdom-91813","Chondroblastic osteosarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvkz8y","pgxind-kftx76ts","pgxcs-kftww4en",1448846621,0.504,965816864,0.336,483029757,0.168,"PGX_AM_BS_MSK_IMPACT_2017-P_0002269_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:04.448000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f59","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzae","pgxind-kftx76vl","pgxcs-kftww4wi",1410462024,0.491,1260161295,0.438,150300729,0.052,"PGX_AM_BS_MSK_IMPACT_2017-P_0002301_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.494000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c2f6b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvkzb7","pgxind-kftx76wl","pgxcs-kftww556",1558957840,0.542,823910475,0.287,735047365,0.256,"PGX_AM_BS_MSK_IMPACT_2017-P_0002318_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:04.519000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c302a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvkzjw","pgxind-kftx777e","pgxcs-kftww7ta",1996932370,0.695,1454273325,0.506,542659045,0.189,"PGX_AM_BS_MSK_IMPACT_2017-P_0002513_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:04.787000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c30b9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvkzqe","pgxind-kftx77fh","pgxcs-kftww9um",146601509,0.051,61703970,0.021,84897539,0.03,"PGX_AM_BS_MSK_IMPACT_2017-P_0002662_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:04.988000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c3119","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvkzup","pgxind-kftx77kx","pgxcs-kftwwb6t",2684117091,0.934,1653522360,0.575,1030594731,0.358,"PGX_AM_BS_MSK_IMPACT_2017-P_0002764_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:05.122000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36776b8c1d6d377c3147","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvkzws","pgxind-kftx77ni","pgxcs-kftwwbsx",1522280977,0.529,795447995,0.277,726832982,0.253,"PGX_AM_BS_MSK_IMPACT_2017-P_0002812_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:05.187000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3192","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl005","pgxind-kftx77rs","pgxcs-kftwwcvo",2052767870,0.714,1021740416,0.355,1031027454,0.359,"PGX_AM_BS_MSK_IMPACT_2017-P_0002885_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:05.291000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c31b7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl01t","pgxind-kftx77tu","pgxcs-kftwwdfq",2015357457,0.701,1229184873,0.428,786172584,0.273,"PGX_AM_BS_MSK_IMPACT_2017-P_0002919_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.344000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c31e2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl03q","pgxind-kftx77w9","pgxcs-kftwwe0j",2638130232,0.918,1803423896,0.627,834706336,0.29,"PGX_AM_BS_MSK_IMPACT_2017-P_0002972_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.405000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3231","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl079","pgxind-kftx780r","pgxcs-kftwwf51",1788474263,0.622,788870087,0.274,999604176,0.348,"PGX_AM_BS_MSK_IMPACT_2017-P_0003043_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.516000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c3282","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvl0av","pgxind-kftx785c","pgxcs-kftwwga5",882935091,0.307,541956831,0.189,340978260,0.119,"PGX_AM_BS_MSK_IMPACT_2017-P_0003138_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:05.641000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c32ac","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0cr","pgxind-kftx787n","pgxcs-kftwwgu8",2121237127,0.738,969988431,0.337,1151248696,0.4,"PGX_AM_BS_MSK_IMPACT_2017-P_0003180_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.699000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c32e1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Spindle Cell Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6519","Spindle Cell Rhabdomyosarcoma","icdom-89123","Spindle cell rhabdomyosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0f5","pgxind-kftx78an","pgxcs-kftwwhlu",2083081650,0.725,1276410978,0.444,806670672,0.281,"PGX_AM_BS_MSK_IMPACT_2017-P_0003232_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:05.773000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c331c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl0hs","pgxind-kftx78e0","pgxcs-kftwwigg",2106785816,0.733,1368624467,0.476,738161349,0.257,"PGX_AM_BS_MSK_IMPACT_2017-P_0003290_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:05.855000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c339d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0nn","pgxind-kftx78lb","pgxcs-kftwwk8f",85843847,0.03,3273091,0.001,82570756,0.029,"PGX_AM_BS_MSK_IMPACT_2017-P_0003435_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.035000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33a2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl0nv","pgxind-kftx78ll","pgxcs-kftwwkat",2813191820,0.979,1549776365,0.539,1263415455,0.439,"PGX_AM_BS_MSK_IMPACT_2017-P_0003440_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:06.042000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33cb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0pq","pgxind-kftx78nx","pgxcs-kftwwkx1",2233495212,0.777,871405812,0.303,1362089400,0.474,"PGX_AM_BS_MSK_IMPACT_2017-P_0003484_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.099000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36786b8c1d6d377c33d9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0qe","pgxind-kftx78op","pgxcs-kftwwl3s",1521971130,0.529,721019820,0.251,800951310,0.279,"PGX_AM_BS_MSK_IMPACT_2017-P_0003498_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:06.119000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3490","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0yn","pgxind-kftx78z6","pgxcs-kftwwno5",2179318611,0.758,803015448,0.279,1376303163,0.479,"PGX_AM_BS_MSK_IMPACT_2017-P_0003668_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:06.379000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c349f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl0zb","pgxind-kftx7901","pgxcs-kftwwnvd",1514672409,0.527,867515173,0.302,647157236,0.225,"PGX_AM_BS_MSK_IMPACT_2017-P_0003686_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.400000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c34db","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl11z","pgxind-kftx793e","pgxcs-kftwwoqg",414204698,0.144,341517620,0.119,72687078,0.025,"PGX_AM_BS_MSK_IMPACT_2017-P_0003746_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.486000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c351b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl14w","pgxind-kftx7970","pgxcs-kftwwpnm",2198803409,0.765,1087056751,0.378,1111746658,0.387,"PGX_AM_BS_MSK_IMPACT_2017-P_0003806_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:06.575000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3537","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl166","pgxind-kftx798l","pgxcs-kftwwq12",1757056470,0.611,967506755,0.337,789549715,0.275,"PGX_AM_BS_MSK_IMPACT_2017-P_0003835_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:06.614000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3554","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl17g","pgxind-kftx79a8","pgxcs-kftwwqex",682415100,0.237,437007645,0.152,245407455,0.085,"PGX_AM_BS_MSK_IMPACT_2017-P_0003862_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.654000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c35ee","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl1ej","pgxind-kftx79iq","pgxcs-kftwwslu",511126045,0.178,306939124,0.107,204186921,0.071,"PGX_AM_BS_MSK_IMPACT_2017-P_0004041_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:06.870000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3614","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1g8","pgxind-kftx79kv","pgxcs-kftwwt66",594557650,0.207,193050286,0.067,401507364,0.14,"PGX_AM_BS_MSK_IMPACT_2017-P_0004079_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.923000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3617","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1gd","pgxind-kftx79l1","pgxcs-kftwwt7o",2398601856,0.834,1472230885,0.512,926370971,0.322,"PGX_AM_BS_MSK_IMPACT_2017-P_0004082_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.927000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c362f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1hg","pgxind-kftx79md","pgxcs-kftwwtja",1408509098,0.49,911482895,0.317,497026203,0.173,"PGX_AM_BS_MSK_IMPACT_2017-P_0004107_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:06.961000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3658","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl1ja","pgxind-kftx79oo","pgxcs-kftwwu2z",976812541,0.34,840986147,0.293,135826394,0.047,"PGX_AM_BS_MSK_IMPACT_2017-P_0004145_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:07.018000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36796b8c1d6d377c3664","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvl1jt","pgxind-kftx79pc","pgxcs-kftwwu8s",1422984600,0.495,622700815,0.217,800283785,0.278,"PGX_AM_BS_MSK_IMPACT_2017-P_0004157_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:07.035000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c3690","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1lr","pgxind-kftx79ru","pgxcs-kftwwuw6",1610496875,0.56,639239338,0.222,971257537,0.338,"PGX_AM_BS_MSK_IMPACT_2017-P_0004198_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.096000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36bc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1nq","pgxind-kftx79ub","pgxcs-kftwwvhd",1227784147,0.427,717104919,0.249,510679228,0.178,"PGX_AM_BS_MSK_IMPACT_2017-P_0004241_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.158000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36d8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1oz","pgxind-kftx79vw","pgxcs-kftwwvwx",1579890071,0.55,684049311,0.238,895840760,0.312,"PGX_AM_BS_MSK_IMPACT_2017-P_0004267_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.197000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36da","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl1p3","pgxind-kftx79w0","pgxcs-kftwwvxw",1216049407,0.423,551432220,0.192,664617187,0.231,"PGX_AM_BS_MSK_IMPACT_2017-P_0004269_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:07.199000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1q4","pgxind-kftx79xb","pgxcs-kftwww90",1946734707,0.677,1237475237,0.43,709259470,0.247,"PGX_AM_BS_MSK_IMPACT_2017-P_0004291_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.232000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c36fe","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Extraskeletal Myxoid Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27502","Extraskeletal Myxoid Chondrosarcoma","icdom-92313","Myxoid chondrosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1qp","pgxind-kftx79y1","pgxcs-kftwwwfa",905339565,0.315,673577421,0.234,231762144,0.081,"PGX_AM_BS_MSK_IMPACT_2017-P_0004306_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.250000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c372f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1sw","pgxind-kftx7a0s","pgxcs-kftwwx54",2019223117,0.702,1262914924,0.439,756308193,0.263,"PGX_AM_BS_MSK_IMPACT_2017-P_0004357_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.318000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c37a1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1y1","pgxind-kftx7a79","pgxcs-kftwwyqm",56648152,0.02,12112214,0.004,44535938,0.015,"PGX_AM_BS_MSK_IMPACT_2017-P_0004473_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:07.478000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c37b6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1yz","pgxind-kftx7a8g","pgxcs-kftwwz0r",2083785420,0.725,1332142628,0.463,751642792,0.261,"PGX_AM_BS_MSK_IMPACT_2017-P_0004499_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.507000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c37c3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl1zk","pgxind-kftx7a96","pgxcs-kftwwz71",1736077259,0.604,679424955,0.236,1056652304,0.368,"PGX_AM_BS_MSK_IMPACT_2017-P_0004512_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.525000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c38e9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl2cr","pgxind-kftx7apx","pgxcs-kftwx3cy",1086440479,0.378,769962873,0.268,316477606,0.11,"PGX_AM_BS_MSK_IMPACT_2017-P_0004804_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:07.937000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367a6b8c1d6d377c38fa","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl2dj","pgxind-kftx7aqv","pgxcs-kftwx3l4",1125454002,0.391,722641284,0.251,402812718,0.14,"PGX_AM_BS_MSK_IMPACT_2017-P_0004819_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:07.961000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3966","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl2ie","pgxind-kftx7awz","pgxcs-kftwx52z",1775275501,0.617,710629719,0.247,1064645782,0.37,"PGX_AM_BS_MSK_IMPACT_2017-P_0004922_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.112000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3a13","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Ewing Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4817","Ewing Sarcoma","icdom-92603","Ewing sarcoma ","icdot-C41.9","Bone, NOS","pgxbs-kftvl2q4","pgxind-kftx7b6p","pgxcs-kftwx7i9",271699615,0.095,63141520,0.022,208558095,0.073,"PGX_AM_BS_MSK_IMPACT_2017-P_0005101_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:08.353000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3a2d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl2ra","pgxind-kftx7b87","pgxcs-kftwx7ws",2321405162,0.807,1381658925,0.481,939746237,0.327,"PGX_AM_BS_MSK_IMPACT_2017-P_0005126_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.389000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3a46","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl2se","pgxind-kftx7b9m","pgxcs-kftwx88s",1999651700,0.696,1022845434,0.356,976806266,0.34,"PGX_AM_BS_MSK_IMPACT_2017-P_0005149_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:08.423000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367b6b8c1d6d377c3afa","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl30i","pgxind-kftx7bjn","pgxcs-kftwxark",1465977964,0.51,749376821,0.261,716601143,0.249,"PGX_AM_BS_MSK_IMPACT_2017-P_0005331_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:08.674000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3b89","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Fibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3043","Fibrosarcoma","icdom-88103","Fibrosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl370","pgxind-kftx7brp","pgxcs-kftwxe8l",1777622629,0.618,513564718,0.179,1264057911,0.44,"PGX_AM_BS_MSK_IMPACT_2017-P_0005484_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.873000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3bb0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl38q","pgxind-kftx7btv","pgxcs-kftwxfce",968317131,0.337,737075133,0.256,231241998,0.08,"PGX_AM_BS_MSK_IMPACT_2017-P_0005524_T03_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:08.928000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3be6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3b5","pgxind-kftx7bwx","pgxcs-kftwxgut",861661718,0.3,421553739,0.147,440107979,0.153,"PGX_AM_BS_MSK_IMPACT_2017-P_0005578_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.003000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3bea","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl3bc","pgxind-kftx7bx5","pgxcs-kftwxgy8",661862463,0.23,306898253,0.107,354964210,0.123,"PGX_AM_BS_MSK_IMPACT_2017-P_0005582_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:09.009000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3bec","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3bf","pgxind-kftx7bx9","pgxcs-kftwxh05",2523720085,0.878,1526452909,0.531,997267176,0.347,"PGX_AM_BS_MSK_IMPACT_2017-P_0005584_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.012000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3bf0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3bl","pgxind-kftx7bxh","pgxcs-kftwxh43",1658334841,0.577,844053474,0.294,814281367,0.283,"PGX_AM_BS_MSK_IMPACT_2017-P_0005588_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.017000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3c05","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Extraskeletal Myxoid Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27502","Extraskeletal Myxoid Chondrosarcoma","icdom-92313","Myxoid chondrosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3cj","pgxind-kftx7byo","pgxcs-kftwxhqn",9728633,0.003,103250,0,9625383,0.003,"PGX_AM_BS_MSK_IMPACT_2017-P_0005607_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.047000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3c80","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3i2","pgxind-kftx7c5q","pgxcs-kftwxl6p",1716057347,0.597,1006662736,0.35,709394611,0.247,"PGX_AM_BS_MSK_IMPACT_2017-P_0005740_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.225000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3cd0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3lp","pgxind-kftx7ca9","pgxcs-kftwxngf",2441400607,0.849,1258571182,0.438,1182829425,0.411,"PGX_AM_BS_MSK_IMPACT_2017-P_0005820_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:09.340000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3d77","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Clear Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3745","Clear Cell Sarcoma of Soft Tissue","icdom-90443","Clearcellsarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl3ta","pgxind-kftx7cjr","pgxcs-kftwxs6q",565857884,0.197,315562980,0.11,250294904,0.087,"PGX_AM_BS_MSK_IMPACT_2017-P_0005989_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.585000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367c6b8c1d6d377c3d83","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvl3tt","pgxind-kftx7ckg","pgxcs-kftwxsi7",1173391758,0.408,602450171,0.21,570941587,0.199,"PGX_AM_BS_MSK_IMPACT_2017-P_0006001_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:09.602000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3e81","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl45a","pgxind-kftx7cys","pgxcs-kftwxzmc",1100310636,0.383,645719043,0.225,454591593,0.158,"PGX_AM_BS_MSK_IMPACT_2017-P_0006258_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:09.966000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367d6b8c1d6d377c3f64","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4fp","pgxind-kftx7dbo","pgxcs-kftwy60c",1861022232,0.647,1225373402,0.426,635648830,0.221,"PGX_AM_BS_MSK_IMPACT_2017-P_0006490_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.282000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c405f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4r1","pgxind-kftx7dpt","pgxcs-kftwyd40",87446905,0.03,19804393,0.007,67642512,0.024,"PGX_AM_BS_MSK_IMPACT_2017-P_0006736_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.639000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4097","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4tk","pgxind-kftx7dsx","pgxcs-kftwyeq8",598043022,0.208,416243996,0.145,181799026,0.063,"PGX_AM_BS_MSK_IMPACT_2017-P_0006792_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.719000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c409e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4tw","pgxind-kftx7dta","pgxcs-kftwyewz",1005727064,0.35,867132124,0.302,138594940,0.048,"PGX_AM_BS_MSK_IMPACT_2017-P_0006799_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.728000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c40d2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Embryonal Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8971","Embryonal Rhabdomyosarcoma","icdom-89103","Embryonal rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4w7","pgxind-kftx7dw9","pgxcs-kftwygdg",1124511246,0.391,720364813,0.251,404146433,0.141,"PGX_AM_BS_MSK_IMPACT_2017-P_0006851_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.800000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c40f1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4xl","pgxind-kftx7dy0","pgxcs-kftwyh98",1966368148,0.684,1266881592,0.441,699486556,0.243,"PGX_AM_BS_MSK_IMPACT_2017-P_0006882_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.843000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c40f3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl4xo","pgxind-kftx7dy4","pgxcs-kftwyhb5",1335102639,0.464,845265660,0.294,489836979,0.17,"PGX_AM_BS_MSK_IMPACT_2017-P_0006884_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:10.846000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4176","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl53l","pgxind-kftx7e5i","pgxcs-kftwyl0x",1025471291,0.357,503540205,0.175,521931086,0.182,"PGX_AM_BS_MSK_IMPACT_2017-P_0007021_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.029000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4212","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5an","pgxind-kftx7eeg","pgxcs-kftwypel",843024823,0.293,466267608,0.162,376757215,0.131,"PGX_AM_BS_MSK_IMPACT_2017-P_0007176_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.248000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c4295","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5gk","pgxind-kftx7elv","pgxcs-kftwyt4j",1900689466,0.661,970173437,0.337,930516029,0.324,"PGX_AM_BS_MSK_IMPACT_2017-P_0007344_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.431000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367e6b8c1d6d377c42b4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5hx","pgxind-kftx7enm","pgxcs-kftwyu0c",1371207245,0.477,746343877,0.26,624863368,0.217,"PGX_AM_BS_MSK_IMPACT_2017-P_0007376_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.474000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c430e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvl5lz","pgxind-kftx7esq","pgxcs-kftwywkr",1064063448,0.37,302684730,0.105,761378718,0.265,"PGX_AM_BS_MSK_IMPACT_2017-P_0007516_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:11.599000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4314","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl5m9","pgxind-kftx7et3","pgxcs-kftwywqm",1097321686,0.382,384896662,0.134,712425024,0.248,"PGX_AM_BS_MSK_IMPACT_2017-P_0007522_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:11.608000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4318","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5mf","pgxind-kftx7etb","pgxcs-kftwywui",1434674993,0.499,811542800,0.282,623132193,0.217,"PGX_AM_BS_MSK_IMPACT_2017-P_0007526_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.613000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c431c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5mm","pgxind-kftx7etj","pgxcs-kftwywyf",1760024173,0.612,1200829466,0.418,559194707,0.195,"PGX_AM_BS_MSK_IMPACT_2017-P_0007530_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:11.619000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4323","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5mx","pgxind-kftx7etx","pgxcs-kftwyx7k",1383883312,0.481,1130091286,0.393,253792026,0.088,"PGX_AM_BS_MSK_IMPACT_2017-P_0007536_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.628000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4332","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Malignant Peripheral Nerve Sheath Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3798","Malignant Peripheral Nerve Sheath Tumor","icdom-95403","Malignant peripheral nerve sheath tumor ","icdot-C47.1","Peripheral nerves and autonomic nervous system of upper limb and shoulder","pgxbs-kftvl5nl","pgxind-kftx7eur","pgxcs-kftwyxm3",1445797744,0.503,796746352,0.277,649051392,0.226,"PGX_AM_BS_MSK_IMPACT_2017-P_0007552_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002410","autonomic nervous system","{}","2020-09-10 17:47:11.649000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c433b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5nz","pgxind-kftx7eva","pgxcs-kftwyxux",1250885598,0.435,731750454,0.255,519135144,0.181,"PGX_AM_BS_MSK_IMPACT_2017-P_0007562_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:11.662000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4389","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5rh","pgxind-kftx7ezo","pgxcs-kftwz036",1027600795,0.357,447075062,0.156,580525733,0.202,"PGX_AM_BS_MSK_IMPACT_2017-P_0007651_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.769000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4398","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Angiosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3088","Angiosarcoma","icdom-91203","Hemangiosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5s5","pgxind-kftx7f0i","pgxcs-kftwz0hp",661646715,0.23,551039418,0.192,110607297,0.038,"PGX_AM_BS_MSK_IMPACT_2017-P_0007667_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.791000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c43e7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5vp","pgxind-kftx7f52","pgxcs-kftwz2qi",536549301,0.187,289827449,0.101,246721852,0.086,"PGX_AM_BS_MSK_IMPACT_2017-P_0007785_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.902000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c43fb","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl5wl","pgxind-kftx7f66","pgxcs-kftwz3c0",2391020577,0.832,1376453906,0.479,1014566671,0.353,"PGX_AM_BS_MSK_IMPACT_2017-P_0007815_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:11.931000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c44bf","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl65c","pgxind-kftx7fhm","pgxcs-kftwz8vr",1871715756,0.651,1320605792,0.459,551109964,0.192,"PGX_AM_BS_MSK_IMPACT_2017-P_0008051_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.203000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c44f2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl67o","pgxind-kftx7fkj","pgxcs-kftwzab2",1748628177,0.608,1209853468,0.421,538774709,0.187,"PGX_AM_BS_MSK_IMPACT_2017-P_0008125_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.274000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a367f6b8c1d6d377c4537","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6ar","pgxind-kftx7fof","pgxcs-kftwzcab",1238680384,0.431,553784047,0.193,684896337,0.238,"PGX_AM_BS_MSK_IMPACT_2017-P_0008191_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:12.370000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4596","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3359","Rhabdomyosarcoma","icdom-89003","Rhabdomyosarcoma, NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6ez","pgxind-kftx7ftt","pgxcs-kftwzeza",495490035,0.172,0,0,495490035,0.172,"PGX_AM_BS_MSK_IMPACT_2017-P_0008325_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.501000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4641","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6mn","pgxind-kftx7g3j","pgxcs-kftwzjua",111217258,0.039,64703624,0.023,46513634,0.016,"PGX_AM_BS_MSK_IMPACT_2017-P_0008526_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.739000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c468d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6q3","pgxind-kftx7g7u","pgxcs-kftwzm0n",1532103850,0.533,858213114,0.299,673890736,0.234,"PGX_AM_BS_MSK_IMPACT_2017-P_0008596_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:12.846000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c46da","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl6tl","pgxind-kftx7gc8","pgxcs-kftwzo5a",1727033662,0.601,1103204104,0.384,623829558,0.217,"PGX_AM_BS_MSK_IMPACT_2017-P_0008720_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:12.952000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c471c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Spindle Cell Rhabdomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6519","Spindle Cell Rhabdomyosarcoma","icdom-89123","Spindle cell rhabdomyosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6wl","pgxind-kftx7gg0","pgxcs-kftwzq25",2146345769,0.747,1114313676,0.388,1032032093,0.359,"PGX_AM_BS_MSK_IMPACT_2017-P_0008791_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.043000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36806b8c1d6d377c4761","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl6zp","pgxind-kftx7gjx","pgxcs-kftwzs17",486203973,0.169,275878927,0.096,210325046,0.073,"PGX_AM_BS_MSK_IMPACT_2017-P_0008877_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.139000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c47d8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl752","pgxind-kftx7gqn","pgxcs-kftwzvi3",1724987773,0.6,872579728,0.304,852408045,0.296,"PGX_AM_BS_MSK_IMPACT_2017-P_0009027_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.304000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4819","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl77z","pgxind-kftx7gub","pgxcs-kftwzxd6",804596401,0.28,385773724,0.134,418822677,0.146,"PGX_AM_BS_MSK_IMPACT_2017-P_0009103_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.395000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4834","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Chondrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C2946","Chondrosarcoma","icdom-92203","Chondrosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl798","pgxind-kftx7gvt","pgxcs-kftwzy39",1446744946,0.503,475748298,0.165,970996648,0.338,"PGX_AM_BS_MSK_IMPACT_2017-P_0009144_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:13.432000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c486e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Pleomorphic Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3705","Pleomorphic Liposarcoma","icdom-88543","Pleomorphicliposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7bv","pgxind-kftx7gz4","pgxcs-kftwzzs0",1095710552,0.381,613329111,0.213,482381441,0.168,"PGX_AM_BS_MSK_IMPACT_2017-P_0009204_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.513000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c48bf","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvl7fk","pgxind-kftx7h3p","pgxcs-kftx0233",2292727719,0.797,799472301,0.278,1493255418,0.519,"PGX_AM_BS_MSK_IMPACT_2017-P_0009314_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:13.625000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c48f8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7i5","pgxind-kftx7h6y","pgxcs-kftx03of",569078141,0.198,501702750,0.175,67375391,0.023,"PGX_AM_BS_MSK_IMPACT_2017-P_0009373_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.706000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4937","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Desmoplastic Small-Round-Cell Tumor","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C8300","Desmoplastic Small Round Cell Tumor","icdom-88063","Desmoplastic small round cell tumor ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7kz","pgxind-kftx7hbs","pgxcs-kftx05g5",1859051703,0.647,1146956370,0.399,712095333,0.248,"PGX_AM_BS_MSK_IMPACT_2017-P_0009452_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.793000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c4939","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7l2","pgxind-kftx7hbw","pgxcs-kftx05i4",1568934998,0.546,782257709,0.272,786677289,0.274,"PGX_AM_BS_MSK_IMPACT_2017-P_0009454_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.796000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c493a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid/Round-Cell Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7l4","pgxind-kftx7hby","pgxcs-kftx05j3",1595366628,0.555,977258039,0.34,618108589,0.215,"PGX_AM_BS_MSK_IMPACT_2017-P_0009455_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.798000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36816b8c1d6d377c497c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxofibrosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6496","Myxofibrosarcoma","icdom-88113","Fibromyxosarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl7o1","pgxind-kftx7hfi","pgxcs-kftx07es",1556662730,0.541,979281861,0.341,577380869,0.201,"PGX_AM_BS_MSK_IMPACT_2017-P_0009531_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:13.890000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4ad8","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl83s","pgxind-kftx7hz2","pgxcs-kftx0fqr",699950379,0.243,559821889,0.195,140128490,0.049,"PGX_AM_BS_MSK_IMPACT_2017-P_0009968_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.384000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4b0c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl865","pgxind-kftx7i20","pgxcs-kftx0gfl",1069688916,0.372,402461971,0.14,667226945,0.232,"PGX_AM_BS_MSK_IMPACT_2017-P_0010028_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:14.457000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4b19","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl86p","pgxind-kftx7i2q","pgxcs-kftx0gnx",1738942169,0.605,756329710,0.263,982612459,0.342,"PGX_AM_BS_MSK_IMPACT_2017-P_0010048_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:14.475000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4b9f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl8cp","pgxind-kftx7iad","pgxcs-kftx0ihw",745386976,0.259,297555474,0.103,447831502,0.156,"PGX_AM_BS_MSK_IMPACT_2017-P_0010205_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:14.662000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4bee","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl8g8","pgxind-kftx7iev","pgxcs-kftx0jlv",1996879912,0.695,938015703,0.326,1058864209,0.368,"PGX_AM_BS_MSK_IMPACT_2017-P_0010301_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:14.773000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4c1e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Synovial Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3400","Synovial Sarcoma","icdom-90403","Synovialsarcoma,NOS ","icdot-C44.9","Skin, NOS","pgxbs-kftvl8ie","pgxind-kftx7ihl","pgxcs-kftx0kaz",1797065484,0.625,936115214,0.326,860950270,0.299,"PGX_AM_BS_MSK_IMPACT_2017-P_0010353_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0000014","zone of skin","{}","2020-09-10 17:47:14.841000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36826b8c1d6d377c4c92","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl8nm","pgxind-kftx7io7","pgxcs-kftx0lxe",2714082960,0.944,1603381371,0.558,1110701589,0.386,"PGX_AM_BS_MSK_IMPACT_2017-P_0010521_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.003000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4d11","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl8vm","pgxind-kftx7ivf","pgxcs-kftx0not",667577568,0.232,419136755,0.146,248440813,0.086,"PGX_AM_BS_MSK_IMPACT_2017-P_0010676_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.181000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4d34","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Leiomyosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3158","Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl8x6","pgxind-kftx7ixf","pgxcs-kftx0o7v",1671402956,0.581,813363023,0.283,858039933,0.298,"PGX_AM_BS_MSK_IMPACT_2017-P_0010718_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.230000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4de4","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Well-Differentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4250","Well Differentiated Liposarcoma","icdom-88513","Liposarcoma, well differentiated ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl954","pgxind-kftx7j7e","pgxcs-kftx0qpe",1514193704,0.527,1098798452,0.382,415395252,0.144,"PGX_AM_BS_MSK_IMPACT_2017-P_0010931_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.475000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4e3e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvl995","pgxind-kftx7jcj","pgxcs-kftx0s05",921384079,0.32,642373476,0.223,279010603,0.097,"PGX_AM_BS_MSK_IMPACT_2017-P_0011028_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:15.599000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4e77","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Dedifferentiated Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C3704","Dedifferentiated Liposarcoma","icdom-88583","Dedifferentiated liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9bp","pgxind-kftx7jfr","pgxcs-kftx0ss1",168283613,0.059,116393746,0.04,51889867,0.018,"PGX_AM_BS_MSK_IMPACT_2017-P_0011094_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.680000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4e97","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9d6","pgxind-kftx7jhl","pgxcs-kftx0t9x",1907245035,0.663,1317534805,0.458,589710230,0.205,"PGX_AM_BS_MSK_IMPACT_2017-P_0011129_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:15.725000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36836b8c1d6d377c4ee9","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9gu","pgxind-kftx7jm9","pgxcs-kftx0ufr",1486850347,0.517,899147294,0.313,587703053,0.204,"PGX_AM_BS_MSK_IMPACT_2017-P_0011220_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:15.842000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c4fef","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9so","pgxind-kftx7k14","pgxcs-kftx0y4n",2098078168,0.73,1163969729,0.405,934108439,0.325,"PGX_AM_BS_MSK_IMPACT_2017-P_0011526_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:16.209000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c4ffc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9t9","pgxind-kftx7k1v","pgxcs-kftx0yay",1544387866,0.537,1029103055,0.358,515284811,0.179,"PGX_AM_BS_MSK_IMPACT_2017-P_0011539_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:16.227000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5006","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Sarcoma, NOS","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9306","Soft Tissue Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9tp","pgxind-kftx7k2f","pgxcs-kftx0yg2",941649297,0.328,621278961,0.216,320370336,0.111,"PGX_AM_BS_MSK_IMPACT_2017-P_0011549_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:16.241000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5007","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9tq","pgxind-kftx7k2h","pgxcs-kftx0ygk",1508994186,0.525,1253443270,0.436,255550916,0.089,"PGX_AM_BS_MSK_IMPACT_2017-P_0011550_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:16.242000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c501f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Osteosarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C9145","Osteosarcoma","icdom-91803","Osteosarcoma, NOS ","icdot-C41.9","Bone, NOS","pgxbs-kftvl9ut","pgxind-kftx7k3u","pgxcs-kftx0ys1",1514397398,0.527,890997100,0.31,623400298,0.217,"PGX_AM_BS_MSK_IMPACT_2017-P_0011575_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001474","bone element","{}","2020-09-10 17:47:16.275000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c5090","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Pleomorphic Sarcoma/Malignant Fibrous Histiocytoma/High-Grade Spindle Cell Sarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C4247","Undifferentiated Pleomorphic Sarcoma","icdom-88303","Malignant fibrous histiocytoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvl9zw","pgxind-kftx7kab","pgxcs-kftx10ep",243996697,0.085,173558596,0.06,70438101,0.025,"PGX_AM_BS_MSK_IMPACT_2017-P_0012119_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue",,"2020-09-10 17:47:16.435000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36846b8c1d6d377c50e0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Myxoid/Round-Cell Liposarcoma","cBP-MSK_IMPACT_2017",,"pgxfus-0002","no followup status","NCIT:C27781","Myxoid Liposarcoma","icdom-88523","Myxoid liposarcoma ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvla3h","pgxind-kftx7kev","pgxcs-kftx11jm",1545144252,0.537,371274553,0.129,1173869699,0.408,"PGX_AM_BS_MSK_IMPACT_2017-P_0012225_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:16.547000",,,,,,"P69Y","PMID:28481359","Zehir A, Benayed R et al. (2017): Mutational landscape of metastatic cancer revealed...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58d6","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcni","pgxind-kftx7nme","pgxcs-kftx1u12",1994035923,0.694,128517148,0.045,1865518775,0.649,"PGX_AM_BS_SARC_MSKCC-PT101MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.390000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58da","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnp","pgxind-kftx7nmm","pgxcs-kftx1u31",1589111822,0.553,73052064,0.025,1516059758,0.527,"PGX_AM_BS_SARC_MSKCC-PT105MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.396000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58db","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnq","pgxind-kftx7nmo","pgxcs-kftx1u3i",1327500275,0.462,1062107237,0.369,265393038,0.092,"PGX_AM_BS_SARC_MSKCC-PT106MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.397000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58dd","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcnu","pgxind-kftx7nms","pgxcs-kftx1u4h",1928631150,0.671,172128740,0.06,1756502410,0.611,"PGX_AM_BS_SARC_MSKCC-PT108MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.400000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e0","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcny","pgxind-kftx7nmz","pgxcs-kftx1u5y",688610869,0.24,304330161,0.106,384280708,0.134,"PGX_AM_BS_SARC_MSKCC-PT110MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.405000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlco2","pgxind-kftx7nn3","pgxcs-kftx1u6x",1282389657,0.446,879645175,0.306,402744482,0.14,"PGX_AM_BS_SARC_MSKCC-PT112MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.408000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e5","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlco7","pgxind-kftx7nn9","pgxcs-kftx1u8e",1003655344,0.349,908192979,0.316,95462365,0.033,"PGX_AM_BS_SARC_MSKCC-PT115MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.412000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58e7","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcoa","pgxind-kftx7nnd","pgxcs-kftx1u9e",896377697,0.312,736442260,0.256,159935437,0.056,"PGX_AM_BS_SARC_MSKCC-PT117MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.415000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58ed","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcoj","pgxind-kftx7nnp","pgxcs-kftx1ucb",1258463343,0.438,102334885,0.036,1156128458,0.402,"PGX_AM_BS_SARC_MSKCC-PT122MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.424000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58ee","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcol","pgxind-kftx7nnr","pgxcs-kftx1ucs",362580205,0.126,100905495,0.035,261674710,0.091,"PGX_AM_BS_SARC_MSKCC-PT123MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.425000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58ef","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcom","pgxind-kftx7nnt","pgxcs-kftx1uda",611706024,0.213,531300461,0.185,80405563,0.028,"PGX_AM_BS_SARC_MSKCC-PT124MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.427000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58f3","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcot","pgxind-kftx7no1","pgxcs-kftx1uf8",1726280986,0.6,348460099,0.121,1377820887,0.479,"PGX_AM_BS_SARC_MSKCC-PT128MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.432000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58fa","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcp5","pgxind-kftx7nof","pgxcs-kftx1uim",1117301730,0.389,842784719,0.293,274517011,0.095,"PGX_AM_BS_SARC_MSKCC-PT134MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.443000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c58fc","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcp8","pgxind-kftx7nok","pgxcs-kftx1ujl",806151868,0.28,175405021,0.061,630746847,0.219,"PGX_AM_BS_SARC_MSKCC-PT136MF","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.446000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5900","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpf","pgxind-kftx7nos","pgxcs-kftx1ulk",1203403287,0.419,701119919,0.244,502283368,0.175,"PGX_AM_BS_SARC_MSKCC-PT13DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.452000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5904","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpl","pgxind-kftx7np0","pgxcs-kftx1unh",484798038,0.169,329380336,0.115,155417702,0.054,"PGX_AM_BS_SARC_MSKCC-PT143MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.457000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5906","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpo","pgxind-kftx7np4","pgxcs-kftx1uqk",546608046,0.19,539139324,0.188,7468722,0.003,"PGX_AM_BS_SARC_MSKCC-PT145MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.460000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5907","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpq","pgxind-kftx7np6","pgxcs-kftx1ur3",706950578,0.246,529336225,0.184,177614353,0.062,"PGX_AM_BS_SARC_MSKCC-PT146MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.462000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c590c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcpy","pgxind-kftx7npg","pgxcs-kftx1utj",829263832,0.288,829090997,0.288,172835,0,"PGX_AM_BS_SARC_MSKCC-PT150MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.469000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5911","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcq6","pgxind-kftx7npq","pgxcs-kftx1uvy",251985488,0.088,95536423,0.033,156449065,0.054,"PGX_AM_BS_SARC_MSKCC-PT155MRC","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.476000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5915","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqd","pgxind-kftx7npy","pgxcs-kftx1uxv",1013423183,0.352,505196746,0.176,508226437,0.177,"PGX_AM_BS_SARC_MSKCC-PT159PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.481000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5918","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqi","pgxind-kftx7nq5","pgxcs-kftx1uzc",1894826820,0.659,156577473,0.054,1738249347,0.605,"PGX_AM_BS_SARC_MSKCC-PT161PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.486000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcql","pgxind-kftx7nq9","pgxcs-kftx1v0b",1448527219,0.504,676546404,0.235,771980815,0.269,"PGX_AM_BS_SARC_MSKCC-PT163PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.489000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqn","pgxind-kftx7nqb","pgxcs-kftx1v0t",1718739313,0.598,117050127,0.041,1601689186,0.557,"PGX_AM_BS_SARC_MSKCC-PT164PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.490000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqo","pgxind-kftx7nqd","pgxcs-kftx1v1b",888008249,0.309,518326066,0.18,369682183,0.129,"PGX_AM_BS_SARC_MSKCC-PT165PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.492000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqq","pgxind-kftx7nqf","pgxcs-kftx1v1s",1211990425,0.422,751544159,0.261,460446266,0.16,"PGX_AM_BS_SARC_MSKCC-PT166PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.493000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c591e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqr","pgxind-kftx7nqh","pgxcs-kftx1v2a",1013817425,0.353,395789831,0.138,618027594,0.215,"PGX_AM_BS_SARC_MSKCC-PT167PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.495000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5921","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcqw","pgxind-kftx7nqn","pgxcs-kftx1v3r",762617291,0.265,593801500,0.207,168815791,0.059,"PGX_AM_BS_SARC_MSKCC-PT16DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.499000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5926","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcr5","pgxind-kftx7nqx","pgxcs-kftx1v68",1315233979,0.457,1309754634,0.456,5479345,0.002,"PGX_AM_BS_SARC_MSKCC-PT174PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.506000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c592a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrb","pgxind-kftx7nr6","pgxcs-kftx1v86",1194942540,0.416,647115083,0.225,547827457,0.191,"PGX_AM_BS_SARC_MSKCC-PT178PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.512000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c592b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrd","pgxind-kftx7nr8","pgxcs-kftx1v8o",804413137,0.28,529536539,0.184,274876598,0.096,"PGX_AM_BS_SARC_MSKCC-PT179PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.514000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c592e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcri","pgxind-kftx7nre","pgxcs-kftx1va6",1478969699,0.514,1311086900,0.456,167882799,0.058,"PGX_AM_BS_SARC_MSKCC-PT181PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.518000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c592f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrj","pgxind-kftx7nrg","pgxcs-kftx1vao",745876360,0.259,745362880,0.259,513480,0,"PGX_AM_BS_SARC_MSKCC-PT182PL","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.520000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5932","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcro","pgxind-kftx7nrm","pgxcs-kftx1vc4",1178877813,0.41,176382235,0.061,1002495578,0.349,"PGX_AM_BS_SARC_MSKCC-PT185SYN","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.524000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5937","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcrw","pgxind-kftx7nrw","pgxcs-kftx1vei",842077309,0.293,662574981,0.23,179502328,0.062,"PGX_AM_BS_SARC_MSKCC-PT18DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.531000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5938","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcry","pgxind-kftx7nry","pgxcs-kftx1vf0",583836264,0.203,348081995,0.121,235754269,0.082,"PGX_AM_BS_SARC_MSKCC-PT190SYN","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.533000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c593b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcs3","pgxind-kftx7ns4","pgxcs-kftx1vgg",310551968,0.108,306776212,0.107,3775756,0.001,"PGX_AM_BS_SARC_MSKCC-PT193SYN","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.537000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5940","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcsb","pgxind-kftx7nse","pgxcs-kftx1viw",120233867,0.042,66438643,0.023,53795224,0.019,"PGX_AM_BS_SARC_MSKCC-PT198SYN","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.544000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5942","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcse","pgxind-kftx7nsi","pgxcs-kftx1vjv",611058267,0.213,575484361,0.2,35573906,0.012,"PGX_AM_BS_SARC_MSKCC-PT19DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.547000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5950","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlct1","pgxind-kftx7ntb","pgxcs-kftx1vqo",1478225081,0.514,30991039,0.011,1447234042,0.503,"PGX_AM_BS_SARC_MSKCC-PT24DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.567000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5952","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlct4","pgxind-kftx7ntg","pgxcs-kftx1vro",715417625,0.249,535508385,0.186,179909240,0.063,"PGX_AM_BS_SARC_MSKCC-PT26DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.571000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36876b8c1d6d377c5954","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlct7","pgxind-kftx7ntk","pgxcs-kftx1vso",1438336829,0.5,1136327362,0.395,302009467,0.105,"PGX_AM_BS_SARC_MSKCC-PT28DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.574000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5955","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlct9","pgxind-kftx7ntm","pgxcs-kftx1vt6",614953792,0.214,414521682,0.144,200432110,0.07,"PGX_AM_BS_SARC_MSKCC-PT29DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.576000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c595b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlctj","pgxind-kftx7nty","pgxcs-kftx1vw2",691470242,0.241,454166849,0.158,237303393,0.083,"PGX_AM_BS_SARC_MSKCC-PT34DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.584000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5962","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlctu","pgxind-kftx7nuc","pgxcs-kftx1w1n",287044186,0.1,230683023,0.08,56361163,0.02,"PGX_AM_BS_SARC_MSKCC-PT40DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.595000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5965","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlctz","pgxind-kftx7nui","pgxcs-kftx1w34",517848598,0.18,403267751,0.14,114580847,0.04,"PGX_AM_BS_SARC_MSKCC-PT43DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.599000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5968","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcu4","pgxind-kftx7nuo","pgxcs-kftx1w4v",1319949881,0.459,720621204,0.251,599328677,0.208,"PGX_AM_BS_SARC_MSKCC-PT46DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.603000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c596a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcu7","pgxind-kftx7nus","pgxcs-kftx1w5u",518859964,0.18,294672913,0.102,224187051,0.078,"PGX_AM_BS_SARC_MSKCC-PT48DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.606000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c596c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcua","pgxind-kftx7nux","pgxcs-kftx1w6u",895497403,0.311,700816099,0.244,194681304,0.068,"PGX_AM_BS_SARC_MSKCC-PT4DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.609000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5972","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcuk","pgxind-kftx7nv9","pgxcs-kftx1w9s",864832476,0.301,670175192,0.233,194657284,0.068,"PGX_AM_BS_SARC_MSKCC-PT55GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.618000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5974","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcun","pgxind-kftx7nvd","pgxcs-kftx1war",873573947,0.304,765822169,0.266,107751778,0.037,"PGX_AM_BS_SARC_MSKCC-PT57GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.621000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5977","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcus","pgxind-kftx7nvj","pgxcs-kftx1wc8",729677270,0.254,569079380,0.198,160597890,0.056,"PGX_AM_BS_SARC_MSKCC-PT5DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.626000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c597a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcux","pgxind-kftx7nvp","pgxcs-kftx1wdo",1344205673,0.468,1177539106,0.41,166666567,0.058,"PGX_AM_BS_SARC_MSKCC-PT62GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.630000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5983","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvc","pgxind-kftx7nw8","pgxcs-kftx1wi1",1811335874,0.63,11930080,0.004,1799405794,0.626,"PGX_AM_BS_SARC_MSKCC-PT70GT","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.644000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5987","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvi","pgxind-kftx7nwg","pgxcs-kftx1wjz",907469322,0.316,647752757,0.225,259716565,0.09,"PGX_AM_BS_SARC_MSKCC-PT74LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.649000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvn","pgxind-kftx7nwm","pgxcs-kftx1wlf",1156612388,0.402,907582242,0.316,249030146,0.087,"PGX_AM_BS_SARC_MSKCC-PT77LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.654000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvp","pgxind-kftx7nwo","pgxcs-kftx1wlx",608895230,0.212,552140549,0.192,56754681,0.02,"PGX_AM_BS_SARC_MSKCC-PT78LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.655000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvs","pgxind-kftx7nws","pgxcs-kftx1wmx",994506594,0.346,926042242,0.322,68464352,0.024,"PGX_AM_BS_SARC_MSKCC-PT7DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.658000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c598e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvu","pgxind-kftx7nwu","pgxcs-kftx1wne",1127927450,0.392,940682261,0.327,187245189,0.065,"PGX_AM_BS_SARC_MSKCC-PT80LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.660000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5990","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcvx","pgxind-kftx7nwy","pgxcs-kftx1wod",1373227406,0.478,1174712929,0.409,198514477,0.069,"PGX_AM_BS_SARC_MSKCC-PT82LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.663000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5998","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwa","pgxind-kftx7nxe","pgxcs-kftx1wsb",1093427206,0.38,847781360,0.295,245645846,0.085,"PGX_AM_BS_SARC_MSKCC-PT8DD","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.675000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c599b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwf","pgxind-kftx7nxk","pgxcs-kftx1wts",1305459590,0.454,1136047985,0.395,169411605,0.059,"PGX_AM_BS_SARC_MSKCC-PT92LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.680000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c599e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwk","pgxind-kftx7nxr","pgxcs-kftx1wva",788179046,0.274,426798624,0.148,361380422,0.126,"PGX_AM_BS_SARC_MSKCC-PT95LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.684000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c599f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwm","pgxind-kftx7nxt","pgxcs-kftx1wvs",1269547370,0.442,1157499326,0.403,112048044,0.039,"PGX_AM_BS_SARC_MSKCC-PT96LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.685000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c59a1","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwp","pgxind-kftx7nxx","pgxcs-kftx1wws",1249031678,0.434,1099376978,0.382,149654700,0.052,"PGX_AM_BS_SARC_MSKCC-PT98LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.688000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c59a2","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction"," Sarcoma, NOS","cBP-SARC_MSKCC",,"pgxfus-0002","no followup status","NCIT:C9118","Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C49.9","Connective, subcutaneous and other soft tissues, NOS","pgxbs-kftvlcwq","pgxind-kftx7nxz","pgxcs-kftx1wx9",383192673,0.133,367024444,0.128,16168229,0.006,"PGX_AM_BS_SARC_MSKCC-PT99LMS","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0002384","connective tissue","{}","2020-09-10 17:47:19.689000",,,,,,"P66Y","geo:GPL3718",,,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,"PMID:20601955","Barretina J, Taylor BS et al. (2010): Subtype-specific genomic alterations define new targets...",,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b07","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldcs","pgxind-kftx7oi8","pgxcs-kftx21z8",990912319,0.345,647290873,0.225,343621446,0.12,"PGX_AM_BS_USARC_MSK_2020-P_0000271_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.210000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b0d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldd2","pgxind-kftx7oil","pgxcs-kftx2240",1835690915,0.639,713051364,0.248,1122639551,0.39,"PGX_AM_BS_USARC_MSK_2020-P_0000576_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.218000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b0e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldd4","pgxind-kftx7oin","pgxcs-kftx224i",1639024541,0.57,807986700,0.281,831037841,0.289,"PGX_AM_BS_USARC_MSK_2020-P_0000711_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.220000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b11","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","High-Grade Endometrial Stromal Sarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C8973","Endometrioid Stromal Sarcoma","icdom-89303","Endometrial stromal sarcoma, NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldd9","pgxind-kftx7oit","pgxcs-kftx226v",255421582,0.089,165741335,0.058,89680247,0.031,"PGX_AM_BS_USARC_MSK_2020-P_0001164_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium",,"2020-09-10 17:47:20.224000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,"NCITgrade-C14158","High Grade",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b13","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddc","pgxind-kftx7oix","pgxcs-kftx227u",2219447370,0.772,1171196058,0.407,1048251312,0.365,"PGX_AM_BS_USARC_MSK_2020-P_0001439_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.226000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b15","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddf","pgxind-kftx7oj1","pgxcs-kftx228t",1109989470,0.386,888138005,0.309,221851465,0.077,"PGX_AM_BS_USARC_MSK_2020-P_0001513_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.229000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b19","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddm","pgxind-kftx7oj9","pgxcs-kftx22ar",1971605805,0.686,861247457,0.3,1110358348,0.386,"PGX_AM_BS_USARC_MSK_2020-P_0001572_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.235000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b1f","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlddv","pgxind-kftx7ojm","pgxcs-kftx22dn",1875049386,0.652,1170841945,0.407,704207441,0.245,"PGX_AM_BS_USARC_MSK_2020-P_0001781_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.244000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b24","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlde3","pgxind-kftx7ojw","pgxcs-kftx22g2",1559064860,0.542,848055290,0.295,711009570,0.247,"PGX_AM_BS_USARC_MSK_2020-P_0001989_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.251000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b25","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvlde5","pgxind-kftx7ojy","pgxcs-kftx22gk",1277349756,0.444,826218832,0.287,451130924,0.157,"PGX_AM_BS_USARC_MSK_2020-P_0002100_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.252000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b28","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvlde9","pgxind-kftx7ok4","pgxcs-kftx22hz",1273894921,0.443,647566473,0.225,626328448,0.218,"PGX_AM_BS_USARC_MSK_2020-P_0002256_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.257000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b2d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldeh","pgxind-kftx7okf","pgxcs-kftx22ke",1996932370,0.695,1454273325,0.506,542659045,0.189,"PGX_AM_BS_USARC_MSK_2020-P_0002513_T02_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.264000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b30","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvldem","pgxind-kftx7okk","pgxcs-kftx22lu",1522280977,0.529,795447995,0.277,726832982,0.253,"PGX_AM_BS_USARC_MSK_2020-P_0002812_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.268000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b32","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldep","pgxind-kftx7okp","pgxcs-kftx22mt",2052767870,0.714,1021740416,0.355,1031027454,0.359,"PGX_AM_BS_USARC_MSK_2020-P_0002885_T01_IM3","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.271000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b36","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvldew","pgxind-kftx7okx","pgxcs-kftx22oq",882935091,0.307,541956831,0.189,340978260,0.119,"PGX_AM_BS_USARC_MSK_2020-P_0003138_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.277000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b3a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldf2","pgxind-kftx7ol5","pgxcs-kftx22qn",2198803409,0.765,1087056751,0.378,1111746658,0.387,"PGX_AM_BS_USARC_MSK_2020-P_0003806_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.283000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b40","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfc","pgxind-kftx7olg","pgxcs-kftx22tk",1216049407,0.423,551432220,0.192,664617187,0.231,"PGX_AM_BS_USARC_MSK_2020-P_0004269_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.292000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b46","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfm","pgxind-kftx7ols","pgxcs-kftx22wh",1086440479,0.378,769962873,0.268,316477606,0.11,"PGX_AM_BS_USARC_MSK_2020-P_0004804_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.301000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b4a","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfs","pgxind-kftx7om0","pgxcs-kftx22yf",1999651700,0.696,1022845434,0.356,976806266,0.34,"PGX_AM_BS_USARC_MSK_2020-P_0005149_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.306000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b4c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfv","pgxind-kftx7om4","pgxcs-kftx22ze",1465977964,0.51,749376821,0.261,716601143,0.249,"PGX_AM_BS_USARC_MSK_2020-P_0005331_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.309000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b4d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldfx","pgxind-kftx7om6","pgxcs-kftx22zv",661862463,0.23,306898253,0.107,354964210,0.123,"PGX_AM_BS_USARC_MSK_2020-P_0005582_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.311000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b50","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Adenosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6336","Uterine Corpus Adenosarcoma","icdom-89333","Adenosarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvldg2","pgxind-kftx7omd","pgxcs-kftx231c",1064063448,0.37,302684730,0.105,761378718,0.265,"PGX_AM_BS_USARC_MSK_2020-P_0007516_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.315000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b54","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldg9","pgxind-kftx7oml","pgxcs-kftx233a",2292727719,0.797,799472301,0.278,1493255418,0.519,"PGX_AM_BS_USARC_MSK_2020-P_0009314_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.321000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b57","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvldge","pgxind-kftx7omr","pgxcs-kftx234r",1220192959,0.424,875972004,0.305,344220955,0.12,"PGX_AM_BS_USARC_MSK_2020-P_0012390_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.326000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b58","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgf","pgxind-kftx7omt","pgxcs-kftx2358",2002574248,0.697,1224084105,0.426,778490143,0.271,"PGX_AM_BS_USARC_MSK_2020-P_0012473_T02_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.327000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b59","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgh","pgxind-kftx7omv","pgxcs-kftx235r",1529333291,0.532,704343806,0.245,824989485,0.287,"PGX_AM_BS_USARC_MSK_2020-P_0013445_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.329000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b5b","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgk","pgxind-kftx7omz","pgxcs-kftx236q",1415684135,0.492,1087439632,0.378,328244503,0.114,"PGX_AM_BS_USARC_MSK_2020-P_0013724_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.331000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b5c","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgm","pgxind-kftx7on1","pgxcs-kftx2378",1400568682,0.487,476898149,0.166,923670533,0.321,"PGX_AM_BS_USARC_MSK_2020-P_0013980_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.333000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b5d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgo","pgxind-kftx7on3","pgxcs-kftx237p",1929358679,0.671,1060764012,0.369,868594667,0.302,"PGX_AM_BS_USARC_MSK_2020-P_0014134_T01_IM5","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.334000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b5e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgp","pgxind-kftx7on5","pgxcs-kftx2387",788531806,0.274,601314828,0.209,187216978,0.065,"PGX_AM_BS_USARC_MSK_2020-P_0014679_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.336000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b61","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Undifferentiated Uterine Sarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C8972","Uterine Corpus Undifferentiated Sarcoma","icdom-88053","Undifferentiated sarcoma ","icdot-C54.9","Corpus uteri","pgxbs-kftvldgu","pgxind-kftx7onb","pgxcs-kftx239o",2457582799,0.855,1626180341,0.566,831402458,0.289,"PGX_AM_BS_USARC_MSK_2020-P_0015013_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.340000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b62","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldgw","pgxind-kftx7ond","pgxcs-kftx23c7",1432085823,0.498,891546929,0.31,540538894,0.188,"PGX_AM_BS_USARC_MSK_2020-P_0015053_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.342000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b63","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Sarcoma, Other","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6339","Uterine Corpus Sarcoma","icdom-88003","Sarcoma,NOS ","icdot-C54.9","Corpus uteri","pgxbs-kftvldgx","pgxind-kftx7onf","pgxcs-kftx23cq",1707734252,0.594,955536645,0.332,752197607,0.262,"PGX_AM_BS_USARC_MSK_2020-P_0015124_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0009853","body of uterus","{}","2020-09-10 17:47:20.343000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b65","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldh1","pgxind-kftx7onj","pgxcs-kftx23dq",2080228242,0.724,1056465704,0.367,1023762538,0.356,"PGX_AM_BS_USARC_MSK_2020-P_0015609_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.346000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b69","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldh7","pgxind-kftx7ons","pgxcs-kftx23fq",2117167530,0.736,1093405738,0.38,1023761792,0.356,"PGX_AM_BS_USARC_MSK_2020-P_0017242_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.352000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b6d","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C6340","Uterine Corpus Leiomyosarcoma","icdom-88903","Leiomyosarcoma,NOS ","icdot-C54.1","Endometrium","pgxbs-kftvldhe","pgxind-kftx7oo0","pgxcs-kftx23hn",1708139122,0.594,1211912926,0.422,496226196,0.173,"PGX_AM_BS_USARC_MSK_2020-P_0017998_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.358000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,"pgxcohort-carriocordo2021heterogeneity","Carrio-Cordo and Baudis - Genomic Heterogeneity in Cancer Types (2021)",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"5f5a36886b8c1d6d377c5b6e","pgxcohort-2021progenetix","Version at Progenetix Update 2021","DUO:0000004","no restriction","Uterine Epithelioid Leiomyosarcoma","cBP-USARC_MSK_2020",,"pgxfus-0002","no followup status","NCIT:C40174","Uterine Corpus Epithelioid Leiomyosarcoma","icdom-88913","Epithelioid leiomyosarcoma ","icdot-C54.1","Endometrium","pgxbs-kftvldhf","pgxind-kftx7oo2","pgxcs-kftx23i5",1770331476,0.616,1034171659,0.36,736159817,0.256,"PGX_AM_BS_USARC_MSK_2020-P_0018223_T01_IM6","{}",-74.01,40.71,"Point","USA","New York City","United States of America","New York City, United States of America",40.71,-74.01,"city","Feature","EFO:0009656","neoplastic sample","UBERON:0001295","endometrium","{}","2020-09-10 17:47:20.359000",,,,,,"P60Y","PMID:32299819","Hensley ML, Chavan SS et al. (2020): Genomic Landscape of Uterine Sarcomas Defined...",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,